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Recombination is fundamental to genome maintenance and contributes to 
diversity in all Domains of life by generating novel sequences from the breaking and 
joining of DNA.  RecA is central to one of the best studied mechanisms of 
recombination, but RecA-independent pathways also have implications for genetic 
engineering, evolution, and DNA replication.  Here, I harness two forms of RecA-
independent recombination for engineering of Legionella pneumophila, while also 
probing replication and repair machinery. Specifically, I make unmarked deletions in L. 
pneumophila using the Flp site-specific recombinase while also examining single-
stranded nucleases and mismatch repair.  I also describe a distinct form of recombination 
that does not require expression of recombinase genes.  Oligonucleotides (oligos) 
generate mutations on the L. pneumophila chromosome by a mechanism that requires 
homologous DNA, but not RecA, RadA or any known phage recombinase.  Instead, 
DNA replication likely contributes, since oligo-induced mutagenesis required ≥ 21 
nucleotides of homology, was strand-dependent, and was most efficient in exponential 
phase.  Mutagenesis appeared to be distinct from previously described mechanisms of 
oligo recombination, as it did not require canonical 5‘ phosphate or 3‘ hydroxyl groups, 
but did require the primosomal protein PriA and DNA Pol I.  After electroporation, oligos 
stimulated excision of 2.1 kb of chromosomal DNA or insertion of 18 bp, and can be 
exploited to generate chromosomal deletions and to insert an epitope into a chromosomal 
coding sequence.  The frequency of mutagenesis also increased substantially when either 
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its RecJ and ExoVII nucleases were inactivated or the oligos were modified by nuclease-
resistant bases.   
L. pneumophila is a diverse species and has a surprising number of Eukaryotic-
like genes.  As the organism is naturally transformable, it is thought that the species 
acquired some of these genes by horizontal gene transfer.  Since divergent Eukaryotic 
sequences may be inefficiently incorporated into the genome by RecA-mediated 
recombination due to the extensive homology required, oligo-induced mutagenesis may 
have evolutionary implications as a mechanism to incorporate divergent DNA sequences 
with only short regions of homology.  Since oligo mutagenesis appears to be conserved, it 










Thesis outline and context 
My thesis examines RecA-independent recombination in Legionella pneumophila, 
specifically its application for genetic engineering as well as testing the contribution of 
recombination, replication, and repair machinery to elucidate underlying mechanisms.   
Chapter Two focuses on harnessing phage recombination in Escherichia coli coupled 
with site-specific Flp recombination in L. pneumophila to construct unmarked deletions, 
while examining the role of single-stranded exonucleases in the process.  Chapter Three 
analyzes a phenomenon I name oligo mutagenesis, a form of RecA-independent 
recombination that relies on short homologous sequences.  I show that oligo mutagenesis 
can not only be applied to engineer L. pneumophila, but is likely conserved among 
Bacteria and could be harnessed for the study of organisms currently lacking genetic 
tools. 
My work is among of the first to approach basic recombination and repair 
mechanisms in the intracellular pathogen L. pneumophila.  Because most studies 
involving basic mechanisms involve model organisms, in the introduction I will highlight 
why L. pneumophila is of particular interest.  Besides its often under-appreciated clinical 
importance and resultant impact on morbidity and mortality worldwide, the unique 
evolutionary history and lifestyle of the organism provide an opportunity to consider how 
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basic mechanisms of recombination can impact an organism‘s ecological niche and 
ability to parasitize its host.  While I do not directly test evolutionary hypotheses, I have 
designed some experiments to indirectly examine these ideas and also consider it an 
important framework for evaluating the impact of my research.   
A related consideration is the importance of examining basic mechanisms in non-
model organisms and to emphasize that similarities do not necessarily indicate that the 
process will be the same.  Acknowledging the limitations of extrapolating from model 
organisms is important, not only for the interpretation of my results, but for all of 
biology.  Much research has focused on the convenient experimental models of 
Escherichia, Bacillus, Drosophila, Danio, Mus, Lambda, SV40, et cetera, but many of 
the assumptions drawn from these results have not been tested in other genera.  Untested 
assumptions not only create bias in the literature, but can confound interpretations of 
specific data.  For example, when considering error-prone replication as an explanation 
for mutation frequency, it becomes difficult to draw on data from E. coli, as L. 
pneumophila appears to have divergent SOS response machinery.   While lacking LexA 
and SulA, L. pneumophilia appears to have two copies of Pol V (Table 1.1).  My data 
emphasize the risks inherent in bias toward previously published models by showing that, 
contrary to described mechanisms of oligo recombination in all three Domains of life, the 
process of oligo mutagenesis I describe depends on a distinct set of replication 
machinery, despite a superficial similarity.   
A portion of this chapter was published by Swanson and Bryan, in ―Legionella 
pneumophila, a Pathogen of Amoebae and Macrophages‖ in Phagocyte-Pathogen 
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Interactions: Macrophages and the Host Response to Infection by ASM Press (2009).  
Used with permission. 
 
An environmental pathogen 
Legionella pneumophila is a Gram-negative bacterium that has evolved strategies 
to parasitize professional phagocytes.  Most Legionella species, including L. 
pneumophila, are aquatic microbes; other species thrive in soil.  There the microbe 
naturally infects amoeba and protozoa.  But, when given the opportunity, L. pneumophila 
can infect human alveolar macrophages and cause the severe pneumonia Legionnaires‘ 
disease.   
Aerosols of contaminated water or soil transmit the disease agent to humans.  
Because the bacterium is ubiquitous in nature, water sources of all kinds can act as 
vehicles for transmission.  The point source is most often identified in epidemic 
outbreaks, where exposures can be evaluated using case-control studies.  Epidemiologists 
usually implicate man-made equipment, including water-cooling towers, whirlpools, and 
showers.  The origin of sporadic disease is more difficult to assess, as is the contribution 
of natural water sources to disease burden.   
A significant portion of Legionnaires‘ disease occurs in the health care setting, 
and these cases account for the highest fatality rates.  Contributing factors include the 
vulnerability of the patient population and the institutional setting, where virulent isolates 
can be efficiently transmitted to the large number of susceptible individuals housed there.  
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Significantly, during the 35 years the Centers for Disease Control has tracked the disease, 
there have been no reports of human-to-human transmission.  Evidently, factors that 
promote spread in fresh water microbial communities are not sufficient for L. 
pneumophila to pass safely and efficiently from the lungs of one susceptible human to 
another.  It is also possible that amoebae are required for the biogenesis of infectious 
particles that can withstand transmission in aerosols. 
 
Burden of disease 
Considered along with Chlamydia pneumoniae and Mycoplasma pneumoniae to 
be an ―atypical‖ etiological agent of pneumonia, L. pneumophila actually causes 
considerable morbidity and mortality (Edelstein and Cianciotto, 2005).  Legionellosis is a 
nationally notifiable disease, with 3,181 cases reported to the CDC in 2008 (Hall-Baker, 
et al., 2010).  The disease is widely under-reported and, although estimates vary widely, 
between 18,000 and 88,000 cases are thought to occur annually in the United States, or 2-
15% of community acquired pneumonias (Foy, et al., 1979, Mulazimoglu and Yu, 2001).  
Of these, between 8,000 and 18,000 require hospitalization (Marston, et al., 1997).  
Mainly afflicting immunocompromised individuals, the disease carries a case fatality rate 
of 5-46%, the highest of the atypical pneumonias (Mulazimoglu and Yu, 2001), with the 
outcome primarily dependent on the immunological state of the person and the choice of 
therapy (Benin, et al., 2002).  While interpreting the trends in overall incidence of 
Legionnaires‘ disease is complicated by increased diagnosis, it is clear that fatality rates 
are decreasing—a pattern likely attributable to more convenient diagnostic tools and 
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rising use of empiric antimicrobial therapy with activity against L. pneumophila.  L. 
pneumophila is also associated with Pontiac Fever, a milder, febrile, non-pneumonic 
illness whose etiology is not clear.  Since Pontiac Fever does not appear to require viable 
bacteria, it is beyond the scope of this thesis. 
 
Outbreaks 
Although epidemics of Legionnaires‘ disease comprise only 25-35% of cases, 
they are a rich source of information about the illness (Edelstein and Cianciotto, 2005).  
The namesake 1976 outbreak, which occurred at a Philadelphia convention of American 
Legion members, highlights both the epidemic potential of the institutional setting and 
the predilection of disease in susceptible individuals.  The convention was attended by 
approximately 4,000 members of the Pennsylvania State American Legion, a group 
predisposed primarily by age, but also by preexisting chronic lung disease and tobacco 
use.  After exposure to contaminated aerosols from the convention hotel‘s air 
conditioning system, 149 Legionnaires and 33 non-Legionnaires were eventually 
diagnosed with the disease, and 29 died (Edelstein, 2008).  Epidemic Legionnaires‘ 
disease continues to be a problem.  For example, in October 2005, 127 residents of a 
home for the elderly in Toronto, Ontario became ill with Legionnaires‘ disease, and 20 of 
them died.  The source of the outbreak was eventually determined to be a cooling tower 
on the roof that spread contaminated aerosols into the building‘s air handling system.  
Typically, the attack rate in epidemics is ~ 5%, and those who become ill have pre-
existing damage to their airways or weakened cell-mediated immune systems.  Healthy 
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individuals can clear the infection:  Once activated by interferon-human macrophages 
can restrict L. pneumophila replication by limiting the microbe‘s iron supply (Byrd and 
Horwitz, 1989, Sporri, et al., 2006, Yoshizawa, et al., 2005).   
 
Clinical features, diagnosis and treatment 
The clinical presentation of Legionnaires‘ disease can range from the average 
febrile pneumococcal-appearing pneumonia to symptoms less commonly associated with 
pneumonia, such as abdominal pain, diarrhea, memory loss, severe headache, and low 
serum sodium (Edelstein and Cianciotto, 2005).  Cough may be unimpressive, and can 
range from non-productive to bloody.  Chest radiography yields pathological changes, 
frequently confluent lobular and bilateral, but nothing diagnostic for Legionnaires‘ 
disease.  Due to the inconsistent nature of symptoms, diagnostic formulas with acceptable 
positive predictive values have been elusive.  Nevertheless, experienced clinicians with 
an appropriate index of suspicion are good judges of disease, and, by applying an 
appropriate diagnostic test, can identify the illness with reasonable frequency 
(Mulazimoglu and Yu, 2001).   
Lung pathology is usually consistent with acute brochiolitis and alveolitis.  
Histology of human, rodent, and primate animal models generally reveals fibrinopurulent 
infiltrates, with macrophages usually comprising a significant portion of the total 
leukocytes (Baskerville, et al., 1983, Winn and Myerowitz, 1981).  Neutrophils make up 
most of the remainder of the infiltrate.  Erythrocytes are also commonly present, 
indicative of vascular damage that can accompany the disease.  Lysed white blood cells 
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are also evident.  Alveolar macrophages appear to phagocytose L. pneumophila to a 
greater extent than neutrophils.  Phagosomes that contain multiple intact bacteria are 
often observed, suggestive of intracellular replication (Baskerville, et al., 1983, Winn and 
Myerowitz, 1981).  The in situ observations of macrophage infection, intracellular 
replication, and phagocyte lysis are mirrored by current in vitro experimental models, 
including interactions with primary macrophages derived from the bone marrow of A/J 
mice (Baskerville, et al., 1983, Byrne and Swanson, 1998). 
Legionella retains Gram‘s stain poorly, which can lead to false negative sputum 
smears and pathology sections.  Culture is still the gold standard of diagnosis, but the 
advent of the urine antigen test has made Legionnaires‘ disease possibly the easiest 
respiratory illness to diagnose with speed and certainty (Edelstein and Cianciotto, 2005).  
The urine antigen test‘s specificity approaches 100%, but only detects L. pneumophila 
serogroup 1, leading to under-diagnosis of other species and serogroups (Benin, et al., 
2002).  Especially in areas reporting a greater prevalence of non-serogroup 1 isolates, a 
negative urine antigen test should not absolutely rule out Legionnaire‘s Disease.  This is 
particularly true in Australia and New Zealand, where serogroup 1 isolates only comprise 
45% of cases (Yu, et al., 2002).  Alternatives to culture and the antigen test include direct 
fluorescent antibody staining, serology, and polymerase chain reaction assays (Benin, et 
al., 2002, Diederen, et al., 2008, Edelstein and Cianciotto, 2005, Hayden, et al., 2001, 
Templeton, et al., 2003). 
Rapid therapeutic intervention is critical for resolution of disease with a low 
mortality rate, and the appropriate chemotherapeutic agent is necessary to achieve 
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clearance (Edelstein and Cianciotto, 2005).  Due to its insensitivity to beta-lactam 
antibiotics, Legionella has contributed to a shift in empiric antimicrobial therapy for 
pneumonia.  Rather than administer narrow range anti-pneumococcal agents, clinicians 
now rely first on drugs that cover a broad range of microorganisms.  Macrolides and 
quinolones are the most common classes of antimicrobials with good activity against 
Legionella.  Acquired resistance to antimicrobials has not been an issue, likely due to 
lack of human-to-human transmission and the acute nature of the illness.  The 
susceptibility pattern of Legionella highlights the intracellular nature of the pathogen:  
The effective and commonly used drug gentamycin is efficacious in vitro and useful in 
the research laboratory, but its inability to penetrate host cells limits its clinical value. 
 
Serogroup epidemiology 
The genus of Legionella is quite diverse, comprising 50 distinct species.  
Nevertheless, the species L. pneumophila contributes to over 90% of the human disease 
burden in the United States and Europe, with smaller percentages contributed by L. 
micdadei, L. longbeachae, and several others (Benin, et al., 2002).  Within L. 
pneumophila, there are at least 15 defined serogroups.  Even though serogroup 1 strains 
account for less than 30% of environmental isolates, they cause the majority of 
Legionnaires‘ disease (Doleans, et al., 2004).  While all Legionella species are adept at 
infecting environmental phagocytes, amoebae and protozoa, it is interesting to consider 
what attributes equip serogroup 1 isolates to more readily infect the alveolar macrophage 
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and how they acquired these determinants.  
 
A DNA-rich lifestyle; a dynamic genome riddled with eukaryotic DNA 
L. pneumophila is equipped to internalize foreign DNA and to recombine the 
genetic material onto its chromosome (Sexton and Vogel, 2004, Stone and Kwaik, 1999).  
Unlike the best studied naturally transformable Gram negative organisms, N. 
gonorrhoeae and H. influenzae, the process does not depend on a specific uptake 
sequence, and the organism appears to indiscriminately take up naked DNA from the 
environment (Johnsborg, et al., 2007, Sexton and Vogel, 2004, Stone and Kwaik, 1999, 
Thomas and Nielsen, 2005).  In nature, the microbe likely persists for extended periods 
within multispecies biofilms, potentially a rich source of both self and diverse foreign 
DNA (Declerck, 2009, Whitchurch, et al., 2002).  When phagocytic amoebae or protozoa 
graze on biofilms, the ingested L. pneumophila can establish a replication niche within a 
vacuole, leading to eventual nutrient exhaustion and host cell lysis—yet another source of 
exposure of Legionella to foreign DNA.  Even during infection of a host, transfer of 
DNA could be envisioned.  A Type IV pilus has been shown to be involved in adherence 
to mammalian and protozoan cells (Stone and Abu Kwaik, 1998), while also being 
essential for natural transformation (Stone and Kwaik, 1999).  Other Type IV secretion 
systems could further contribute to the exposure of the bacterium to host DNA.   
To establish a replication vacuole within a professional phagocyte, L. 
pneumophila relies on a specialized secretion system that can deliver bacterial proteins 
directly to the host cytosol (Vogel, et al., 1998).  Derived from machinery that transfers 
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plasmids during conjugation with another bacterium, Type IV secretion systems can 
transport DNA or protein across both the bacterial and the phagosomal membranes 
(Vincent, et al., 2006).  Such adapted conjugation systems are utilized by a variety of 
microbes, including the plant pathogen Agrobacterium tumefaciens and the mammalian 
pathogens Helicobacter pylori, Bordetella pertussis, Bartonella henselae, and Coxiella 
burnetii.  In L. pneumophila, however, the secretion system also results in host membrane 
permeability, including accessibility of the nucleus to DNA tracking dyes (Whitfield, et 
al., 2009), and could result in further association between host and bacterial DNA even if 
the apparatus is not directly involved in DNA transfer.   
The DNA-rich life of this pathogen could contribute to the observed species 
diversity.  Although the ~3.5 Mb L. pneumophila chromosome is predicted to encode 
~3000 proteins, only ~ 2400 of these are common to four sequenced L. pneumophila 
(Cazalet, et al., 2004).  Moreover, there is an extraordinarily high frequency of eukaryotic 
motifs embedded in the L. pneumophila genome:  Nearly 3.5% of the predicted proteins 
have eukaryotic motifs (Bruggemann, et al., 2006, Cazalet, et al., 2004, de Felipe, et al., 
2005, Gomez-Valero, et al., 2009, Lurie-Weinberger, et al., 2010).  These include 
ankyrin domains, which mediate protein-protein interactions; F-box and U-box domains, 
a feature of components of the ubiquitination pathway; a homologue of sphingosine-1-
phosphate lyase, an enzyme that modulates whether cells induce autophagy or cell death; 
two apyrases, secreted proteins that degrade extracellular nucleotide di- or triphosphates; 
and three serine-threonine kinases, signal transduction proteins.  In a PCR screen of 77 
Legionella isolates, most of the eukaryotic-like genes were conserved, suggesting 
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importance to the lifestyle of the organism (Lurie-Weinberger, et al., 2010).  Yet, a 
handful of unique eukaryotic-like genes were found even amongst strains within the same 
serogroup—suggesting recent and continuing gene acquisition (Lurie-Weinberger, et al., 
2010).  Presumably, the organism‘s environmental hosts supply ample eukaryotic DNA 
which L. pneumophila efficiently incorporates, ultimately retaining those DNA sequences 
that increase fitness and losing those that decrease it.  It is tempting to speculate that 
eukaryotic motifs that are broadly conserved in the species equip L. pneumophila to 
modulate the biology of its host phagocyte.  Supporting this notion is the recent 
observation that the eukaryotic-like F-box containing Type IV secretion effector AnkB is 
necessary for intracellular bacterial growth and hijacks the polyubiquitination machinery 
of the host (Price, et al., 2009).  One of the many outstanding questions, however, is how 
Legionella incorporates these divergent sequences into its chromosome and whether 
previously described mechanisms can account for the observed diversity. 
 
Recombination and the exchange of genetic material 
L. pneumophila can take up free DNA from the environment and incorporate it 
into its genome, an ability restricted to approximately 1% of known bacterial species 
(Thomas and Nielsen, 2005).  Independently of the ability to take up naked DNA, nearly 
all organisms have the potential for recombination, or the breakage and joining of DNA 
molecules that can result in exchange of genetic information.  Although critical for repair 
processes and maintenance of a stable genome, recombination also contributes to 
evolution.  Genetic drift, or small changes in DNA sequence, is typically due to the error 
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rate of DNA polymerases, whereas genetic shift, or bigger evolutionary jumps, often 
requires mechanisms of recombination to rearrange existing sequences, incorporate new 
ones, or remove sequences that decrease fitness (Thomas and Nielsen, 2005).  The 
simplest example is the rearrangement of parental DNA to form a single DNA molecule 
that makes every human unique; aberrant recombination events can lead to cancer or 
inherited diseases (Chen, et al., 2010).  Understanding the mechanisms of recombination 
is fundamental to understanding biology from the basic microbe to the human.  While 
some forms of recombination, such as non-homologous end joining, do not require 
specific DNA sequences, I focus here on common forms of recombination that require 
homologous DNA molecules or specific recognition sequences. 
 
RecA-dependent recombination 
Perhaps the most ubiquitous and well-studied type of recombination relies on 
RecA/RadA/Rad51-like proteins and related machinery that execute many aspects of 
recombination, repair, and replication, as well as contribute to horizontal gene transfer 
and the experimentalists‘ genetic engineering tool kit (Kuzminov, 1999, Lusetti and Cox, 
2002, Thomas and Nielsen, 2005, Volodin, et al., 2005).  These well-described 
recombination systems support the exchange between two DNA molecules that have 
large regions of homology to mediate efficient cross over or gene conversion events 
(Kuzminov, 1999, Lovett, et al., 2002, Thomas and Nielsen, 2005).  The RecA protein 
forms a nucleoprotein filament on single-stranded DNA (ssDNA), which facilitates 
strand invasion and annealing to complementary double-stranded target DNA (dsDNA), 
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followed by strand transfer, branch migration, and resolution (Snyder and Champness, 
2007b, Volodin, et al., 2005).  The process is generally considered to proceed in a 
RecBCD- or RecFOR-dependent manner (Lovett, et al., 2002).  RecBCD has nuclease 
and helicase activity, with a particular affinity to double-stranded breaks, where it digests 
one strand, thereby allowing RecA filament formation and strand invasion (Lovett, et al., 
2002).  On the other hand, RecFOR is thought to play a dominant role in assisting the 
loading of RecA in single-stranded gaps that have been stabilized by Single-Stranded 
Binding Protein and have had the RecJ single-stranded nuclease digest the exposed 5‘ 
terminus (Corrette-Bennett and Lovett, 1995, Han, et al., 2006, Lovett, et al., 2002).  
Both RecBCD and RecFOR pathways lead to branched intermediates called Holliday 
junctions, which can migrate to increase pairing, followed by cleavage and ligation to 
resolve the complex 4-stranded intermediate (Lovett, et al., 2002, Snyder and 
Champness, 2007b).  It is noteworthy that L. pneumophilia does not appear to have 
RecBCD (Table 1.1), and thus the E. coli literature would suggest that most of its RecA-
dependent recombination proceeds by the RecFOR pathway.  Interestingly, when using 
standard laboratory conditions for natural transformation, formation of recombinant 
colonies is dependent on RecA but is not significantly decreased in the absence of RecF 
or RecJ (data not shown).  While more careful examination of the frequencies of 
recombination in these different genetic backgrounds is needed, these data suggest that 






Bacteriophages often utilize host machinery for necessary recombination 
functions, but they can also encode their own enzymes to facilitate the process.  While a 
discussion of the many decades of phage biology is beyond the scope of this thesis, 
understanding the Red genes of phage λ (and related genes of the Rac phage) is important 
for many of the underlying assumptions of oligo mutagenesis (Chapter 3), as well as the 
justification for studying it in the first place.  The Red system is comprised of β, γ, and 
exo genes, producing the Beta, Gam, and Exo proteins (Datsenko and Wanner, 2000).  
Gam protects linear double-stranded DNA from host RecBCD nucleolytic degradation, 
and exo encodes an exonuclease activity that degrades the 5‘ end of a double-stranded 
molecule, leaving a 3‘ single-stranded overhang (Snyder and Champness, 2007b).  Beta 
then binds the exposed 3‘ single-stranded tail, protecting it from degradation and 
facilitating strand annealing to a homologous DNA molecule (Yu, et al., 2000).  Though 
RecA is important for some λ recombination that occurs by strand invasion, the process 
can also occur in a RecA-independent fashion—particularly when utilizing short regions 
of homology (Poteete and Fenton, 1993, Poteete and Fenton, 2000, Stahl, et al., 1997, 
Yu, et al., 2000).   
The most commonly accepted model of RecA-independent λ Red recombination 
is the ‗annealing/integration‘ model (Fig. 1.1), which dictates that Beta binds single-
stranded DNA in the cell and, in lieu of strand invasion, facilitates its annealing to 
exposed single-stranded DNA at the replication fork (Costantino and Court, 2003, Ellis, 
et al., 2001, Huen, et al., 2006).  If the substrate is ssDNA, only Beta is required, whereas 
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a dsDNA substrate requires Exo.  If the host strain is RecBCD
+
, Gam is required for 
optimal efficiency (Datta, et al., 2008, Ellis, et al., 2001).  In the case of ssDNA 
oligonucleotides (oligos), complementary oligos undergo recombination with differing 
frequencies.  Recombination with oligos annealing to the lagging strand in the replication 
fork is thought to occur more readily due to greater expanse of chromosomal ssDNA 
(Ellis, et al., 2001).  Evidence suggests that following annealing, DNA polymerase 
extends the oligo during its ligation into the nascent strand and physical incorporation 
into the target DNA molecule (Grogan and Stengel, 2008, Huen, et al., 2006). 
The striking ability of λ Red to catalyze efficient recombination with lengths of 
homology as few as 36 nucleotides is particularly convenient for genetic engineering.  In 
particular, the Red genes can be expressed from a prophage or plasmid, and regions of 
homology can be encoded by synthetic oligonucleotides at low cost (Datsenko and 
Wanner, 2000, Datta, et al., 2008, Thomason, et al., 2007a, Yu, et al., 2000).  This 
process of recombination using short homologies and phage recombinases is referred to 
as ‗recombineering.‘ Advantages over traditional restriction enzyme based cloning and 
allelic exchange are increased efficiency and precision without having to use existing 
restriction sites or incorporate new ones.  The drawbacks of recombineering are two-fold, 
however.  The system is only functional in E. coli and closely related organisms, and it 
requires exogenous expression of the recombinase genes, which then usually need to be 
removed from the host strain.  The first drawback has led to a search for phage 
recombinase genes in other organisms that may support a similar application, with the 
most notable success being in the Mycobacteria field (Datta, et al., 2008, van Kessel and 
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Hatfull, 2007).  In fact, a pair of Rac prophage-like recombinase genes has been isolated 
from a putative defective prophage region of a strain of L. pneumophila that undergoes 
phase variation of virulence traits due to a 30 kb episome that undergoes RecA-
independent integration and excision (Datta, et al., 2008, Luneberg, et al., 2001).  Datta 
et al. (2008) showed these L. pneumophila phage recombinases can function similar to 
Beta and Exo when expressed in an optimal system in E. coli.  We have also cloned these 
genes into a Legionella shuttle vector and demonstrated recombination activity when 
expressed in E. coli (Fig. 1.2).  However, I did not observe activity in L. pneumophila in 
any of the conditions tested (data not shown).  To circumvent the obstacle of discovering 
phage recombinase genes, Chapter 2 describes how existing tools in E. coli can facilitate 
engineering of L. pneumophila, while Chapter 3 describes a recombineering-like activity 
that does not require expression of exogenous phage genes.  Incidentally, this phage-
independent activity was initially observed as a low-level background frequency of 
recombination in strains containing ‗no insert‘ control vectors when searching for 
conditions optimal for expression of the Legionella phage genes. 
 
Site-specific recombination 
Yet another broad category of recombination is site-specific.  Rather than rely on 
general homologous sequences, this pathway relies on specific proteins to recognize 
specific target sequences and can result in integration, excision, inversions, or other 
genomic rearrangements.  Although notably absent from L. pneumophila (Table 1.1), the 
broadly conserved XerCD recombinases facilitate resolution of multimers during DNA 
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replication in E. coli, integration of the cholera toxin phage in Vibrio cholerae, and loss 
of the 57-kb gonococcal
 
genetic island in Neisseria gonorrhoeae (Blakely, et al., 1993, 
Dominguez, et al., 2010, Huber and Waldor, 2002).  Site-specific recombination plays 
other roles in pathogenesis, such as regulation of the Type 1 fimbriae in uropathogenic E. 
coli (Bryan, et al., 2006, Klemm, 1986).  Perhaps two of the best known site-specific 
recombinases, however, are the Cre recombinase from bacteriophage P1 and the Flp 
recombinase of Saccharomyces cerevisiae, due to their utility for genetic engineering in a 
vast array of organisms (Schweizer, 2003).  flp was discovered on the 2-μm plasmid of S. 
cerevisiae, where it encodes a recombinase that recognizes two 48 bp FRT sites and 
catalyzes the interconversion of the plasmid between two isoforms (Schweizer, 2003, 
Senecoff, et al., 1985).  The minimal FRT site is only 34 bp and contains two inverted 
symmetry sequences flanking an 8 bp core (Fig. 1.3; Schweizer, 2003, Senecoff, et al., 
1985).  When two FRT sites flank a DNA sequence and are in the same orientation, Flp-
mediated recombination excises the intervening sequence; in contrast, if the FRT sites are 
inverted relative to each other, the entire sequence is inverted (Fig. 1.3; Schweizer, 2003).  
This versatility, combined with high activity in a large number of organisms, make the 
Flp/FRT system a useful genetic engineering tool, particularly for the deletion of 
antibiotic resistance cassettes.  In Chapter 2, we apply Flp for the engineering of L. 




Intersection of recombination, replication, and repair 
Central to all organisms is the ability to replicate their chromosome with high 
enough fidelity that essential genes do not suffer inactivating mutations.  While the 
processive replicative DNA polymerase of most organisms (DNA Pol III in E. coli) is 
highly accurate at synthesizing DNA from the template strand, it cannot on its own 
accord overcome the many obstacles to chromosome replication with minimal error.  
Nearly every round of replication is thought to be interrupted by chromosomal insults, 
including single-stranded nicks or gaps, double-stranded breaks, base dimers, 
chromosomal multimers, and other lesions (Kuzminov, 1999, Lusetti and Cox, 2002).  
Circumvention of these insults can involve site specific recombinases, RecA-mediated 
recombination, and many other replication and repair proteins.  While RecA can 
contribute to horizontal gene transfer and incorporation of transformed sequences, it role 
in replication is probably its most important function.   
One of the interactions between replication and recombination well illustrated by 
Rangarajan et al. (Fig 1.4; 2002) and more generally reviewed elsewhere (Kuzminov, 
1999, Lusetti and Cox, 2002) is the ability of replication to continue when the fork 
encounters UV-induced damage.  When the replication fork encounters a DNA lesion, 
synthesis is uncoupled, creating ssDNA and fork arrest.  RecFOR then facilitates the 
loading of RecA in this single-stranded gap, followed by a fork regression facilitated by 
RecG and synthesis by DNA Pol II.  Although DNA Pol II can synthesize up to ~ 1.6 kb, 
it is not sufficient for restarting and continuing normal replication.  Since DnaA can only 
initiate replication at the origin, the replication restart protein PriA is required, as it can 
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recognize the stalled structure that has been re-modeled by RecG and then load the 
primary replicative polymerase Pol III.  This complex process avoids having to employ 
one of the error-prone translesion polymerases to overcome the obstacle to replication 
and can also provide time for nucleotide excision repair to remove the lesion 
(Rangarajan, et al., 2002).   
Yet another repair pathway that is coupled with replication is methyl directed 
mismatch repair (MDMR).  MDMR recognizes slight DNA helix distortions including 
those involving mismatches, frameshifts, and incorporation of base analogs such as 2-
aminopurine that can occur during replication (Modrich, 1991, Snyder and Champness, 
2007a).   When the system is absent, cells accumulate a high number of mutations and are 
often referred to as having a ‗mutator‘ phenotype.   Key features of MDMR are the 
ability to differentiate between template and nascent strands during replication, recognize 
and excise mismatches, and fill in the resultant gap using the original template.  Initiating 
the MDMR pathway is recognition and binding of the helix distortion by a MutS dimer, 
followed by MutL and MutH binding (Modrich, 1991, Snyder and Champness, 2007a).  
MutH is the active nuclease that cleaves the newly synthesized error-containing strand, 
which it accomplishes by recognizing the methylation status of the strands (Modrich, 
1991, Snyder and Champness, 2007a).  During the normal life cycle of the cell, the Dam 
DNA methylase selectively methylates the adenine of GATC sequences; however, this 
process lags behind DNA replication such that newly synthesized dsDNA is hemi-
methylated (Barras and Marinus, 1989).  Following MutH cleavage, redundant single 
stranded exonucleases (ssExos) degrade the cleaved strand facilitated by helicase II 
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unwinding (Burdett, et al., 2001, Modrich, 1991, Viswanathan, et al., 2001).  DNA Pol 
III then fills in the gap (Modrich, 1991).  Three considerations relevant to this thesis are 
that MDMR is highly active at repairing base mismatches in E. coli, mismatches are not 
all recognized with the same efficiency, and only small (< 5 bp) lesions are recognized 
(Costantino and Court, 2003, Modrich, 1991, Swingle, et al., 2010b). 
When considering any individual component related to replication, homologous 
recombination, or repair processes, it is important to remember these elaborate 
interactions and how species differences can inform conclusions.  For example, RecA-
independent recombination often requires replication, even if only to expose ssDNA, 
since it lacks the strand invasion activity of RecA.  λ recombination and oligo 
mutagenesis both exhibit this requirement, yet differ in how they accomplish the 
mutagenic event.  Chapter 3 demonstrates that, unlike λ recombination, where DNA 
polymerase extends oligos like an Okazaki fragment, polymerase does not likely extend 
the oligo during oligo-induced mutagenesis; instead, it may slip/hop over the oligo and 
re-start downstream.  Both Chapter 2 and 3 demonstrate that compared to E. coli, L. 
pneumophila has fewer single-stranded nucleases and a less active mismatch repair 
system, observations consistent with an evolutionary history of utilizing a dynamic 




Table 1.1.    Abbreviated list of absent and duplicate proteins in Legionella.* 
 
 
Notable duplicate proteins in L. 
pneumophila.  
UmuC [lpg1232 and lpg1704] (E. coli)  






















*Abbreviated list of notable recombination, repair, or proteins of related function either 
absent or present in duplicate in L. pneumophila as assessed by searching the genome 
sequence of L. pneumophila Philadelphia (NC_002942) by psi-BLAST using the model 
organism indicated.  Not present defined as: no BLAST hits with expect values < 1 x 10-10, 
closest hit missing critical domain or components, or closest hit matches another well-defined 
protein. 
  
Notable proteins not present in L. 
pneumophila.  
RecBCD (E. coli)  
AddAB (Bacillus)  
MutS2 (Bacillus)  
Ku (Bacillus)  
RecET (Rac/E. coli)  
Bet, Exo (Lambda/E. coli)  
UvsX (T4/E. coli)  
SbcCD (E. coli)  
ExoI/SbcB (E. coli)  
ExoX (E. coli)  
PriB, PriC, DnaT (E. coli)  
Pol II (E. coli)  
LexA, SulA (E. coli)  
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Figure 1.1.  Strand annealing/integration model of λ Red recombination with an 
oligonucleotide as described in the text, where oligo is physically incorporated into  
the nascent strand.  Red line with black center represents an oligo with homology to a 
chromosomal sequence (red) and a foreign sequence (black).  Light blue ovals indicates β 
binding protein. Green Pac-Man indicates repair enzymes. Loop represents sequence as 
small as a single nucleotide or as long as several kilobases.  Model based primarily on 
(Costantino and Court, 2003, Ellis, et al., 2001, Grogan and Stengel, 2008, Huen, et al., 






































Figure 1.2.  Legionella phage recombinase genes orfBC mediate recombination with 
oligos in a DNA- and strand-dependent manner, as predicted by λ Red recombination, 
when expressed under ptac control in E. coli on a RSF1010-based shuttle plasmid.  
Oligos corresponding to RpoB encode a point mutation conferring rifampin resistance.  
Assay is analogous to the rifampin resistance assay described in more detail in Chapter 3.  
When tested in L. pneumophila, no conditions were observed where expression of 
recombinase genes resulted in frequencies above ‗no insert‘ controls, but a low frequency 
of DNA-dependent mutagenesis was observed that was independent of phage gene 
expression (data not shown, Chapter 3).  Data represent mean ± SEM of 3 independent 




















Figure 1.3.  Flp recombination.  A) 34 bp minimal FRT site.  Large arrows indicate 
inverted symmetry elements; box indicates asymmetric core; small arrows indicate Flp 
cleavage sites.  B) Orientation of FRT sites dictates fate of intervening DNA.  Adapted 











Figure 1.4. Model for replication restart involving RecFOR, PriA, pol II and pol III 
proteins.  Lesions in DNA cause uncoupling of DNA synthesis leading to regions of 
ssDNA.  These regions are subsequently coated by RecA, with the assistance of RecFOR 
proteins.  The arrested replication fork regresses so that the uncoupled lagging strand 
becomes a template for DNA synthesis by pol II.  After pol II dissociates from the 
template, RecG promotes fork regression in the opposite direction to RecA/RecFOR, and 
thereby facilitates lesion bypass without translesion replication.  PriA recognizes this 
structure and promotes loading of pol III holoenzyme to the nascent DNA, in order to 
reconstitute a processive replication fork capable of complete genome duplication.  





Efficient generation of unmarked deletions in Legionella pneumophila 
 
SUMMARY 
Unmarked gene deletions facilitate studies of Legionella pneumophila multi-
component processes, such as motility and exonuclease activity.  For this purpose, FRT-
flanked alleles constructed in Escherichia coli using λ-Red recombinase were transferred 
to L. pneumophila by natural transformation.  Resistance cassettes were then efficiently 
excised using the Flp site-specific recombinase encoded on a plasmid that is readily lost 
from the host strain.  This chapter is published in part by Bryan, Harada, and Swanson in 
Applied and Environmental Microbiology (2011).  Used with permission. 
 
INTRODUCTION 
Legionella pneumophila virulence strategies can be studied by exploiting its 
genome sequence, natural competence, and growth in artificial media (Molofsky and 
Swanson, 2004, Newton, et al., 2010).  However, research has been complicated by 
limited selectable markers and the microbe‘s functional redundancy, including numerous 
secretion substrates (Cianciotto, 2009, Hubber and Roy, 2010, Isberg, et al., 2009).  To 
facilitate construction of strains with multiple unmarked non-polar deletions, we coupled 
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phage-mediated recombination in Escherichia coli with Flp-mediated excision in L. 
pneumophila.  By exploiting a λ phage enzyme to mediate homologous recombination 
between DNA substrates with as few as 35 nucleotides of homology, so-called 
recombineering offers several advantages over restriction enzyme-based cloning, 
including increased efficiency and precision (Court, et al., 2002, Datsenko and Wanner, 
2000, Thomason, et al., 2007a, Thomason, et al., 2007b, Yu, et al., 2000).  The 
Saccharomyces cerevisiae Flp site-specific recombinase excises DNA flanked by directly 
repeated 34 bp FRT sites (Cox, 1983, Falco, et al., 1982, Golic and Lindquist, 1989, 
Morschhauser, et al., 1999, O'Gorman, et al., 1991, Schweizer, 2003, Senecoff, et al., 
1985).  Here we efficiently generate unmarked deletions in L. pneumophila using Flp 
induced from plasmids, which are then cured from the strain.  Compared to traditional 




Construction of null alleles with FRT-flanked antibiotic resistance cassettes. 
To construct alleles, 500-1000 bp flanking each gene to be deleted was amplified 
by PCR from the chromosome of wild-type L. pneumophila and cloned into pGEM T 
easy (Promega) using E. coli DH5α as the host (Fig 2.0, Table 2.1).  The gene of interest 
was replaced by an FRT-flanked cat or kan cassette from pKD3 or pKD4, respectively 
(Datsenko and Wanner, 2000), using recombineering and E. coli DY330 (Fig 2.0, Table 
2.1; Thomason, et al., 2007a, Thomason, et al., 2007b).  The recombinant allele from 
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pGEM was then transferred to the Lp02 chromosome by natural transformation (Fig 2.0; 
Sexton and Vogel, 2004, Stone and Kwaik, 1999).  An FRT-flanked gentamycin 
resistance cassette was also constructed that can be amplified with the same primers used 
for the cat and kan genes (Table 2.1).   
 
FRT-flanked cassettes are excised using vectors that express Flp.   
To construct a shuttle vector for efficient expression of the Flp recombinase by L. 
pneumophila, flp was cloned into a gentamycin-resistant and sucrose-sensitive derivative 
of the broad host range plasmid pMMB206, yielding pMMBFlp (Table 2.S1).  Vector 
pMMBFlp encodes an inducible and functional Flp recombinase (Fig 2.1A, Table 2.S1).  
However, since this plasmid was difficult to cure from the host strain (Fig 2.1B), it is 
suitable for stable flp expression in L. pneumophila or for development of tools in other 
species (Table 2.S1).  For both transient Flp expression and ready segregation from L. 
pneumophila, pBSFlp was constructed by replacing the RSF1010 origin of replication of 
pMMBFlp with the ColE1 ori from pBluescript KS- (Table 2.1). 
 
Flp-mediated excision of cassettes and removal of vector.   
pBSFlp was transferred by electroporation (Bryan and Swanson, 2011, Chen, et 
al., 2006, Marra, et al., 1992) to L. pneumophila strains harboring FRT-flanked deletion 
constructs, and transformants were selected on ACES-buffered charcoal yeast extract 
(Pasculle, et al., 1980) supplemented with 100 μg/mL thymidine (CYET), gentamycin 
(10 μg/mL), and IPTG (200 μM) (Fig 2.0).  After 5-6 days incubation, individual 
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colonies from the transformation were patched onto medium without antibiotics and 
IPTG and incubated overnight.  Next, clones were isolated by streaking onto CYET 
containing 5% sucrose, and their phenotypes and genotypes determined (Fig 2.0).  To 
verify the versatility of the method, deletions were constructed in lpg1782 (fliA), 
lpg2217, lpg0826 (xseA), lpg1461 (recJ); an xseA recJ double mutant was also generated 
(Table 2.1).   
 
Motility.   
Bacterial strains were grown to the exponential stage of growth, then back-diluted 
and grown to an initial OD600 of ~3.5.  Wet mounts were observed through an inverted 
phase microscope at 400X magnification at least three times as the broth cultures 
achieved OD600 = 3.70 - 4.70.  
 
Lysosomal degradation.   
Percentage of intact bacteria after 2 hour infection of murine bone marrow-
derived macrophages was assessed by fluorescence microscopy at an MOI ~1 as 





pBSFlp-mediated excision and vector loss is highly efficient.   
For every locus examined, the vast majority of clones had excised the resistance 
cassette and lost the plasmid when utilizing pBSFlp.  When generating mutants in fliA, 
lpg2217, xseA, and recJ, 100% of the total clones (n=96) lost the desired resistance 
cassette when plated on medium containing IPTG, whereas 89% (n=44) of the isolates on 
medium without IPTG had done so.  Loss of vector was also highly efficient:  100% 
(n=96) of clones lacked the vector after re-streaking on sucrose-containing medium.   
The ability of Flp recombinase to excise two cassettes in one step was also 
examined.  A double recJ::FRT xseA::FRT unmarked deletion mutant was constructed in 
three steps:  one step for each cassette insertion, then Flp-mediated excision of both 
cassettes in a single final step (Table 2.1).  In contrast, traditional allelic exchange 
methods utilizing counter selection would require four selection steps, costing the 
researcher more time while increasing the chances of second-site mutations.  Minimizing 
strain passage was particularly important for the nuclease mutants, whose DNA repair is 
predicted to be defective. 
 
Mutations in multiple genes with redundant function reveal phenotypes.   
To examine whether functionally redundant genes can be studied by constructing 
multiple ummarked deletions in a single strain, we investigated the individual and 
combined effects of the RecJ and ExoVII (XseA) nucleases.  E. coli has four canonical 
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single-stranded nucleases (ssExos) with a great deal of redundancy (Burdett, et al., 2001, 
Dutra, et al., 2007, Viswanathan, et al., 2001, Viswanathan and Lovett, 1998), whereas 
only two of these enzymes are annotated in the L. pneumophila genome (Bryan and 
Swanson, 2011, Chien, et al., 2004).  In E. coli, increased sensitivity to the base analog 2-
aminopurine (2-AP) is not revealed until three or four of its ssExos are mutated (Burdett, 
et al., 2001, Viswanathan, et al., 2001).  High concentrations of 2-AP saturate methyl-
directed mismatch repair, with mismatches recognized by MutS leading to MutH-
mediated strand cleavage (Burdett, et al., 2001, Modrich, 1991).  Subsequent strand 
processing requires exonucleolytic cleavage or else the repair event is aborted and toxic 
intermediates accumulate (Burdett, et al., 2001, Viswanathan, et al., 2001).   Nuclease 
mutants also exhibit increased sensitivity to nalidixic acid (Chase and Richardson, 1977, 
Viswanathan, et al., 2001).  To test genetically if the L. pneumophila RecJ and ExoVII 
nucleases are redundant and together provide the majority of ssExo activity, we examined 
the susceptibility of single and double mutants to 2-AP and nalidixic acid.  When treated 
with either DNA damaging agent, the plating efficiency of the double mutant was 
decreased compared to either single mutant, suggesting overlapping function (Fig 2.2).   
 
Unmarked fliA deletion alleles are not polar on motAB.   
Compared to insertion mutations, unmarked mutations pose a lower risk of polar 
effects on downstream genes.  For example, a transposon mutation in the gene encoding 
the flagellar sigma factor, fliA, completely eliminates flagella and motility, and these 
defects are only partially complemented (Table 2.2; Molofsky, et al., 2005).  Positioned 9 
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bp 3‘ of fliA is the motAB locus (Fig 2.3A), which encodes ion channels critical for 
flagellar motion, as < 5% of motAB mutant L. pneumophila exhibit motility (Table 2.2; 
Molofsky, et al., 2005).  
To test polarity of fliA mutations generated with Flp, we compared the resulting 
motility phenotypes to those of the fliA transposon mutant (Table 2.1).  Motility was 
scored microscopically, since soft agar assays are not applicable for the non-chemotactic 
L. pneumophila (Byrne and Swanson, 1998).  Plasmid-born fliA restored full motility 
only to the fliA unmarked mutant strain (Table 2.2).  Since the partial motility of both the 
fliA transposon and the FRT-cat-FRT mutant strains carrying fliA in trans resembled that 
of the motAB mutant (Table 2.2), both of the insertion mutations are likely polar. 
In addition to reducing polar effects, complete unmarked deletions reduce the 
chances that sequences not deleted by transposon insertions may still be transcribed and 
translated, occasionally leading to a protein with aberrant activity.  We examined this 
possibility by observing whether the various mutants in fliA were able to avoid lysosomal 
degradation by murine macrophages at two hours post-infection.  The fliA::kan 
transposon insertion mutant contains an insertion at residue 201 of 239—leaving most of 
the protein unaltered by the mutation, yet the strain is more susceptible to lysosomal 
degradation than wild-type cells (Fig 2.3; Molofsky, et al., 2005).  This defect is fully 
complemented, however, suggesting that polarity on motAB is unlikely to be responsible 
for the phenotype (Molofsky, et al., 2005).  In contrast to the insertion mutation, a mutant 
strain with a complete deletion of the coding sequence of fliA does not have a defect in 
lysosomal avoidance (Fig 2.3).  While there are many possible explanations for these 
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differences, one consistent with our results is that the transposon insertion strain produces 
a truncated and functionally altered protein that results in the observed degradation 
phenotype, but this phenotype is recessive when the wild-type protein is over-expressed.  
These data illustrate the value of unmarked non-polar and complete deletions by 
demonstrating that, even when a phenotype of a mutation can be genetically 
complemented, it can still be difficult to assign a phenotype to a gene with confidence 
when less precise genetic inactivation tools are utilized.  
 
DISCUSSION 
Unmarked deletions in Legionella.   
A powerful approach to study fundamental bacterial processes is the construction 
and analysis of unmarked non-polar mutations.  Certain experimental questions, 
including whether factors are functionally redundant, require that multiple mutations be 
constructed in a single strain.  To facilitate the genetic manipulation, we developed an 
efficient tandem approach in which recombinant alleles are first constructed in E. coli 
using the λ-Red recombinase system, and then Flp-mediated excision is induced in L. 
pneumophila. 
 
Exonuclease and mismatch repair potential of L. pneumophila.   
Genome sequences suggest L. pneumophila has a reduced exonucleolytic 
potential, at least as assessed by the number of major single-stranded exonucleases 
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compared to model organisms (Altschul, et al., 2009, Cazalet, et al., 2004, Chien, et al., 
2004).  Our observations that L. pneumophila exonuclease double mutant cells are 
sensitive to DNA damaging agents support this genomic prediction.  It was notable, 
however, that the L. pneumophila double mutant was more susceptible to 2-AP than the 
corresponding E. coli double mutant, yet it was more resistant than the E. coli quadruple 
mutant (Burdett, et al., 2001).  Since in E. coli nucleases are necessary for methyl-
directed mismatch repair (MDMR) and the susceptibility to 2-AP is dependent on 
recognition of mismatches by repair machinery (Burdett, et al., 2001, Viswanathan, et al., 
2001), L. pneumophila may have a less responsive MDMR system than E. coli or recruit 
non-canonical mechanisms to repair base mismatches.  These observations are consistent 
with mismatch repair playing a relatively minor role in correcting base changes induced 
by oligo mutagenesis in L. pneumophila (Bryan and Swanson, 2011).  Alternatively, this 
pathogen may have unrecognized ssExos.  Interestingly, indirect data from oligo 
mutagenesis experiments may also suggest a contributing, but minor, role of 
unrecognized exonucleases (Bryan and Swanson, 2011).  Nevertheless, the extreme 
sensitivity of the double mutant to nalidixic acid suggests that RecJ and ExoVII are L. 
pneumophila‘s main ssExos.  In concert with the organism‘s ability to undergo natural 
transformation, a reduced exonucleolytic potential and less sensitive mismatch repair 
system provide mechanistic support for epidemiological genomic studies (Bruggemann, 
et al., 2006, Cazalet, et al., 2008, Cazalet, et al., 2004) that suggest Legionella 
pneumophila occupies an evolutionary niche that relies on a diverse and dynamic genome 
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Figure 2.1.  After efficiently curing antibiotic resistance cassettes from the  
L. pneumophila chromosome, plasmids expressing the Flp recombinase can be 
segregated from the host strain. A) Flp-mediated excision of a cat cassette was 
examined in a letA::FRT-cat-FRT strain using pMMBFlp and IPTG induction in broth, 
and then plating on medium with and without chloramphenicol (Table 2.S1).  B) Loss of 
Flp-encoding plasmids with either an RSF1010 (pMMBFlp) or ColE1 (pBSFlp) origin of 
replication.  For cultures that were selected for plasmid loss with sucrose, overnight 
cultures were first grown in the absence of sucrose, then exponential phase cultures were 
normalized, resuspended, and grown overnight in AYET + 5% sucrose without 
antibiotics.  After plating on media with and without gentamycin, the presence of the 






No Drug 2-Aminopurine Nalidixic Acid
 
 
Figure 2.2.  Exonuclease double mutants are sensitive to 2-aminopurine and  
nalidixic acid.  Indicated strains were grown to the post-exponential phase of growth, as 
assessed by motility, cultures normalized to an OD600 of 1.0, and 10-fold serial dilutions 
plated on CYET without drug or CYET supplemented with 350 μg/ml of 2-AP or 2 μg/ml 
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Figure 2.3.  fliA transposon insertion mutant cells, but not fliA::FRT complete 
deletion mutant cells, evade degradation poorly when phagocytized by 
macrophages.  A) Putative fliA operon structure and relative location of transposon 
insertion into the protein.  Regions are predicted from alignment with E. coli σ
70
: region 2 
contains the -10 promoter recognition helix and the main core RNA polymerase binding 
domain, region 3 is involved in binding the core RNA polymerase and occasionally -10 
sequences, and region 4 binds the -35 promoter element.  B)  Murine bone marrow-
derived macrophages were infected for 2 hours with wild-type L. pneumophila or 
indicated strain grown to the exponential (E) or post-exponential (PE) growth phase.  
>100 infected macrophages were scored for the presence of intact or degraded L. 
pneumophila.  Data represents the mean ± SEM of 3 independent experiments.  * 
Indicates statistically significant from WT PE at α = 0.05 using one-way ANOVA and 
Bonferroni post-hoc.  N.S. indicates not significant. 
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Table 2.1.    Abbreviated list of bacterial strains and plasmids.* 
 
Strain Genotype or plasmid Source 
E. coli and plasmids  
DH5α 
supE44 ∆lacU169 (80 lacZ∆M15) hsdR17 
recA1 endA1 gyrA96 thi-1 relA1 Laboratory collection 
DY330 W3110 ∆lacU169 gal490 λcI857 ∆(cro-bioA) (Yu, et al., 2000) 
 pGEM-T easy Promega 
 pKD3 (FRT-cat-FRT allele) 
 (Datsenko and Wanner, 
2000) 
 pKD4 (FRT-kan-FRT allele) 
 (Datsenko and Wanner, 
2000) 
MB838 DH5α λpir endA::FRT  pR6KγFRT-gent-FRT This work 
MB790 DH5α  pMMBFlp This work 
MB791 DH5α  pBSFlp This work 
MB750 DH5α  pGEMfliA This work 
MB751 DH5α  pGEMΔfliA::FRT-cat-FRT This work 
  
L. pneumophila   
MB110 Lp02 wild type, thyA, hsdR, rpsL (Str
R
) (Berger and Isberg, 1993) 
MB811 Lp02 ΔfliA::FRT-cat-FRT  This work 
MB818 Lp02 ΔfliA::FRT  This work 
MB758 Lp02 recJ::FRT-cat-FRT (Bryan and Swanson, 2011) 
MB819 Lp02 ΔrecJ::FRT This work 
MB759 Lp02 xseA::FRT-kan-FRT (Bryan and Swanson, 2011) 
MB820 Lp02 ΔxseA::FRT This work 
MB760 Lp02 recJ::FRT-cat-FRT, xseA::FRT-kan-FRT (Bryan and Swanson, 2011) 
MB821 Lp02 recJ::FRT, xseA::FRT This work 
 
*See Table 2.S1 for complete strain table. 
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Table 2.2.    Motility phenotypes. 
 
Strain Percent 
Motile* Strain designation Chromosome Plasmid 
Lp02 Wild-type post-exponential None > 95% 
Lp02 Wild-type exponential None     0 % 
MB560 motAB::gent  None < 5% 
MB808 fliA::kan transposon insertion pMMBGent-empty     0 % 
MB510 fliA::kan transposon insertion pMMBGent-FliA < 5% 
MB814 ΔfliA::FRT-cat-FRT  pMMBGent-FliA < 5% 
MB816 ΔfliA::FRT             pMMBGent-empty     0 % 
MB817 ΔfliA::FRT              pMMBGent-FliA > 95% 
 
*Motility of > 10
4
 cells scored as a population in two independent experiments, as 
observed periodically from OD600 = 3.70 - 4.70, except WT exponential, which was 





Table 2.S1.  Bacterial strains and plasmids. 
E. coli and plasmids   
DH5α 
supE44 ∆lacU169 (80 lacZ∆M15) hsdR17 recA1 endA1 gyrA96 thi-1 
relA1λpir Laboratory collection 
DH5α 
λpir 
supE44 ∆lacU169 (80 lacZ∆M15) hsdR17 recA1 endA1 gyrA96 thi-1 
relA1 λpir Laboratory collection 
DY330 W3110 ∆lacU169 gal490 λcI857 ∆(cro-bioA) (Yu, et al., 2000) 
 pGEM-T easy Promega 
 pKD3 (FRT-cat-FRT allele) 
(Datsenko and 
Wanner, 2000) 
 pKD4 (FRT-kan-FRT allele) 
(Datsenko and 
Wanner, 2000) 
MB838 pR6KγFRT-gent-FRT This work 
 pCP20  (source of flp gene) 
(Datsenko and 
Wanner, 2000) 
 pMM237 (source of sacB gene) (McClain, et al., 1996) 
 pBluescript KS- (source of ColE1 ori) Stratagene 




(Molofsky, et al., 
2005) 
 pMMBGent-FliA 




(pMMB206 ∆mob with gentamycin resistance cassette replacing cat) This work 
MB789 pMMBbve 
(pMMBGent with sacB cloned downstream of the MCS) This work 
MB790 pMMBFlp 
(pMMBbve with flp cloned under ptac control) This work 
MB791 pBSFlp 
(pMMBFlp with ColE1 ori replacing RSF1010 ori) This work 
MB792 pGEMletA This work 
MB793 pGEMΔletA::FRT-cat-FRT This work 
MB750 pGEMfliA This work 
MB751 pGEMΔfliA::FRT-cat-FRT This work 
MB748 pGEMxseA 
(Bryan and Swanson, 
2011) 
MB749 pGEMΔxseA::FRT-kan-FRT 
(Bryan and Swanson, 
2011) 
MB747 pGEMΔrecJ:FRT-cat-FRT 
(Bryan and Swanson, 
2011) 
MB794 pGEMlpg0558 This work 
MB795 pGEMΔlpg0558::FRT-cat-FRT This work 
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MB796 pGEMlpg1116 This work 
MB797 pGEMΔlpg1116::FRT-cat-FRT This work 
MB798 pGEMlpg1889 This work 
MB799 pGEMΔlpg1889::FRT-cat-FRT This work 
MB800 pGEMlpg1918 This work 
MB801 pGEMΔlpg1918::FRT-cat-FRT This work 
MB802 pGEMlpg2217 This work 
MB803 pGEMΔlpg2217::FRT-cat-FRT This work 
MB804 pGEMlpg2343 This work 
MB805 pGEMΔlpg2343::FRT-cat-FRT This work 
MB806 pGEMlpg2918 This work 
MB807 pGEMΔlpg2918::FRT-cat-FRT This work 
 
L. pneumophila*   
MB110 Lp02 wild type, thyA, hsdR, rpsL (StrR) 
(Berger and Isberg, 
1993) 
MB413 letA::kan transposon insertion (Hammer, et al., 2002) 
MB808 Lp02 fliA::kan transposon insertion, pMMBGent-empty (Molofsky, et al., 2005) 
MB510 Lp02 fliA::kan transposon insertion, pMMBGent-FliA (Molofsky, et al., 2005) 
MB560 Lp02 motAB::gent (Molofsky, et al., 2005) 
MB809 Lp02 ΔletA::FRT-cat-FRT, pMMBbve (vector control) This work 
MB810 Lp02 ΔletA::FRT-cat-FRT, pMMBFlp This work 
MB811 Lp02 ΔfliA::FRT-cat-FRT  This work 
MB812 Lp02 ΔfliA::FRT-cat-FRT, pMMBFlp This work 
MB813 Lp02 ΔfliA::FRT-cat-FRT, pBSFlp This work 
MB814 Lp02 ΔfliA::FRT-cat-FRT, pMMBGent-FliA This work 
MB815 Lp02 ΔfliA::FRT, Supplemental Method This work 
MB816 Lp02 ΔfliA::FRT, Supplemental Method, pMMBGent-empty This work 
MB817 Lp02 ΔfliA::FRT, Supplemental Method, pMMBGent-FliA This work 
MB818 Lp02 ΔfliA::FRT  This work 
MB758 Lp02 ΔrecJ::FRT-cat-FRT 
(Bryan and Swanson, 
2011) 
MB819 Lp02 ΔrecJ::FRT This work 
MB759 Lp02 ΔxseA::FRT-kan-FRT 
(Bryan and Swanson, 
2011) 
MB820 Lp02 ΔxseA::FRT This work 
MB760 Lp02 ΔrecJ::FRT-cat-FRT, ΔxseA::FRT-kan-FRT 
(Bryan and Swanson, 
2011) 
MB821 Lp02 ΔrecJ::FRT, ΔxseA::FRT This work 
MB822 Lp02 Δlpg0558::FRT-cat-FRT This work 
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MB823 Lp02 Δlpg0558::FRT, Supplemental Method This work 
MB824 Lp02 Δlpg1116::FRT-cat-FRT This work 
MB825 Lp02 Δlpg1116::FRT, Supplemental Method This work 
MB826 Lp02 Δlpg1889::FRT-cat-FRT This work 
MB827 Lp02 Δlpg1889::FRT, Supplemental Method This work 
MB828 Lp02 Δlpg1918::FRT-cat-FRT This work 
MB829 Lp02 Δlpg1918::FRT, Supplemental Method This work 
MB830 Lp02 Δlpg2217::FRT-cat-FRT This work 
MB831 Lp02 Δlpg2217::FRT, Supplemental Method This work 
MB832 Lp02 Δlpg2217::FRT This work 
MB833 Lp02 Δlpg2343::FRT-cat-FRT This work 
MB834 Lp02 Δlpg2343::FRT, Supplemental Method This work 
MB835 Lp02 Δlpg2918::FRT-cat-FRT This work 
MB836 Lp02 Δlpg2918::FRT, Supplemental Method This work 
*Strains were constructed as described in text, expect for those listed as constructed with 
the Supplemental Method (also see Fig 2.1 and Fig 2.S1). 
Supplemental Method for Table 2.S1: 
To induce Flp expression and excision of resistance cassettes, pMMBFlp was 
transferred by electroporation to strains containing FRT-flanked deletion constructs, 
which were then cultured overnight in AYET containing IPTG (200 μM) and gentamycin 
(10 μg/mL).  To remove IPTG and antibiotic, cells were washed twice and then cultured 
overnight in AYET to mid-exponential phase.  To enrich for bacteria that had lost 
pMMBFlp, cells were diluted into AYET + 5% sucrose, cultured overnight or until 
growth was visible, and then isolated on CYET + 5% sucrose.  Finally, colonies which 
were likely to have lost or inactivated sacB, identified by their non-mucoid morphology 
were screened for gentamycin and chloramphenicol sensitivity, and the size of the 
putative unmarked deletion allele was verified by PCR.  The predicted scar sequence 
following Flp-mediated excision was confirmed by sequencing two independent 
deletions.  To test the fidelity of the method, deletions were constructed in numerous loci 
that were relevant to other projects in our laboratory:  letA, fliA, lpg0558, lpg1116, 
lpg1889, lpg1918, lpg2217, lpg2343 and lpg2918.  Although we occasionally observed 
unusual growth characteristics after the antibiotic cassette was excised by this method 
(Fig 2.S1), we nevertheless describe the unmarked strains here in the event they are of 
interest to others in the community.  On the other hand, we have not observed unusual 
growth patterns for the corresponding antibiotic-resistant progenitors or the unmarked 




































Figure 2.S1. Growth of strains following Flp excision. Aberrant growth was observed 
for fliA (A) and lpg2217 (B) mutants obtained before and after Flp-mediated excision and 
sucrose selection when utilizing pMMBFlp in broth (Supplemental Method, described in 
Table 2.S1), but not pBSFlp on plates (described in text).  Shown are the mean ± SD for 
triplicate wells in one experiment representative of two assays performed on separate 
days.  Error bars are typically masked by the indicator symbols.  A letA::kan mutant is 
shown as a specificity control for its characteristic growth phenotype (Hammer, et al., 
2002).  Kaoru Harada contributed to these data. 
Data indicate no unusual growth characteristics for strains cultured to induce Flp 
expression and lose vector as described in the text.  In contrast, the extra passages or 
some unknown effect of sucrose selection in broth for the Supplemental Method from 
Table 2.S1 often yielded strains exhibiting a fast-growth phenotype, with occasional 






Oligonucleotides stimulate genomic alterations of Legionella pneumophila 
 
SUMMARY 
Genetic variation generates diversity in all kingdoms of life.  The corresponding 
mechanisms can also be harnessed for laboratory studies of fundamental cellular 
processes.  Here we report that oligonucleotides (oligos) generate mutations on the L. 
pneumophila chromosome by a mechanism that requires homologous DNA, but not 
RecA, RadA or any known phage recombinase.  Instead we propose that DNA replication 
contributes, since oligo-induced mutagenesis required ≥ 21 nucleotides of homology, was 
strand-dependent, and was most efficient in exponential phase.  Mutagenesis did not 
require canonical 5‘ phosphate or 3‘ hydroxyl groups, but the primosomal protein PriA 
and DNA Pol I contributed.  After electroporation, oligos stimulated excision of 2.1 kb of 
chromosomal DNA or insertion of 18 bp, and non-homologous flanking sequences were 
also processed.  We exploited this endogenous activity to generate chromosomal 
deletions and to insert an epitope into a chromosomal coding sequence.  Compared to E. 
coli, L. pneumophila encodes fewer canonical single-stranded exonucleases, and the 
frequency of mutagenesis increased substantially when either its RecJ and ExoVII 
nucleases were inactivated or the oligos modified by nuclease-resistant bases.  In addition 
to genetic engineering, oligo-induced mutagenesis may have evolutionary implications as 
46 
 
a mechanism to incorporate divergent DNA sequences with only short regions of 
homology.  This chapter was published by Bryan and Swanson in Molecular 
Microbiology (2011).  Used with permission. 
 
INTRODUCTION 
The strategies that equip Legionella pneumophila to infect human alveolar 
macrophages evolved during its co-evolution with freshwater amoebae.  This 
environmental pathogen has an unusually diverse genome, with numerous eukaryotic-like 
motifs and hundreds of genes unique to individual strains, even within the same species 
and serogroup (Cazalet, et al., 2008, Cazalet, et al., 2004, Chien, et al., 2004, Gomez-
Valero, et al., 2009, Lurie-Weinberger, et al.).  Horizontal transmission has contributed a 
number of genes that are critical to the bacterium‘s ability to replicate within phagocytes, 
evade host defenses, and cause disease (Cazalet, et al., 2008, Cazalet, et al., 2004, Chien, 
et al., 2004, Gomez-Valero, et al., 2009, Isberg, et al., 2009, Shin and Roy, 2008). 
 Although horizontal gene transfer can occur by several mechanisms, it frequently 
depends on homologous recombination mediated primarily by either the bacterial RecA 
enzyme or bacteriophage recombinases (Thomas and Nielsen, 2005).  Experimentalists 
harness these recombination systems to engineer the bacterial genome to study 
fundamental cellular processes.  In general, RecA-mediated recombination is inefficient 
for substrates with < 50 bp of homology (Dutra, et al., 2007, Lovett, et al., 2002, Lusetti 
and Cox, 2002); in L. pneumophila, directed mutagenesis typically requires > 250 bp of 
homology (Sexton and Vogel, 2004).  In contrast, phage-encoded single-stranded binding 
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proteins, primarily RecT and Beta homologs, can mediate recombination with < 50 bp of 
homology, thereby facilitating use of synthetic oligonucleotides (oligos) as substrates 
(van Kessel and Hatfull, 2007, Yu, et al., 2000, Zhang, et al., 1998).  Indeed, in E. coli 
and a few other species, phage recombinases will mediate high frequency pinpoint 
recombination within short regions of homology (Datsenko and Wanner, 2000, Lesic and 
Rahme, 2008, Ranallo, et al., 2006, van Kessel and Hatfull, 2007, Yu, et al., 2000).  
Although the so called recombineering or λ-Red method is highly efficient for genetic 
engineering, its application is limited to these phages‘ host or closely related bacteria and 
necessitates expression of exogenous genes in the species of interest. 
Recently Dutra et al (Dutra, et al., 2007) and Swingle et al (Swingle, et al., 
2010b) described recombination in bacteria stimulated by oligos by a process that is 
independent of both RecA and exogenous phage recombinases.  Swingle and colleagues 
introduced small nucleotide changes in the chromosomes of four different bacterial 
species, suggesting that the process of RecA- and phage-independent oligo recombination 
is likely conserved among bacteria.  Moreover, by a mechanism that remains to be 
determined, oligos can stimulate deletion of ~ 500 bp from the Pseudomonas syringae 
chromosome, albeit with low efficiency and fidelity (Swingle, et al., 2010b). 
RecA- and phage-independent oligo recombination has been proposed to occur 
via a similar mechanism as λ-Red mediated recombination, but without the necessity of a 
single-stranded binding protein (Murphy and Marinus, 2010, Swingle, et al., 2010b).  The 
annealing/integration model for λ-Red mediated recombination holds that oligos anneal at 
the replication fork and are incorporated into the nascent strand by direct extension and 
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ligation by DNA polymerase and ligase, respectively (Ellis, et al., 2001, Huen, et al., 
2006, Li, et al., 2003).  In all three Domains of life, as illustrated by E. coli λ-Red 
(Grogan and Stengel, 2008, Huen, et al., 2006), mammalian cells (Radecke, et al., 2006), 
and the Archaeon Sulfolobus acidocaldarius (Grogan and Stengel, 2008), the 
annealing/integration model has been empirically supported by the decrease in 
recombination frequency observed for oligos that are non-extendable by DNA 
polymerase, despite particular mechanistic differences in these divergent oligo 
recombination systems.   
Here we extend knowledge of oligo-induced chromosomal mutagenesis by 
analyzing in L. pneumophila both native and heterologous genomic alleles, excision of 
large DNA segments, and insertion of short sequences.  Furthermore, we exploit this 
pathway to construct defined markerless mutations and to insert an epitope tag.  Our data 
also highlight notable mechanistic differences from previously described recombination 
systems, as we document mutagenesis by oligos that are non-extendable by DNA 
polymerase.  These observations emphasize the value of testing directly whether 
observations in model organisms hold for other species of bacteria.  The implications of 
oligo-induced chromosomal mutation for genetic engineering as well as the evolution of 





Bacterial strains and resistance cassettes.   
Legionella pneumophila strain Lp02 and derivatives were cultured as previously 
described (Byrne and Swanson, 1998); E. coli DH5α, BW25113, JW2669, HB101 and 
derivatives were cultured using standard laboratory conditions.  Chloramphenicol (5 and 
25 μg/ml), gentamycin (10 μg/ml), rifampin (5 and 50 μg/ml), ampicillin (100 μg/ml), 
streptomycin (0.5 and 1 mg/ml), and metronidazole (10 µg/ml) were used for selection of 
L. pneumophila and E. coli, respectively.  Metronidazole-streptomycin plates were 
poured fresh and either immediately used or refrigerated for use within one week.  
Isogenic mutations in strain Lp02 were generated by constructing recombinant alleles in 
E. coli after cloning into pGEM T easy (Promega, Madison, WI) and replacing the 
desired sequence with a resistance cassette by recombineering (Bryan, et al., 2011, 
Datsenko and Wanner, 2000, Thomason, et al., 2007a), except for the recJ::cat allele, 
which was made by overlap-extension PCR.  Recombinant alleles were transferred to 
Lp02 by natural transformation (Bryan, et al., 2011, Sexton and Vogel, 2004).  Where 
necessary, resistance cassettes were removed by FLP recombinase-mediated excision 
(Bryan, et al., 2011).  See supplementary information for complete strain and oligo list 
(Tables 3.S2-4).  The recA mutants were confirmed by their inability to undergo natural 
transformation under standard laboratory conditions and slightly decreased growth 
phenotype (Luneberg, et al., 2001).  The cat-rdxA-rpsL cassette was assembled by 
overlap-extension PCR by amplifying the appropriate fragments from pKD3 (Datsenko 
and Wanner, 2000), pRDX (Goodwin, et al., 1998, LeBlanc, et al., 2006), and E. coli 
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DH5α.  In a second overlap-extension step, the cat-rdxA-rpsL cassette was fused with 
~500 bp of flanking DNA 5‘ and 3‘ to the L. pneumophila fliA gene.  The fliA::cat-rdxA-
rpsL allele was cloned into pGEM T easy and used as a template to construct another 
allele in which cat-rdxA-rpsL was inserted at the start of fliA by recombineering in E. 
coli, as above.  The cat-rdxA-rpsL cassette flanked with several restriction sites has also 
been cloned using an R6Kγ origin of replication, creating pR6KcatrdxArpsL (Table 
3.S1).  The cassette can be amplified using the forward primer sequence 5‘-
tgtgacggaagatcacttcg-3‘ and the reverse primer sequence 5‘- ttaagccttaggacgcttcacg-3‘.  
To support replication and allow phenotype verification in a streptomycin resistant 
background strain, the plasmid is carried by an HB101λpir endA::frt strain (Table 3.S1).  
To rescue sub-clones with different origins of replication and allow phenotype 
verification, an HB101 endA::frt strain is used (Table 3.S1).  The colony morphology of 
clones containing the cat-rdxA-rpsL cassette were often observed to be slightly 
heterogeneous in both L. pneumophila and E. coli, with clones yielding smaller colonies 
displaying the strongest counter-selectable phenotype.  The growth of strains containing 
the cat-rdxA-rpsL cassette was also slightly retarded (Fig 3.S1).    
 
Transformations. 
 For electroporation, L. pneumophila cells were cultured overnight to exponential 
phase and diluted ~ 25- to 100-fold into 35 mL of AYET without antibiotics in a 250 mL 
flask at 37 ºC with shaking at 250 rpm.  Strains containing plasmids were maintained by 
selecting for thymidine prototrophy.  Unless noted, cells were cultured overnight to 
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OD600 = 1.00  ± 0.05 and then chilled on ice for ~10 min prior to centrifugation of 30 ml 
of the culture at 4600 g for 7 min at 4 ºC.  Cells were washed once with 30 ml ice-cold 
sterile distilled deionized water and transferred to a 1.5 ml tube.  After centrifugation at 
full speed for 50-60 sec at 4 ºC in a microcentrifuge, cells were washed twice with 1 ml 
of water and then resuspended in a final volume of ~ 240 µL.   50 µL of cells were 
electroporated with 1 – 5000 pmol of oligo in 1 cm path length cuvettes at 1.8 kV, 100 
ohms, and 25 μF and immediately transferred to 5 mL of broth.  Cultures were incubated 
at 37 ºC on a rotating wheel without selection overnight or until at least the late 
exponential growth phase (~ 10 doublings).  100 μl of each culture was spread onto 1-3 
plates with and without the appropriate antibiotic.  Data for the rifampin-resistance assay 
likely under represents the true frequency, since the growth rate of rif
R
 cells was slower 
compared to wild-type cells (Fig 3.S1).  In contrast, the growth rate of the cat::kan strain 
and derivative cat recombinants were comparable (Fig 3.S1).   
E. coli cells were cultured as for λ-Red induction (Thomason, et al., 2007a), with 
some modification.  Cells were grown overnight, then diluted 70-fold into 55 ml of fresh 
LB containing ampicillin selection for plasmid backbone in a 250 mL flask at 37 ºC with 
shaking at 250 rpm.  Cultures were grown to OD600 = 0.42  ± 0.02 and then chilled on ice 
for ~10 min prior to centrifugation of 50 ml of the culture at 4600 g for 7 min at 4 ºC.  
Cells were washed once with 35 ml ice-cold sterile distilled deionized water and 
transferred to a 1.5 ml tube.  After centrifugation at full speed for 30-40 sec at 4 ºC in a 
microcentrifuge, cells were washed once with 1 ml of water and then resuspended in a 
final volume of ~ 400 µL.   50 µL of cells were electroporated with 1 nmol of oligo in 1 
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cm path length cuvettes at 1.8 kV, 200 ohms, and 25 μF and immediately transferred to 1 
mL of LB.  Cultures were incubated for 4 h at 37 ºC on a rotating wheel maintaining 
selection for plasmid backbone, but without selection for parental (kan
R
) or derivative 
recombinant allele (cm
R
).  100 μl of each culture was spread onto 1-3 plates with and 
without the appropriate antibiotic. 
Oligos were purchased as standard de-salted reagents without further purification 
from either Invitrogen (Carlsbad, CA) or IDT (Coralville, IA), except for the 130mer and 
161mer oligo, which were purchased as Ultramers from IDT.  To produce double-
stranded DNA, oligos were heated and then slowly cooled in the presence of 10 mM 
TrisHCl/50mM NaCl, dialyzed, and final concentration adjusted to 0.1 nmol/µL.  To 
assess whether single stranded DNA remained after annealing, oligos were examined by 
agarose gel migration pattern and ethidium bromide staining (Goedhart and Gadella, 
2005) and determined to have ≤ 10 pmol of ssDNA (data not shown)—a molar quantity 
insufficient to mediate observable mutagenesis over no DNA controls (Fig 3).  Oligos 
modified by a 3‘ inverted thymidine nucleotide (invT), 3‘ phosphate (3‘ PO4
-
), and a 3‘ 
dideoxy (ddC) were verified to be non-extendable by DNA polymerase using PCR with 
L. pneumophila genomic DNA as a template.  PCR reactions were conducted with each 
of following enzymes whose exonuclease activity varies:  Taq DNA polymerase (NEB); 
Platinum Taq High Fidelity, a mixture of Taq DNA polymerase and Pyrococcus species 
GB-D polymerase (Invitrogen); and Deep Vent Polymerase (NEB), comprised of only the 
Pyrococcus species GB-D polymerase containing an intact 3‘→5‘ exonuclease domain.  
PCR reactions using unmodified oligos or those protected by phosphorothioate bonds 
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alone yielded product as expected.  Oligos with invT and 3‘ PO4
-
 never yielded product, 
while ddC oligos yielded a faint band only when Deep Vent Polymerase was supplied at 
high concentration. 
All data shown are the mean ± SEM of independent experiments, except for Fig 
3.9C, in which 2-3 individual experiments are shown because of colony heterogeneity, 
spontaneous resistance, and variability in solid medium freshness confounded calculating 
means that accurately represented frequency.  Since individual electroporations 
occasionally varied due to conditions unrelated to mutagenesis frequency (i.e. air bubble 
in cuvette, inexplicable slower recovery compared to similar cultures, etc), data from 
individual electroporations were excluded if the time constant was less than 2.0 for L. 
pneumophila or 4.0 for E. coli or, when ≥ 4 electroporations were conducted for a given 
condition, the Grubbs test for outliers was significant at p < 0.05.  No more than one 
value was excluded per condition using the Grubbs test. 
 
RESULTS 
Oligo-induced mutagenesis in L. pneumophila is distinct from classical homologous 
recombination.   
While investigating a L. pneumophila RecT-like phage recombinase (Datta, et al., 
2008, Luneberg, et al., 2001), we observed that, after electroporation, oligos stimulated a 
modest increase in the corresponding mutation frequency, independently of an exogenous 
recombinase.  To monitor the frequency of an oligo-induced point mutation, 1 nmol of a 
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71 nucleotide (nt) oligo homologous to rpoB and containing a point mutation that confers 
rifampin resistance (Nielsen, et al., 2000) was introduced by electroporation into wild-
type L. pneumophila strain Lp02.  The oligo corresponding to the top (+) strand encodes 
a C→T transition and a T-G mismatch, while the oligo corresponding to the bottom (-) 
strand encodes a G→A transition and A-C mismatch.  Oligos corresponding to each 
DNA strand or their annealed dsDNA product (+/-) each increased the frequency of 
rifampin resistance compared to samples that were not exposed to exogenous DNA (Fig 
3.1A).  Consistently, the oligo corresponding to the bottom strand was more mutagenic  
( - ; Fig 3.1A).  We predict that the bottom (-) oligos anneal to the lagging strand during 
DNA synthesis, based on the single predicted L. pneumophila origin of replication (Gao 
and Zhang, 2007) and its position and orientation in the chromosome.  However, because 
no empirical evidence has verified the predicted origin or distinguished the lagging 
versus leading strands of the L. pneumophila chromosome, we will simply designate 
strands as top (+) or bottom (-).   We shall refer to the transfer of information from a 
synthetic oligo to the chromosome of L. pneumophila as ―oligo-induced mutagenesis‖ for 
brevity, without implying mechanism. 
To test whether classical homologous recombination pathways contribute to 
oligo-induced mutagenesis, three approaches were applied.  First, an isogenic recA::cat 
strain was constructed and compared to wild type, revealing that RecA did not affect the 
frequency of rifampin resistance (Fig 3.1A).  Most, but not all (Lovett, et al., 2002), 
RecA-dependent homologous recombination proceeds by one of two different 
mechanisms, the RecBCD or RecFOR pathways (Kuzminov, 1999).  Since L. 
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pneumophila does not encode a canonical RecBCD enzyme (Table 1.1; Altschul, et al., 
1997, Cazalet, et al., 2004,  Chien, et al., 2004), oligo mutagenesis is likely independent 
of this pathway.  To assess the contribution of RecFOR, we analyzed an isogenic 
recF::cat mutant.  Similar to the recA mutant, no reduction in oligo-induced mutagenesis 





/ total CFU for recF versus 8 x 10
-6
 for WT).  As a third test of the similarity 
to classical recombination pathways, we analyzed the impact of the length of homology.  
The frequency of rifampin resistance was similar when cells were treated with oligos 
between 21 and 161 nt of homology (Fig 3.1B), a pattern distinct from RecA- and phage-
based recombination systems (Lovett, et al., 2002,  Sexton and Vogel, 2004,  Yu, et al., 
2000).  The dependence on homology but not canonical recombination enzymes indicates 
that oligo-induced mutagenesis is distinct from classical homologous recombination. 
We next assessed whether the selectable mutation must be encoded by the oligo, 
or exposure to excessive single-stranded DNA was sufficient for mutagenesis.  After 
treatment with a 71 nt oligo encoding the wild-type rpoB sequence, the frequency of 
rifampin resistance increased slightly over background, but remained well below the 
frequencies generated by oligos that encode the point mutation (Fig 3.1A).  Similar 
results have been reported for P. syringae (Swingle, et al., 2010a).  Therefore, we tested 
whether this slight increase in mutation frequency was either restricted to sequences 
encoded by the oligo, a general response to an influx of single-stranded DNA, or a local 
but indirect effect.  For this purpose, we introduced 31 nt oligos of wild-type sequence 
that corresponded to a region that was either centered on the target nucleotide, directly 5‘ 
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or 3‘ of the target base, or elsewhere on the chromosome but matched for GC content.  In 
each condition tested, only those oligos encompassing the mutation resulted in mutation 
frequencies greater than the no DNA control (Fig 3.1C).  Furthermore, a higher mutation 
frequency was measured at the trend level for no mutation oligos of 71 nt compared to 31 
nt (9.7 x 10
-8
 vs. 4.8 x 10
-8
, respectively, p = 0.0505), again implicating a role for the 
oligo at the specific target sequence.  A similar pattern has been observed in E. coli 
(Donald L. Court, personal communication; Oppenheim, et al., 2004).  This background 
mutation rate could be due to the error rate of either chemical synthesis, which is greater 
for longer oligos (manufacturer‘s information), or one of L. pneumophila’s three 
annotated translesion polymerases (Table 1.1; Chien, et al., 2004).  Whatever the process, 
these results provide no evidence for either a local indirect process, such as a repair 
mechanism within the replication fork, or a general response to single-stranded DNA, 
such as SOS (Table 1.1). 
 
Oligo-induced mutagenesis is strand- and growth-phase dependent.   
Strand dependence (Fig 3.1A) has been used to infer that a recombination event 
occurs at the replication fork.  However, interpreting strand dependence is complicated 
by the observation that the efficiency of the E. coli mismatch repair system is affected by 
the DNA sequence (Costantino and Court, 2003, Ellis, et al., 2001, Li, et al., 2003, 
Modrich, 1991, Su, et al., 1988).  Therefore, as a more stringent probe of strand-
dependence, we inactivated mismatch repair of L. pneumophila by mutating mutS, the 
component of the repair complex that initially recognizes and binds a single base 
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mismatch or insertion and deletion loops (Su and Modrich, 1986).  Consistent with the 
pattern observed in wild-type L. pneumophila (Fig 3.1A), the oligo corresponding to the 
bottom (-) strand of the annotated sequence (AE017354; Chien, et al., 2004) stimulated a 
slightly higher frequency of rifampin resistance (3-fold) in the mutant than did the 
complementary oligo (Fig 3.2A).  Thus, the strand-dependence observed in both wild-
type and mutS L. pneumophila is consistent with the hypothesis that oligos induce 
mutation at the replication fork (Costantino and Court, 2003, Li, et al., 2003). 
In general, the mutS strain yielded a higher frequency of rifampin resistance than 
wild type.  We measured a 2.5-fold increase for the control sample electroporated without 
DNA, a 5.6-fold increase for the top strand (T-G mismatch), and a 4.6-fold increase for 
the bottom strand (A-C mismatch; Fig 3.2A).  Accordingly, the L. pneumophila mismatch 
repair system may actively repair the base change encoded by the oligo.  Interestingly, 
even though the A-C and T-G mismatches are considered good substrates for repair 
(Modrich, 1991, Su, et al., 1988), the efficiency of mismatch repair in L. pneumophila 
appeared to be significantly lower than in E. coli, where a >100-fold difference between 
mutS and wild-type cells has been observed (Costantino and Court, 2003, Swingle, et al., 
2010b).  There is no evidence for a second mutS homolog in the genome of L. 
pneumophila to explain this difference (Table 3.S1).  Instead, compared to model 
organisms, this pathogen may rely on some unrecognized repair system or endure more 
frequent base mismatches (Bryan, et al., 2011). 
To investigate by an independent approach the model that oligos induce mutations 
at replication forks, we compared exponential and post-exponential phase cultures.  
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Unlike replicating bacteria, post-exponential phase cells did not acquire rifampin 
resistance at an elevated rate (Fig 3.2B).  To a first approximation, the growth phase 
difference did not reflect electroporation efficiency, since the frequency of transformation 
with an autonomously replicating plasmid was similar for exponential and post-
exponential phase cultures (Fig 3.2B).  Together, both the strand- and growth phase-
dependence are consistent with the hypothesis that oligo-induced mutagenesis occurs at 
the replication fork, a feature that can be exploited to optimize its application and gain 
insight to its underlying mechanism. 
 
Oligo-induced mutagenesis is limited by exonucleases.   
While important for chromosome fidelity and processing of DNA repair 
intermediates, single-stranded exonucleases significantly decrease the efficiency of 
RecA-independent recombination in E. coli (Dutra, et al., 2007).  Whereas E. coli 
encodes four major single-stranded exonucleases (Dutra, et al., 2007), the L. 
pneumophila genome bears only the canonical RecJ and ExoVII (XseA) nucleases (Table 
1.1; Altschul, et al., 1997, Cazalet, et al., 2004, Chien, et al., 2004).  Exonucleases often 
exert redundant activity, since a mutant phenotype is typically observed only after several 
enzymes have been inactivated (Dutra, et al., 2007).  Therefore, to determine the impact 
of exonuclease activity on oligo-induced mutagenesis in L. pneumophila, we constructed 
and analyzed a recJ xseA double mutant strain.  Consistent with the prediction of 
genomic instability in exonuclease-deficient cells (Dutra, et al., 2007), the exonuclease 
double mutant had a higher percentage of stringy cells, less predictable growth patterns, 
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and lower numbers of viable cells than wild-type cultures.  Unlike wild-type cultures, 
which acquired rifampin resistance at measurable frequencies only when exposed to high 
DNA concentrations (≥100 pmol per electroporation for statistically significant 
differences from the no DNA control), recJ xseA mutants sustained oligo-induced 
mutations at lower DNA concentrations (≥10 pmol per electroporation for frequencies 
significantly different from no DNA control; Fig 3.3). 
As an independent test of the impact of exonucleases, we incorporated one 
Locked Nucleic Acid (LNA) and three phosphorothioate bonds (PT) at both the 5‘ and 3‘ 
ends of a 45 nt oligo.  A phosphorothioate bond contains a sulfur in place of a non-
bridging oxygen in the oligo backbone, whereas LNAs contain a methylene bridge 
between the 2‘-O atom and the 4‘-C atom of the nucleotide (manufacturer‘s information).  
Both DNA modifications limit degradation by nucleases in an oligo recombination 
system in eukaryotic cells (Parekh-Olmedo, et al., 2002); PT bonds have also been used 
in prokaryotes (Grogan and Stengel, 2008, Huen, et al., 2006).  The LNA modification 
also stabilizes the annealed oligo-DNA molecule, as judged by melting temperature 
(manufacturer‘s information).  When examined in oligo mutagenesis of L. pneumophila, 
the modified oligos stimulated a higher frequency of rifampin resistance in both wild-
type and exonuclease-deficient bacteria (Fig 3.3).  The elevated frequency of oligo-
induced mutagenesis by the modified oligos may reflect either the higher stability of the 
LNA oligo-DNA complex or the ability of some unidentified L. pneumophila 
exonuclease to degrade ssDNA.  In either case, the increased mutation frequencies 
observed with modified oligos will facilitate application of oligo-induced mutagenesis for 
60 
 
genetic engineering.  
 
Oligos stimulate RecA-independent excision of large DNA fragments.   
While point mutations contribute to evolutionary drift, the mechanisms 
underlying larger genomic changes are of particular interest for L. pneumophila given the 
diversity documented within the species (Cazalet, et al., 2008, Cazalet, et al., 2004, 
Chien, et al., 2004, Gomez-Valero, et al., 2009, Lurie-Weinberger, et al.).  Deletions of 
more than a few nucleotides have been observed (Dutra, et al., 2007, Swingle, et al., 
2010b) but remain to be examined in detail.  Therefore, to investigate whether oligos can 
stimulate large deletions in the chromosome of L. pneumophila, we first disrupted a 
chloramphenicol-resistance gene with a 950 bp kanamycin-resistance gene and then 
replaced the fliA locus with this cassette (Fig 3.4A).  Next, L. pneumophila was treated 
with an oligo homologous to the cat sequences that directly flank the kan-resistance 
insertion.  Fidelity of excision of the kan gene was then measured as the number of 
chloramphenicol-resistant colonies per total colonies.  Oligos with as few as 22 nt of 
homology on each side of the insertion (44 nt total length) stimulated excision of the 950 
bp kan gene, as measured by chloramphenicol-resistance.  No chloramphenicol-resistant 
colonies were detected when DNA was omitted.  Oligos ≥ 60 nt in length generated a 
slightly higher frequency of excision, but the frequency of excision from the chromosome 
was no greater with longer oligos (Fig 3.4B).  Typically, between 15 and 50 recombinant 
colonies were observed per plate using unmodified 60mer oligos, while >200 CFU was 
sometimes observed with certain modifications.  To verify that oligos stimulate excision 
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of chromosomal DNA, several colonies obtained in two independent experiments were 
analyzed in more detail.  The chloramphenicol-resistance phenotype was confirmed for 
all isolates (> 20 per experiment), as judged by robust growth on appropriate medium.  
Furthermore, the fliA locus was the size expected for all isolates screened (≥ 7 per 
experiment), as determined by PCR.  Therefore, oligos with only short sequences of 
homology can stimulate large chromosomal deletions.   
Since oligos may promote chromosomal deletions and point mutations by 
different processes, we investigated several additional parameters.  By constructing a 
recA::gent derivative of the strain containing the cat::kan cassette, we determined that 
RecA does not appear to contribute to the generation of either chromosomal deletions or 
point mutations stimulated by the corresponding oligos (Fig 3.4B, Fig 3.1A).  Compared 
to oligos designed to introduce a single base change, a stronger strand-dependence was 
observed for oligos that stimulate excision of the 950 bp kanamycin resistance gene (~ 3-
fold versus ~ 70-fold difference).  This greater differential between complementary 
oligos is expected due to the predicted requirement of strand annealing across larger 
regions of ssDNA and subsequent D-loop formation (Fig 3.10).  Another difference 
between the point mutation and large deletion assay is that chloramphenicol-resistant 
colonies were not generated by the corresponding annealed dsDNA for the large deletions 
(+/-; Fig 3.4B versus Fig. 3.1A).  Large excisions mediated by a homologous ssDNA 
may contribute to bacterial evolution, since natural transformation of dsDNA substrates 
can generate ssDNA in the cytoplasm (Johnsborg, et al., 2007).   
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Since many bacteria harbor plasmids, we next investigated whether circular DNA 
is a substrate for oligo mutagenesis.  This experiment also addressed the potential 
contribution of other processing enzymes, such as endonucleases.  To this end, we cloned 
annealed dsDNA oligos into an RSF1010-based plasmid and examined its ability to 
confer chloramphenicol resistance to cells containing the cat::kan allele.  This plasmid is 
predicted to supply short regions of homology either as both circular double-stranded 
molecules or as circular single-stranded molecules generated during plasmid replication.  
No recombinant colonies were obtained in two independent experiments performed with 
and without selection for the plasmid backbone (limit of detection ~3 x 10
-10
 CFU/ml).  
That no recombinants were observed could be due to either a very low efficiency or a 
mechanistic requirement for linear DNA.  In either case, in nature intact plasmids are 
unlikely to stimulate appreciable mutagenesis by processes akin to oligo mutagenesis. 
 
Oligo-stimulated excision is sensitive to orientation in the chromosome. 
 Although models in which oligos induce mutagenesis at the replication fork are 
supported by both strand- and growth phase-dependence (Fig 3.2), it is also possible that 
the transcription machinery or growth phase-specific factors contribute.  Transcription 
does promote non-canonical recombination pathways in yeast (Liu, et al., 2002) and E. 
coli (Ikeda and Matsumoto, 1979), but not λ-Red mediated recombination (Li, et al., 
2003).  Therefore, to test whether transcription enhances oligo-stimulated excision, the 
cat::kan cassette was also inserted in the reverse orientation at the fliA locus, and then the 
frequency of excision was measured using the identical set of oligos (+ and -; Fig 3.4A).  
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If the direction that the replication fork moves affects oligo insertion, we predicted that 
the relative efficiency of mutagenesis by each oligo pair would switch.  Indeed, the 
reverse pattern that we observed, namely in this case the bottom strand oligo (+) was 
more mutagenic than the top strand (-; Fig 3.4B), is consistent with models in which 
exogenous oligos mediate mutagenesis during DNA replication, not transcription. 
We next tested whether oligo mutagenesis was also strand-dependent when the 
substrate was plasmid DNA.  Using this approach we also tested whether our 
observations were species-specific.  For this experiment, we cloned the cat::kan allele in 
both orientations into an RSF1010-based broad host range plasmid.  Oligo-induced 
mutagenesis of this plasmid substrate was than examined in recA mutants of L. 
pneumophila and E. coli (BW25113 derivative, Table 3.S1) using the same set of oligos 
as the chromosomal assay.  In both species, oligo mutagenesis of the plasmid was more 
efficient, and strand dependence was consistent, though more modest, than for the L. 
pneumophila chromosomal substrate (Fig 3.4C).  Therefore, the ability of oligo 
mutagenesis to excise large fragments of DNA is not unique to L. pneumophila.  
Accordingly, these data verify and extend the observations of Swingle et al. who 





Oligo mutagenesis is not inhibited by 3’ modified oligos that are non-extendable by 
DNA polymerase. 
Oligo recombination by divergent systems in all three Kingdoms relies on 
extension of the oligo by DNA polymerase, as judged by the decreased mutation rate of 
oligos that contain 3‘ dideoxy modifications (Grogan and Stengel, 2008, Huen, et al., 
2006, Radecke, et al., 2006).  Therefore, we sought to determine if a similar 
annealing/integration model holds for the RecA- and phage-independent oligo 
mutagenesis observed in L. pneumophila.  To this end, we utilized three different 3‘ 
modifications to generate oligos that are non-extendable by DNA polymerase and 
protected from exonucleolytic cleavage by three sequential phosphorothioate 
modifications.  To rule out any modification-specific effects, we examined oligos whose 
extension was blocked by either a 3‘ inverted thymidine nucleotide (invT), a 3‘ phosphate 
(3‘ PO4
-
), or a 3‘ dideoxy (ddC).  The 3‘ inverted thymidine nucleotide and 3‘ phosphate 
modifications also increase nuclease resistance (Ortigao, et al., 1992; manufacturer's 
information).  To reduce exonucleolytic cleavage of the modifications, which would 
allow extension from internal nucleotides, we also utilized recJ xseA double nuclease 
mutant L. pneumophila.  Since λ-Red recombination in E. coli is sensitive to the 
concentration of oligo (Huen, et al., 2006), we performed experiments with both limiting 
(0.1 nmol per electroporation) and near-saturating amounts (1 nmol per electroporation, 
our standard condition).  In no experiment did non-extendable oligos reduce the 
frequency of mutagenesis; indeed, the frequency typically increased (Fig 3.5A). 
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To assess whether the increase in mutation frequency from non-extendable oligos 
is specific to RecA- and phage-independent oligo mutagenesis in L. pneumophila or 
instead is a conserved feature of the bacterial process, we examined the 3‘ inverted 
thymidine modified oligo in our plasmid system in both L. pneumophila and E. coli. 
Consistent with mutagenesis of the L. pneumophila chromosome, the frequency of 
mutagenesis by non-extendable oligos was increased in both species, not decreased (Fig 
5B).  To confirm that our inverted thymidine oligo decreased recombination frequencies 
in a λ-dependent system, we employed our plasmid assay in E. coli DY330 and used 
limiting oligo concentrations (1 pmol per electroporation) to reduce confounding effects 
of oligo mutagenesis.  In three independent experiments, we observed a mean 4.3-fold 
reduction in recombination frequency with the invT oligo compared to the unmodified 
oligo, as expected from previous studies using dideoxy oligos (Grogan and Stengel, 2008, 
Huen, et al., 2006) and in stark contrast to the ~10-fold increase in phage-independent 
oligo mutagenesis measured in E. coli (Fig 3.5B). 
 
Oligo mutagenesis is not increased by 5’ phosphate modification compared to 5’ 
hydroxyl oligos. 
To test if other parameters of the annealing/integration model apply to oligo-
induced mutagenesis in L. pneumophila, we investigated whether oligos are directly 
ligated into the nascent strand by comparing mutagenesis by oligos that contain either 5‘ 
phosphate or hydroxyl groups.  To reduce degradation of the 5‘ end, the terminus was 
protected by three sequential phosphorothioate modifications and a recJ xseA double 
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nuclease mutant was employed.  In both wild-type and exonuclease mutant cells, the 
mutagenesis frequencies were similar for oligos with 5‘ phosphate versus 5‘ hydroxyl 
groups (Fig 3.6).  Likewise, LNA-protected oligos, which have a 5‘ hydroxyl, supported 
high frequencies of oligo-induced point mutations (Fig 3.3).  Thus, the effect of 
modifications of both the 5‘ and 3‘ ends of the oligos on L. pneumophila mutagenesis 
was opposite that reported for λ-Red mediated recombination in E. coli and S. 
acidocaldarius (Grogan and Stengel, 2008). 
 
PriA and Pol I, but not RadA, contribute to oligo mutagenesis. 
Since the features of oligo-induced mutagenesis of L. pneumophila differ from 
previously described recombination systems, we applied genetics to investigate its 
mechanistic requirements.  Having no evidence for either classical homologous 
recombination or contributions by a phage-encoded single-stranded binding protein 
(Table 3.S1), we tested the RecA paralog RadA, which contributes to recombination in 
different systems to varying degrees (Beam, et al., 2002, Lovett, 2006, Seitz, et al., 1998, 
Slade, et al., 2009).  Under the conditions tested, the radA and wild-type cells exhibited 
similar frequencies of oligo mutagenesis (Fig 3.7). 
Since oligo-induced mutagenesis was strand dependent but elongation 
independent, we reasoned that when oligos anneal at the fork, the advancing replicative 
polymerase hops over the oligo and re-starts downstream.  Initiation of replication 
outside of the origin requires the primosomal proteins PriA or PriC (Gabbai and Marians, 
Lovett, 2005).  Since L. pneumophila does not appear to have PriC (Table 1.1), we 
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analyzed the impact of a priA mutation in our cat::kan assay strain.  Consistent with a 
defect in replication restart, compared to wild type the priA-deficient strain had a higher 
number of filamentous cells, slower growth, and plateaued at lower culture densities.  
When subjected to oligo-induced mutagenesis, priA mutant cells had a significantly 
reduced mutation frequency compared to wild-type cells (Fig 3.7).  In contrast, E. coli 
priA mutants are not impaired for λ-Red dependent recombination (Huen, et al., 2006).  
The low background frequency of mutagenesis observed in the priA mutant may reflect 
accumulation of suppressor mutations, given that mutant colonies were more 
heterogeneous than normal.   
Rather than extend, if the replicative polymerase hops over an annealed oligo, and 
then PriA directs the enzyme to restart, a single-stranded gap would remain after passage 
of the replisome.  Since many gap-repair systems require DNA polymerase I (Kuzminov, 
1999), we constructed a strain which lacks the entire predicted polymerase domain.  
Similar to the priA strain, these polA mutant cells displayed characteristics typical of 
replication and repair mutants, although the cultures grew to normal cell densities.  When 
subjected to oligo mutagenesis, the polA polymerase domain mutant exhibited a mutation 
frequency significantly lower than wild type (Fig 3.7).  These data are consistent with a 
requirement for proficient single-strand gap repair.  However, we have not ruled out other 
potential roles or confounding effects for DNA Pol I activity, such as oligo extension or 
limitation of the region of ssDNA available.  It remains possible that the reduced rate of 
oligo mutagenesis for both the priA and polA polymerase domain mutant strains reflects a 
paucity of replication forks due to their poor growth.  However, we find this explanation 
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unlikely, since the recJ xseA nuclease mutant cells displayed a similarly high proportion 
of filamentous cells, reduced growth rate, and variable recovery after electroporation, yet 
sustained oligo mutagenesis more frequently than wild-type cells did (Fig 3.3).   
 
Homologous oligos flanked by non-homologous sequences have decreased, but not 
abolished, ability to stimulate oligo mutagenesis.   
In its natural aquatic reservoir, the DNA L. pneumophila encounters and takes up 
via natural transformation is unlikely to contain perfectly homologous DNA.  More 
likely, DNA substrates may include small conserved motifs flanked by non-homologous 
sequences.  Therefore, to gain insight to both potential evolutionary impact and 
mechanism, we tested whether oligos with non-homologous ends are mutagenic.  L. 
pneumophila was exposed to oligos containing 60 nt of homology (30 nt on either side of 
kan cassette, as above) and flanked by either 10 or 35 nt of non-homologous sequence on 
both the 5‘ and 3‘ ends.  To control for amount of homology, as well as for the total 
length of the oligo, we also introduced entirely homologous 60mer, 80mer or 130mer 
oligos.  To test the contribution of classical homologous recombination, we analyzed a 
recA mutant strain.  In general, the addition of non-homologous sequences decreased, but 
did not abolish, mutagenesis (Fig 3.8).  The slightly higher frequency observed for the 
130mer compared to 60-80mer entirely homologous oligos may be due to the higher 
purity of the 130mer Ultramer compared to standard de-salted 60-80mers (manufacturer‘s 
information).  To ascertain whether recombinant colonies incorporated any non-
homologous nucleotides, we sequenced the corresponding locus of mutants generated 
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with either the entirely homologous 80mer oligo (6 clones), the oligo containing 10 nt of 
non-homologous sequence on both 5‘ and 3‘ ends (6 clones), or the oligo with 10 nt of 
non-homologous sequence plus 3‘ nuclease-resistant cap (8 clones).  In all cases, the 
identical cat sequence was obtained, and non-homologous sequences were not inserted.  
Together, these results indicate that non-homologous flanking DNA can be processed 
from the homologous sequences, which stimulate the mutagenic process. 
Natural DNA substrates could have much longer non-homologous sequences than 
the 10-35 nt investigated here.  Since synthesis of longer oligos is a technical and 
economic hurdle, as a surrogate for longer non-homologous sequences, we genetically 
inactivated exonucleases and/or protected the 3‘ ends from nucleases.  Unmodified oligos 
bearing non-homologous ends stimulated a similar mutation frequency in the recJ xseA 
exonuclease mutants and wild-type cells, suggesting enzymes other than RecJ or XseA 
can process the oligo.  However, when the exonuclease mutant was treated with 3‘ 
nuclease-resistant oligos bearing non-homologous ends, the mutation frequency 
decreased to near the limit of detection.  These data suggest that the oligos are likely 
processed by RecJ, XseA, and/or other exonucleases, but are less likely to be processed 
by endonucleases.  Taken together, our results indicate that, to facilitate exchange of 
genetic information and acquisition of selectable phenotypes, L. pneumophila can process 
single-stranded DNA molecules, including non-homologous sequences that may inhibit 




Oligo-stimulated excision can be exploited to generate markerless chromosomal 
mutations by counter-selection.   
Having observed excision of large DNA fragments by a direct gain-of-function 
selection (Fig 3.4-8), to approximate what occurs in the environment we tested whether 
deletions can be obtained with a less stringent loss-of-function selection.  While doing so, 
we investigated whether oligo mutagenesis can be harnessed to construct markerless 
mutations without expression of phage recombinase proteins, an application that has been 
proposed but not yet realized in bacteria (Dutra, et al., 2007, Murphy and Marinus, 
Swingle, et al., 2010b).  To accommodate the low frequency of excision (Fig 3.4) and 
high frequency of spontaneous mutation of many counter-selectable cassettes, we first 
constructed a cassette containing three genes in tandem:  cat, conferring chloramphenicol 
resistance; rdxA, conferring metronidazole sensitivity; and rpsL, conferring streptomycin 
sensitivity.  Next, the chromosomal fliA locus was replaced by natural transformation 
with this 2.1 kb double counter-selectable cassette by isolating chloramphenicol-resistant 
colonies.  After electroporation with an oligo homologous to the fliA sequences directly 
flanking the cassette, cells that had excised the counter-selectable markers were isolated 
on medium containing metronidazole and streptomycin.  Indeed, defined markerless 
deletions of fliA were obtained in each of three independent experiments, as determined 





Oligo-induced mutagenesis can be harnessed to insert DNA onto the chromosome.   
Next we assessed whether oligos also stimulate insertion of foreign DNA—an 
important and previously unexplored activity that could inform mechanism, evolution, 
and genetic engineering.  The cat-rdxA-rpsL cassette was first placed at the translational 
start of the fliA gene.  Next, bacteria were electroporated with an oligo having 36 nt of 
homology to the sequences flanking the cassette as well as 18 nt encoding a 6(x)His tag 
(Fig 3.9B).  In each of two independent experiments, clones were isolated in which the 
cat-rdxA-rpsL cassette was excised and the 18 nt 6(x)His-tag sequence was inserted.  
Each of four clones obtained in one experiment were confirmed by sequencing.  Thus, L. 
pneumophila can insert into the chromosome at least short sequences of foreign DNA, 
provided the elements are flanked by short regions of homology (Fig 3.9B, C). 
To investigate the fidelity of the oligo insertion process, we performed phenotypic 
and molecular analysis of the engineered fliA locus.  By screening metronidazole- and 
streptomycin-resistant clones obtained after electroporation of the oligo encoding the His 
tag (Fig 3.9B), we determined that the majority, though not all, of the clones had also lost 
the chloramphenicol resistance phenotype (Fig 3.9C).  A portion of these 
chloramphenicol-sensitive clones were confirmed by PCR and/or sequencing to have the 
desired 6(x)His tag sequence (Fig 3.9B, C), whereas a separate class of mutants were 
chloramphenicol sensitive, but did not encode the His tag.  To distinguish between 
excision of a large fragment of DNA and acquisition of point mutations in the counter-
selectable cassettes, the chloramphenicol-sensitive recombinants were screened by PCR.  
A striking degree of heterogeneity in the size of the products was observed.  Some clones 
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yielded products larger or smaller than expected; other clones yielded no product, 
suggesting loss of one or both of the primer sites.  To further investigate these clones, 
five representative fliA alleles of aberrant sizes were sequenced.  All five isolates 
contained deletions of various lengths, consistent with the inactivation of the cat, rdxA, 
and rpsL alleles, but no other patterns were obvious (Fig 3.9D).  Similar results were 
observed when the cat-rdxA-rpsL strain was simply grown overnight and selected on 
metroniadazole-streptomycin plates—suggesting these large deletions also occur 
independently of exposure to oligo DNA.   Despite the high degree of heterogeneity, 
100% of the clones derived from oligo transformations that yielded in the initial PCR 
screen a product of the correct size also encoded the desired sequence modification, as 
determined by an independent PCR strategy and/or the nucleotide sequence of the allele.  
Thus, the strong pressure for metronidazole and streptomycin resistance selects for rare 
large and variable chromosomal deletions.  However, when homologous foreign DNA in 
the form of an oligo is also present, the propensity for the corresponding sequence to be 
deleted from the chromosome increases. 
 
DISCUSSION 
Here we report that L. pneumophila sustains a moderate frequency of mutation 
when exposed only to short sequences of homologous DNA at high concentrations (Fig 
3.1, 3.4).  This oligo-induced mutagenesis is RecA- and RadA-independent (Fig 3.1, 3.5-
7).  The mutation frequency increases when exonucleases are inactivated and moderately 
decreases when non-homologous sequences flank the regions of homology (Fig 3.7, 3.8).  
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Although phage-like sequences are detectable within the genome (Cazalet, et al., 2004), 
no phage recombinases homologous to RecT or Beta have been identified within our 
wild-type strain sequence (Table 3.S1; Altschul, et al., 1997, Chien, et al., 2004).  While 
unknown phage genes may underlie our observations, it is difficult to test, and we have 
no evidence to support that possibility.  Oligo mutagenesis does not appear to utilize 
canonical 5‘ phosphate or 3‘ hydroxyl groups, but the primosomal protein PriA and DNA 
polymerase I each contribute (Fig 3.5-7).  As a genetic engineering tool, short oligos can 
direct precise deletions and insertions, and the desired recombinants be identified by a 
PCR screen (Fig 3.9).  Taken together, our results suggest that both single nucleotide 
changes as well as larger chromosomal deletions likely occur at the replication fork, 
rather than during transcription or by canonical recombination (Fig 3.2, 3.4, 3.7).   
Certain aspects of oligo-induced mutagenesis of L. pneumophila are similar to 
classical homologous recombination and phage recombination systems, but other features 
are distinct.  Like both RecA- and phage-mediated recombination, oligo-induced 
mutagenesis requires DNA homology.  Homologous recombination is conserved among 
all kingdoms of life, with most organisms possessing a RecA/RadA/Rad51-like 
recombination system that executes many aspects of recombination, repair, and 
replication (Kuzminov, 1999, Lusetti and Cox, 2002).  These well-described 
recombination systems usually rely on large regions of homology to mediate efficient 
cross over or gene conversion events (Kuzminov, 1999,  Lovett, et al., 2002, Thomas and 
Nielsen, 2005).  In contrast, the use of λ-Red phage recombination system as a genetic 
engineering tool continues to increase because homologous recombination is stimulated 
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by sequences with < 50 bp of homology (Yu, et al., 2000).  Likewise, oligo-induced 
mutagenesis requires only short regions of homology.  However, in contrast to the known 
phage systems, the relationship between efficiency of oligo-induced mutation and length 
of homology is not linear (Fig 3.1B; Lovett, et al., 2002, Yu, et al., 2000).  Oligo-induced 
mutagenesis also differs from both RecA- and phage-dependent recombination in its 
requirement for higher concentrations of DNA, possibly due to greater susceptibility to 
exonucleases (Fig 3.3; Dutra, et al., 2007, Swingle, et al., 2010b).   
Mechanistic requirements also distinguish oligo-induced mutagenesis from λ-Red 
mediated recombination.  While λ-Red requires a free 5‘ phosphate and a 3‘ terminus that 
can be extended by DNA polymerase (Grogan and Stengel, 2008, Huen, et al., 2006), 
phage-independent oligo mutagenesis does not (Fig 3.5, 3.6).  While sensitivity to 5‘ and 
3‘ end modifications may be masked by nucleolytic cleavage, several indirect results 
suggest this is not the case.  First, non-extendable oligos were mutagenic in both L. 
pneumophila and E. coli, ruling out cleavage by a species-specific nuclease.  Second, 
similar mutation frequencies were obtained whether or not modifications were protected 
by either sequential phosphorothioate bonds or potent nuclease-resistant nucleotides, 
even in the recJ xseA double nuclease mutant.  Third, when oligos with non-homologous 
ends were protected with 3‘ caps, the frequency of mutagenesis decreased to near limit-
of-detection in the recJ xseA mutants.  Fourth, no recombinants were observed when 
homologous donor DNA was provided as a circular molecule.  Fifth, since the lengths of 
homology present just met the threshold needed for maximal efficiency (Fig 3.4-6), 
endonucleolytic cleavage was predicted to decrease the length of homology and decrease 
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mutation frequency, but this pattern was not observed.  The requirement for PriA in oligo 
mutagenesis (Fig 3.7), but not in λ-Red recombination (Huen, et al., 2006), is also 
consistent with the notion that, whereas polymerase extends an oligo as an Okazaki 
fragment during λ-Red recombination, replication re-starts downstream of the oligo 
during phage-independent oligo mutagenesis.  Based on this series of results, we propose 
that during oligo-induced mutagenesis, DNA polymerase does not directly extend oligos 
and DNA ligase does not directly ligate the oligo to the nascent strand.  
Taking into consideration its similarities and differences from both classical 
homologous recombination and phage recombination systems, we currently favor a 
modified strand annealing mechanism for oligo-induced mutagenesis (Fig 3.10).  In this 
model, DNA replication generates single-stranded DNA at the replication fork, followed 
by transient looping out of predominantly the lagging strand (Fig 3.1, 3.2, 3.4).  The 
exposed ssDNA provides a substrate for homologous oligos to anneal and stabilize minor 
or more extensive ―D-loops‖.  In turn, the replication fork stalls due to the secondary 
structure of the D-loop and the dsDNA encountered by DNA polymerase (Bzymek and 
Lovett, 2001, Canceill and Ehrlich, 1996, Saveson and Lovett, 1997, Swingle, et al., 
2010b, Viguera, et al., 2001).  Exonucleases digest any flanking non-homologous 
sequences, either before or after the oligo anneals (Fig 3.8).  The mutagenesis frequency 
could be reduced when helicases at the fork recognize non-homologous flaps, thereby 
dislodging the annealed oligo and aborting the event.  Regardless of oligo processing, 
PriA mediates replication re-start downstream of the annealed oligo (Fig 3.3, 3.5-7).  An 
unknown post-replication repair mechanism then processes the D-loop using the oligo as 
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a template.  Finally, the oligo itself is processed, or possibly excised entirely (Fig 3.5, 3.6, 
3.8).  The resultant single-stranded gap is repaired by DNA Pol I (Fig 3.7).  Strong 
antibiotic or other evolutionary pressures can capture the rare excision of large fragments 
of DNA.  By stabilizing D-loops, homologous DNA that anneals increases the propensity 
for deletion of the corresponding nucleotides; alternatively, the oligos could insert any 
intervening sequences (Fig 3.4-9).  By incorporating mismatch repair, the same model 
can account for point mutations or other minor genetic changes (Fig 3.1-3).  
Nevertheless, a template switch model similar to that proposed for λ-Red (Poteete, 2008) 
also accommodates our data (Fig 3.11), and distinguishing between the two mechanisms 
would be difficult  with the tools currently available for L. pneumophila. 
That physical annealing of homologous oligos contributes to mutagenesis is 
inferred by a number of observations.  By manipulating GC content of the oligos, 
Swingle et al correlated predicted binding affinity and mutagenesis frequency (Swingle, 
et al., 2010b).  Our observation that the frequency of mutagenesis in exonuclease mutant 
bacteria was increased by LNA-modification (Fig 3.3), which stabilizes binding to 
template DNA, is also consistent with direct annealing of the oligo.  The homologous 
DNA template could potentially originate from a second chromosomal copy during 
replication, foreign DNA taken up via natural transformation, or a synthetic 
oligonucleotide introduced via electroporation, as we have shown here.  Even in the 
absence of exogenous homologous DNA sequences, excision of ssDNA loops likely 
occurs as a stochastic process, as judged by the chloramphenicol-sensitive phenotype of 
colonies selected with metronidazole and streptomycin in the control samples that were 
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not treated with DNA (data not shown).  Whether stimulated by exogenous DNA or not, 
such infidelity during DNA replication would equip bacteria with a mechanism to alter 
the size of their chromosomes, conferring an advantage to cells that incorporate 
beneficial DNA or excise sequences that are unnecessary or harmful in particular 
environmental conditions. 
Oligo recombination can be a powerful genetic engineering tool for organisms 
that lack efficient phage recombinase systems.  Here we exploited oligos to construct 
defined markerless mutations within the chromosome or to insert short sequences that 
encode an epitope tag.  This enables the researcher to order custom-designed oligos of 
precise sequence, thereby reducing allele construction steps.  By engineering a novel 
counter-selectable cassette (Fig 3.9), we decreased the background of spontaneously 
resistant isolates, permitting plating cells at high density on selective media.  As a result, 
we obtained the desired mutants in every experiment conducted.  To increase the 
frequency of the desired mutation, oligo modifications predicted to limit exonucleolytic 
attack and increase annealing strength can be incorporated (Fig 3.3, 3.5).  Oligos have 
been shown to promote chromosomal point mutations in several genera (Swingle, et al., 
2010b), and we extend those observations by demonstrating that oligos induce large 
deletions in both L. pneumophila and E. coli (Fig 3.4, 3.5).  While the application beyond 
Gram negative organisms is unknown, the apparent contributions by conserved 
replication components rather than specific phage genes suggests broad applicability. 
Therefore, oligo mutagenesis techniques are likely applicable to a large range of 
organisms, including those where genetic tools are limited.  While adaptation to different 
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species may require tailored selectable markers and transformation conditions and has 
thus far been less efficient than phage-based recombineering, it may be less cumbersome 
than the herculean task of searching for and optimizing a species-specific phage 
recombinase that supports efficient recombination, as van Kessel and Hatful have done 
for the Mycobacteria community (van Kessel and Hatfull, 2007). 
L. pneumophila exhibits extraordinary genomic diversity and high plasticity, 
including the presence of eukaryotic-like motifs that contribute to pathogenesis (Cazalet, 
et al., 2008, Cazalet, et al., 2004, Chien, et al., 2004, Gomez-Valero, et al., 2009, Lurie-
Weinberger, et al., 2010, Price, et al., 2009).  The species‘ variability may reflect the 
organism‘s ability to take up foreign DNA in its natural reservoir of aquatic biofilms and 
phagocytic amoebae and protozoa.  Indeed, Ogata and colleagues identified in the 
Rickettsia bellii genome several open reading frames similar to either eukaryotic or 
Legionellaceae sequences, which may indicate promiscuous and reciprocal gene 
exchange within host amoebae (Ogata, et al., 2006).  Natural isolates of L. pneumophila 
do undergo both intergenic (Coscolla and Gonzalez-Candelas, 2007) and intragenic 
recombination (Ko, et al., 2003), including at loci associated with virulence.  In addition 
to classical homologous recombination, we speculate that, in concert with its ability to 
take up free DNA from the environment, a process akin to oligo-induced mutagenesis 
may also contribute to emergence of pathogenic strains.  In particular, short homologous 
sequences can facilitate the incorporation of novel DNA sequences, including those that 
encode eukaryotic-like motifs, even if flanked by non-homologous sequences (Fig 3.8, 
3.9).  Although in initial studies we did not detect oligo-induced mutagenesis after natural 
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transformation, most likely because of the high DNA concentrations needed, we did not 
pursue this possibility exhaustively.  Nevertheless, considering evolutionary time scales, 
as well as environmental conditions that may stimulate natural transformation or suppress 
exonucleases, it is feasible that oligo-induced mutagenesis generates diversity within the 
species.  Furthermore, compared to model organisms, L. pneumophila encodes a minimal 
mismatch repair system and fewer single stranded nucleases (Figs 3.2, 3.3, Table 1.1; 
Altschul, et al., 1997, Bryan, et al., 2011, Cazalet, et al., 2004, Chien, et al., 2004).  
Perhaps natural competence, an extended half-life of single-stranded DNA molecules, 
and a modest editing machinery comprise an evolutionary strategy by which L. 
pneumophila increases the propensity to modify its genome to adapt to a broad array of 
eukaryotic hosts—including at least 13 species of amoeba, 2 species of ciliated protozoa, 




Figure 3.1.  Oligo-induced mutagenesis is RecA-independent and insensitive to  
lengths of homology ≥ 21 nt.  A) Wild-type or recA::cat mutant L. pneumophila were 
transformed with 1 nmol of an oligo corresponding either to the top (+) or bottom (-) 
strand of the annotated genomic rpoB sequence or to their dsDNA annealed product (+/-).  
Oligos of 71 nt encoded either wild-type rpoB sequence or a point mutation that confers 
rifampin resistance (Rif
R
; RpoB H541Y).  B) Wild-type cells were electroporated with 
RpoB H541Y oligos of the lengths indicated.  C) Wild-type cells were electroporated 
with oligos 31 nt in length corresponding to the bottom (-) strand.  Oligo A→G 
corresponds to the oligo encoding the point mutation conferring rifampin resistance.  WT 
represents the no mutation control oligo with wild-type rpoB sequence centered around 
the nucleotide that confers rifampin resistance.  5‘, 3‘, and Opp. indicate oligos directly 
5‘, directly 3‘, or on the opposite side of the chromosome as the mutation conferring 
rifampin resistance.  Rif
R
 values represent the mean ± SEM ≥ 3 independent experiments 
performed on separate days.  * Indicates statistically significant difference from no DNA 
control at α = 0.05 by two-tailed t-test with Welch‘s correction, where appropriate, and 






































































































































































Figure 3.2. Oligo-induced mutagenesis is strand- and growth-phase dependent.  A) 
Wild-type or mutS::cat mutant L. pneumophila were electroporated with RpoB H541Y 
oligos corresponding to the top (+) or bottom (-) strand as in Fig. 1.  P-value was 
determined by two-tailed t-test with Welch‘s correction.  B) Wild type cultured to 
exponential (OD600 ~ 1.00 ± 0.05) or post-exponential (> 95% motile, OD600 > 4.0) 
growth phase were electroporated with either an oligo or a control plasmid that confers 
gentamycin resistance (Gent
R
) and cultured overnight or for 1.5 h, respectively, before 
plating on selective medium.  Values represent the mean ± SEM of ≥ 3 independent 


































Figure 3.3.  Oligo-induced mutagenesis is limited by exonucleases.  Wild-type or 
recJ::cat xseA::kan double mutant L. pneumophila were electroporated with the 
concentration shown of either a standard 45 nt oligo (solid line) or a corresponding oligo 
containing a single Locked Nucleic Acid (LNA) and 3 phosphorothioate bonds at both 
the 5‘ and 3‘ ends (dashed line).  Each data point represents the mean ± SEM of ≥ 4 





Figure 3.4. Oligo-induced mutagenesis can excise large fragments of DNA and is 
sensitive to orientation in the chromosome.  A) The genomic orientations and expected 
phenotypes of L. pneumophila whose fliA gene is replaced by a cat gene containing an 
insertion of a 950 bp kan gene.  B) The cat::kan strains with cassette in orientation shown 
and either the wild-type or recA::gent allele were cultured and treated as before.  
Experiments testing dsDNA used 1 nmol of annealed 70 nt oligos; tests of oligo length 
and RecA-dependence used 1 nmol of bottom (-) oligo; tests of orientation in the 
chromosome used 5 nmol of a 70 nt oligo.  C) The same set of oligos was introduced into 
recA mutants of E. coli and L. pneumophila containing the fliA::cat::kan allele cloned in 
either orientation on a RSF1010-based plasmid.  Total plasmid containing colonies 
indicates colonies exhibiting phenotypes conferred by the plasmid backbone—ampicillin 
resistance for E. coli and thymidine prototrophy for L. pneumophila.  Values represent 
the mean ± SEM of ≥ 3 independent experiments performed on separate days.  ^, 
approximate limit of detection when no recombinant colonies were obtained; +/-, 





































































































Figure 3.5.  Oligo mutagenesis is not inhibited by 3’ modified oligos that are non-
extendable by DNA polymerase.  A)  Wild-type, recA mutant, and recA xseA recJ triple 
mutant bacteria were electroporated with either 1 nmol or 0.1 nmol (1:10 dilution) of 
60mer oligos that were unmodified, protected at the 3‘ end by 3 sequential 
phosphorothioate modifications (PT alone), or protected at the 3‘ end by 3 sequential 
phosphorothioate modifications with either a 3‘ phosphate (PO4
-
), 3‘ dideoxy (ddC), or 3‘ 
inverted thymidine (invT).  B) Unmodified or 3‘ inverted thymidine capped oligos were 
introduced into recA mutants of E. coli and L. pneumophila containing the fliA::cat::kan 
allele cloned in either orientation on a RSF1010-based plasmid.  Total plasmid containing 
colonies indicates colonies exhibiting phenotypes conferred by the plasmid backbone—
ampicillin resistance for E. coli and thymidine prototrophy for L. pneumophila.  Values 
represent the mean ± SEM of ≥ 3 independent experiments performed on separate days.  

























































































































Figure 3.6.  Oligo mutagenesis is not increased by 5’ phosphate modification  
compared to unmodified 5’ hydroxyl oligos.  Wild-type and recA xseA recJ triple 
mutant bacteria were electroporated with 1 nmol of 60mer oligos that were either 
unmodified, and therefore contained a 5‘ hydroxyl (OH
-
), or contained a 5‘ phosphate 
(PO4
-
) modification.  PT indicates that the 5‘ end was protected from nucleolytic cleavage 
by 3 sequential phosphorothioate bonds.  Values represent the mean ± SEM of ≥ 3 
independent experiments performed on separate days.  ^, approximate limit of detection 








































Figure 3.7.  PriA and Pol I, but not RadA, contribute to oligo mutagenesis.  Wild-
type or bacteria with mutations in radA, priA, or the polymerase domain of polA (DNA 
Pol I) were electroporated with 1 nmol of the unmodified 60mer oligo or the oligo 
modified by 3 sequential phosphorothioate bonds at the 3‘ end and a 3‘ inverted 
thymidine. Values represent the mean ± SEM of ≥ 3 independent experiments performed 
on separate days.  ^, approximate limit of detection (LOD) when no recombinant 
colonies were obtained;  #, in 1 out of 3 replicates no colonies were observed and the 
LOD was used in the calculation of the mean; *, statistically significant difference from 
wild-type cells using the same oligo at α = 0.05 by two-tailed t-test with Welch‘s 
correction, where appropriate, and adjusted by Bonferroni‘s correction for multiple 













































Figure 3.8.  Homologous oligos flanked by non-homologous sequences have  
decreased, but not abolished, mutagenic activity.  Wild-type, recA mutant, and recA 
xseA recJ triple mutant bacteria were electroporated with 1 nmol of the indicated oligo.  
Values represent the mean ± SEM of ≥ 3 independent experiments performed on separate 
days.  h, length of homologous sequence; nh, length of non-homologous sequence 
flanking the homologous DNA at both the 5‘ and 3‘ ends; PT, oligo was protected from 
nucleolytic digestion at the 3‘ end with 3 sequential phosphorothioate bonds; invT, oligo 
with a 3‘ inverted thymidine base; ^, approximate limit of detection (LOD) when no 
recombinant colonies were obtained; #, in 1 out of 3 replicates no colonies were observed 










CmS PCR CmS PCR 
Exp. 1 60% 23% 83% 27%
Exp. 2 92% 40% 72% 9%





















Figure 3.9. Oligo-induced mutagenesis can be harnessed for genetic manipulation  
of the chromosome. A) The genomic orientation and phenotype of L. pneumophila 
whose fliA gene is replaced by a cat-rdxA-rpsL selectable/counter-selectable cassette and 
an 84 nt oligo with homology directly flanking the fliA open reading frame.  Excision of 
the cassette results in a defined markerless deletion. B) The genomic orientation and 
phenotype of L. pneumophila encoding the cat-rdxA-rpsL selectable/counter-selectable 
cassette at the translational start of the fliA gene and a 90 nt oligo with 36 nt of homology 
directly flanking the fliA open reading frame and 18 nt encoding a 6(x)His tag.  C) The 
percentage of total restreaked metronidazole-resistant (Mtz
R
) and streptomycin-resistant 
(Strep
R
) colonies that were chloramphenicol-sensitive (Cm
S
), and the percentage of the 
Cm
S
 clones whose deletions were confirmed by PCR in 2-3 representative experiments.  
D) Heavy line indicates position and size of PCR product of parental strain.  The 
structure of five representative alleles from the same experiment that were 
chloramphenicol-sensitive and yielded PCR products of aberrant sizes as determined by 







2.  Oligo anneals & D-loop forms
3. Polymerase hops & restarts downstream
4. D-loop processed
1.  DNA replication;
Transient strand looping out & oligo transformation
Direction of replication
5. Excision/repair of oligo
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Figure 3.10.  Strand annealing model of oligo-induced mutagenesis in  
L. pneumophila as described in the text.  Yellow line with black center represents an 
oligo with homology to a chromosomal sequence (yellow) and a foreign sequence 
(black).  Green Pac-Man characters indicate exonucleases or other unknown repair 


















































Figure 3.S1.  Growth curves of strains used in oligo mutagenesis assays and their 
recombinant derivatives.   Indicated strains were growth overnight in AYET, 
normalized, and OD600 followed for 48 hours in a Bioscreen Growth Curve Analyzer.  A) 
Wild-type Lp02 and three derivative rifampin resistant clones used in the point mutation 
assay, B) wild-type Lp02, fliA::cat::kan cells used in the large excision assay, and two 
derivative  recombinant fliA::cat  clones, and C) wild-type Lp02, fliA::cat-rdxA-rpsL 
strain used to construct the clean deletion in fliA, and resultant markerless deletion 
mutants in fliA.  Data is representative of two independent experiments and represents the 
mean ± SD of triplicate wells of a single experiment (In general, error bars are masked by 
time point symbols.).   
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Table 3.S1.  Bacterial strains and plasmids. 
E. coli and plasmids  
DH5α 
supE44 ∆lacU169 (80 lacZ∆M15) hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 Laboratory collection 
DY330 W3110 ∆lacU169 gal490 λcI857 ∆(cro-bioA) (Yu, et al., 2000) 
HB101 
F– Δ(gpt-proA)62 leuB6 glnV44 ara-14 galK2 lacY1 Δ(mcrC-
mrr) rpsL20 (Strr) xyl-5 mtl-1 recA13 
(Lacks and Greenberg, 
1977) 
MB738 HB101 λpir This work 
MB739 HB101 endA::frt This work 
MB740 HB101 λpir endA::frt This work 
 pKD3 
 (Datsenko and Wanner, 
2000) 
 pKD4 
(Datsenko and Wanner, 
2000) 
 pRDX 
(Goodwin, et al., 1998, 
LeBlanc, et al., 2006) 
  pGEM-T easy Promega 
MB442 DH5α pMMB206 ∆mob 
(Molofsky and Swanson, 
2003) 
MB741 DH5α pMMBGent This work 
MB742 DH5α pGEMrecA This work 
MB743 DH5α pGEMrecA::frt-cat-frt This work 
MB744 DH5α pGEMrecA::gent This work 
MB773 DH5α pGEMrecF This work 
MB774 DH5α pGEMrecF::frt-cat-frt This work 
MB745 DH5α pGEMmutS This work 
MB746 DH5α pGEMmutS::frt-cat-frt This work 
MB747 DH5α pGEMrecJ::frt-cat-frt This work 
MB748 DH5α pGEMxseA This work 
MB749 DH5α pGEMxseA::frt-kan-frt This work 
MB750 DH5α pGEMfliA This work 
MB751 DH5α pGEMfliA::frt-cat-frt This work 
MB752 DH5α pGEMfliA::cat::kan This work 
MB753 DH5α pGEMfliA::cat::kan opposite orientation This work 
MB754 MB740 pGEMfliA::cat-rdxA-rpsL (cassette replacing fliA) This work 
MB755 
MB740 pGEMfliA::cat-rdxA-rpsL (cassette inserted at start 
of FliA) This work 
MB776 HB101 λpir endA::frt, pR6KcatrdxArpsL This work 
JW2669 BW25113 recA::frt-kan-frt (Baba, et al., 2006) 
MB839 BW25113 recA::frt This work 
MB840 DH5α pJB98cat::kan This work 
MB841 DH5α pJB98cat::kan-Opp This work 
MB842 BW25113 recA::frt,  pJB98cat::kan This work 
MB843 BW25113 recA::frt,  pJB98cat::kan This work 
MB844 DH5α pGEMradA This work 
MB845 DH5α pGEMradA::gent This work 
MB846 DH5α pGEMpolA(polymerase domain) This work 
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MB847 DH5α pGEMpolA(polymerase domain)::gent This work 
MB848 DH5α pGEMpriA This work 
MB849 DH5α pGEMpriA::gent This work 
 
L. pneumophila  
MB110 Lp02 wild type, thyA, hsdR, rpsL (StrR) (Berger and Isberg, 1993) 
MB756 Lp02 recA::frt-cat-frt This work 
MB775 Lp02 recF::frt-cat-frt This work 
MB757 Lp02 mutS::frt-cat-frt This work 
MB758 Lp02 recJ::frt-cat-frt This work 
MB759 Lp02 xseA::frt-kan-frt This work 
MB760 Lp02 recJ::frt-cat-frt, xseA::frt-kan-frt This work 
MB761 Lp02 fliA::cat::kan This work 
MB762 MB761 (fliA::cat::kan), recA::gent This work 
MB763 Lp02 fliA::cat::kan opposite orientation This work 
MB764 Lp02 fliA::cat-rdxA-rpsL (for precise deletion) This work 
MB765 Lp02 fliA clean deletion (MB764 cured with oligoAB201) This work 
MB766 Lp02 fliA::cat-rdxA-rpsL (insertion at FliA start) This work 
MB767 Lp02 His-FliA (MB766 cured by oligoAB314) This work 
MB768 MB766 with 1878 bp excision (allele rdxA5) This work 
MB769 MB766 with 2870 bp excision (allele rdxA20) This work 
MB770 MB766 with 2452 bp excision (allele rdxA21) This work 
MB771 MB766 with 2785 bp excision (allele rdxA30) This work 
MB772 MB766 with 2482 bp excision (allele rdxA32) This work 
MB850 Lp02 recA::gent This work 
MB851 Lp02 recA::gent, pJB98-oligoAB243/4 This work 
MB852 Lp02 recA::gent, pJB98cat::kan This work 
MB853 Lp02 recA::gent, pJB98cat::kan-Opp This work 
MB821 Lp02 recJ::frt, xseA::frt (Bryan, et al., 2011) 
MB855 Lp02 recJ::frt, xseA::frt, fliA::cat::kan This work 
MB856 Lp02 recJ::frt, xseA::frt, fliA::cat::kan, recA::gent This work 
MB857 Lp02 fliA::cat::kan, radA::gent This work 
MB858 Lp02 fliA::cat::kan, polA(polymerase domain)::gent This work 
MB859 Lp02 fliA::cat::kan, priA::gent This work 





Table 3.S2.  Oligos used for direct mutagenesis in L. pneumophila and E. coli. 
oligoAB54 Top (+) strand, 71nt, RpoB H526Y 
5'  TTA TGG ATC AAG TGA ATC CAT TAT CTG GTG 
TTA CGT ATA AAA GAC GTG TAT CAG CTC TTG 
GGC CAG GTG GT  3' 
oligoAB55 Bottom (-) strand, 71nt, RpoB H526Y 
5'  ACC ACC TGG CCC AAG AGC TGA TAC ACG TCT 
TTT ATA CGT AAC ACC AGA TAA TGG ATT CAC 
TTG ATC CAT AA  3' 
oligoAB202 Bottom (-) strand, 71nt, No mutation control 
5'  ACC ACC TGG CCC AAG AGC TGA TAC ACG TCT 
TTT ATG CGT AAC ACC AGA TAA TGG ATT CAC 
TTG ATC CAT AA  3' 
oligoAB221 Bottom (-) strand, 11nt, RpoB H526Y 5'  TTT ATA CGT AA  3' 
oligoAB220 Bottom (-) strand, 21nt, RpoB H526Y 5'  CGT CTT TTA TAC GTA ACA CCA  3' 
oligoAB219 Bottom (-) strand, 31nt, RpoB H526Y 
5'  ATA CAC GTC TTT TAT ACG TAA CAC CAG ATA 
A  3' 
oligoAB203 Bottom (-) strand, 41nt, RpoB H526Y 
5'  AGC TGA TAC ACG TCT TTT ATA CGT AAC ACC 
AGA TAA TGG AT  3' 
oligoAB204 Bottom (-) strand, 161nt, RpoB H526Y 
5'  TGT ATG TAC GTC ACG GAC TTC AAA TCC AGC 
CCG CTC ACG TGT TAA ACC ACC TGG CCC AAG 
AGC TGA TAC ACG TCT TTT ATA CGT AAC ACC 
AGA TAA TGG ATT CAC TTG ATC CAT AAA CTG 
TGA TAA CTG ACT GGA TCC AAA AAA CTC TTT 
AAT TGC GGC GG  3' 
oligoAB253 Bottom (-) strand, 45nt, RpoB H526Y 
5'  AGA GCT GAT ACA CGT CTT TTA TAC GTA ACA 
CCA GAT AAT GGA TTC  3' 
oligoAB256 
Bottom (-) strand, 45nt, LNA (+), 
phosphorothioate (*), RpoB H526Y 
5'  +A*G*A* GCT GAT ACA CGT CTT TTA TAC GTA 
ACA CCA GAT AAT GGA* T*T*+C  3' 
oligoAB243 Top (+) strand, 70nt, excise kan from cat 
5'  CTT TCA TTG CCA TAC GTA ATT CCG GAT GAG 
CAT TCA TCA GGC GGG CAA GAA TGT GAA TAA 
AGG CCG GAT A  3' 
oligoAB244 Bottom (-) strand, 70nt, excise kan from cat 
5'  TAT CCG GCC TTT ATT CAC ATT CTT GCC CGC 
CTG ATG AAT GCT CAT CCG GAA TTA CGT ATG 
GCA ATG AAA G  3' 
oligoAB201 Bottom (-) strand, 84nt, fliA precise deletion 
5'  CAA TCC TAT TAA AGT CAA AGT ATC CAT ACT 
TAT TTT GAT ACT CTC CTT ACA ATA ACA GCA 
GAT TGT AGT TAT TAG TAA TTT GGT  3' 
oligoAB314 Bottom (-) strand, 90nt, 6(x)His-FliA 
5'  TTG TTG ATT TAC TTT GCT GTA TGC AGC CAA 
AGC ATC GTG ATG ATG ATG ATG ATG CAC GAT 
ACT CTC CTT ACA ATA ACA GCA GAT TGT AGT  3' 
oligoAB349 Bottom (-) strand, 31nt, No mutation control 
5' ATA CAC GTC TTT TAT GCG TAA CAC CAG ATA A 
3' 
oligoAB350 
Bottom (-) strand, 31nt, WT sequence, directly 
5' to RpoB H526Y mutation 
5' CGT AAC ACC AGA TAA TGG ATT CAC TTG ATC 
C 3' 
oligoAB351 
Bottom (-) strand, 31nt, WT sequence, directly 
3' to RpoB H526Y mutation 
5' CCT GGC CCA AGA GCT GAT ACA CGT CTT TTA T 
3' 
oligoAB407 
Bottom (-) strand, 31nt, WT sequence, anneals 
in lpg1846 
5' CCA AAG CGT AAG TTG CAT AAA TAT ACT CCA 
T 3' 
oligoAB295 Bottom (-) strand, 44nt, excise kan from cat 
5' TTC ACA TTC TTG CCC GCC TGA TGA ATG CTC 
ATC CGG AAT TAC GT 3' 
oligoAB309 Bottom (-) strand, 60nt, excise kan from cat 
5' GGC CTT TAT TCA CAT TCT TGC CCG CCT GAT 
GAA TGC TCA TCC GGA ATT ACG TAT GGC AAT 3' 
oligoAB367 Bottom (-) strand, 80nt, excise kan from cat 
5' AGT TTT ATC CGG CCT TTA TTC ACA TTC TTG 
CCC GCC TGA TGA ATG CTC ATC CGG AAT TAC 
GTA TGG CAA TGA AAG ACG GT 3' 
oligoAB366 Bottom (-) strand, 130nt, excise kan from cat 
5' AAG ACC GTA AAG AAA AAT AAG CAC AAG TTT 
TAT CCG GCC TTT ATT CAC ATT CTT GCC CGC CTG 
ATG AAT GCT CAT CCG GAA TTA CGT ATG GCA 
ATG AAA GAC GGT GAG CTG GTG ATA TGG GAT 
AGT GTT C 3' 
oligoAB370 
Bottom (-) strand, 60nt, excise kan from cat, 
phosphorothioate (*) 
5' GGC CTT TAT TCA CAT TCT TGC CCG CCT GAT 
GAA TGC TCA TCC GGA ATT ACG TAT GGC* A*A*T 
3' 
oligoAB382 
Bottom (-) strand, 60nt, excise kan from cat, 
phosphorothioate (*), 3' PO4
- 
5' GGC CTT TAT TCA CAT TCT TGC CCG CCT GAT 






Bottom (-) strand, 60nt, excise kan from cat, 
phosphorothioate (*), 3' ddC 
5' GGC CTT TAT TCA CAT TCT TGC CCG CCT GAT 
GAA TGC TCA TCC GGA ATT ACG TAT GGC* 
A*A*T-ddC 3' 
oligoAB369 
Bottom (-) strand, 60nt, excise kan from cat, 
phosphorothioate (*), 3' invT 
5' GGC CTT TAT TCA CAT TCT TGC CCG CCT GAT 
GAA TGC TCA TCC GGA ATT ACG TAT GGC* 
A*A*T-invT 3' 
oligoAB360 




--GGC CTT TAT TCA CAT TCT TGC CCG CCT 
GAT GAA TGC TCA TCC GGA ATT ACG TAT GGC 
AAT 3' 
oligoAB380 
Bottom (-) strand, 60nt, excise kan from cat, 
phosphorothioate (*) 
5' G*G*C* CTT TAT TCA CAT TCT TGC CCG CCT 
GAT GAA TGC TCA TCC GGA ATT ACG TAT GGC 
AAT 3' 
oligoAB381 
Bottom (-) strand, 60nt, excise kan from cat, 
phosphorothioate (*), 5' PO4
- 
5' PO4
--G*G*C* CTT TAT TCA CAT TCT TGC CCG CCT 
GAT GAA TGC TCA TCC GGA ATT ACG TAT GGC 
AAT 3' 
oligoAB365 
Bottom (-) strand, 60nt, excise kan from cat, 
plus 10nt non-homologous 
5' AGT AGG TAC GGG CCT TTA TTC ACA TTC TTG 
CCC GCC TGA TGA ATG CTC ATC CGG AAT TAC 
GTA TGG CAA TTG CAT CAG TC 3' 
oligoAB368 
Bottom (-) strand, 60nt, excise kan from cat, 
plus 35nt non-homologous 
5' AGC TGA TAG CAT ATT GAC CTG ACC ATA AGT 
AAC TAG GCC TTT ATT CAC ATT CTT GCC CGC 
CTG ATG AAT GCT CAT CCG GAA TTA CGT ATG 
GCA ATG CGT AGA TCG ATC GAC GAA TTA GCA 
GCC TAC GAT C 3' 
oligoAB378 
Bottom (-) strand, 60nt, excise kan from cat, 
plus 10nt non-homologous,  phosphorothioate 
(*) 
5' AGT AGG TAC GGG CCT TTA TTC ACA TTC TTG 
CCC GCC TGA TGA ATG CTC ATC CGG AAT TAC 
GTA TGG CAA TTG CAT CA*G* T*C 3' 
oligoAB379 
Bottom (-) strand, 60nt, excise kan from cat, 
plus 10nt non-homologous,  phosphorothioate 
(*), 3' invT 
5' AGT AGG TAC GGG CCT TTA TTC ACA TTC TTG 
CCC GCC TGA TGA ATG CTC ATC CGG AAT TAC 





Table 3.S3.  Oligos used for strain construction. 
oligoAB13 gent R into p206 
5'  ACC CGG CAT TCG CTG CGC TTA TGG CAG 
AGC AGG GAA CGG CTT GAA CGA ATT GT  3' 
Replace cat with aacC1in 
pMMB206 to construct 
pMMBGent oligoAB31 gent F into p206 
5'  TCG GTG AAC GCT CTC CTG AGT AGG 
ACA AAT CCG CCG GAT GAA GGC ACG AAC 
CCA GTT G  3' 
        
oligoAB190 E coli endA P0 
5'  TTC GCT ACG TTG CTG GCT CGT TTT AAC 
ACG GAG TAA GTG TGT GTA GGC TGG AGC 
TGC TTC  3' 
  




oligoAB191 E coli endA P2 
5'  GTG GGG TAG GGG TTA ACA AAA AGA 
ATC CCG CTA GTG TAG GCA TAT GAA TAT 
CCT CCT TAG TTC CT  3' 
oligoAB193 E coli endA F ck 5'  CCG GAG CCA AAA CTC TCT TAC AC  3' 
oligoAB194 E coli endA R ck 5'  CTC ACA GGC AGC AAT TGC AAT C  3' 
     
oligoAB209 recA 500 bp 5‘ F 5'  CGA ATT AGC CTA TGA ATC GGC AC  3' 
Amplification of recA to construct  
pGEMrecA oligoAB210 recA 500 bp 3‘ R 5'  GAA GCT ACT ATT TGA TGA CCG CG  3' 
     
oligoAB213 recA P0 
5'  TGA ACG CCA ATT TGG CAA AGG GTC 
TGT AAT GCG TAT GGG TGT GTA GGC TGG 
AGC TGC TTC  3' 
Deletion of recA by 
recombineering to construct 
pGEMrecA::frt-cat-frt oligoAB214 recA P2 
5'  CTC GCG CCT GGT TAA CAG ACG CAA 
GGC GCT ATC GAA TGC TCA TAT GAA TAT 
CCT CCT TAG TTC CT  3' 
     
oligoAB315 recA-gent F 
5'  GAA CGC CAA TTT GGC AAA GGG TCT 
GTA ATG CGT ATG GGG ATG AAG GCA CGA 
ACC CAG TTG  3' 
Deletion of recA by 
recombineering to construct 
pGEMrecA::gent oligoAB316 recA-gent R 
5'  GCG CCT GGT TAA CAG ACG CAA GGC 
GCT ATC GAA TGC TCG GCT TGA ACG AAT 
TGT TAG GTG  3' 
     
oligoAB263 recF 500 bp 5‘ F 5' GAA TGG CTA TAT CGC GAT ATT CCT G 3' 
Amplification of recF to construct  
pGEMrecF oligoAB264 recF 500 bp 3‘ R 5' GAC AGG AAT ACC ACG ACC ATC ATC 3' 
     
oligoAB271 recF P0 
5' GAT AAT TAT CAA TAC ATT ATT ATG CCT 
ATG AAA ATA TGA TGT GTA GGC TGG AGC 
TGC TTC 3' 
Deletion of recA by 
recombineering to construct 
pGEMrecF::frt-cat-frt oligoAB272 recF P2 
5' TCC ATT AAT TTG TGT TCC ACG TGA AAC 
ATT CTA TAC ATA TGA ATA TCC TCC TTA 
GTT CCT 3' 
       
oligoAB211 mutS 500 bp 5‘ F 
5'  CTT CAA CCA GTA TTG AGA AAT GAC CC  
3' 
Amplification of mutS to construct 
pGEMmutS oligoAB212 mutS 500 bp 3‘ R 5'  GCA TAA GGT TGG CCA GGA TC  3' 
     
oligoAB215 mutS P0 
5'  TAT TGT TTT CAT AAA AAT CAA TAC CAC 
CAA CAT GCC TTA TGT GTA GGC TGG AGC 
TGC TTC  3' 
Deletion of mutS by 
recombineering to construct 
pGEMmutS::frt-cat-frt oligoAB216 mutS P2 
5'  GTA ATA ACT ACA TCA ATT GAT GCT CTC 
GGC ACA CTC CAG GCA TAT GAA TAT CCT 
CCT TAG TTC CT  3' 
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oligoAB267 recJ 500 bp 5‘ F 




Construction by overlap-extension 
PCR of recJ::frt-cat-frt 
  
  
oligoAB268 recJ 500 bp 3‘ R 5'  GCT TAT CAC AAC CTG CTT CAA CC  3' 
oligoAB277 recJ R 5‘fuseP0 
5'  GAA GCA GCT CCA GCC TAC ACA TTA 
ATC AGC ATG CGT CAG ACT TC  3' 
oligoAB278 recJ F P0fuse3‘ 
5'  GAA GTC TGA CGC ATG CTG ATT AAT GTG 
TAG GCT GGA GCT GCT TC  3' 
oligoAB279 recJ R 3‘fuseP2 
5'  ATC CTA TGA TTA GGC CAG GAT TTT AAA 
TCC ATA TGA ATA TCC TCC TTA GTT CCT  3' 
oligoAB280 recJ F P2fuse3‘ 
5'  AGG AAC TAA GGA GGA TAT TCA TAT 
GGA TTT AAA ATC CTG GCC TAA TCA TAG 
GAT  3' 
     
oligoAB265 xseA 500 bp 5‘ F 5'  GCG CCT CAG TAA GGT ATT GG  3' 
Amplification of xseA to construct 
pGEMxseA oligoAB266 xseA 500 bp 3‘ R 5'  GAA TGC GGA TCT CTT GGC TG  3' 
     
oligoAB273 xseA P0 
5'  ATT GCC AAT ACT GAC CGT GAG TCA GCT 
GAA TAG ACA AGT TGT GTA GGC TGG AGC 
TGC TTC  3' 
Deletion of xseA by 
recombineering to construct 
pGEMxseA::frt-kan-frt oligoAB274 xseA P2 
5'  ACC TCA CAA GCA AGA CTT CCT TTT GCT 
AAA CGG ACC ATA TGA ATA TCC TCC TTA 
GTT CCT  3' 
     
oligoAB64 fliA 500 bp 5‘ F 
5'  TGA TGA TTT GGA CTA TAT GAT TAT TGA 
TAC CGC  3' 
Amplification of fliA to construct 
pGEMfliA oligoAB65 fliA 500 bp 3‘ R 5'  CCC AAC ACC GCA CCT AAA ATT C  3' 
     
oligoAB149 fliA P0 
5'  CTA ATA ACT ACA ATC TGC TGT TAT TGT 
AAG GAG AGT ATC TGT GTA GGC TGG AGC 
TGC TTC  3' 
Deletion of fliA by 
recombineering to construct 
pGEMfliA::frt-cat-frt oligoAB150 fliA P2 
5'  CAA TCC TAT TAA AGT CAA AGT ATC CAT 
ACT TAT TTT CAT ATG AAT ATC CTC CTT 
AGT TCC  3' 
     
oligoAB241 kan into cat F 
5'  AGT TTT ATC CGG CCT TTA TTC ACA TTC 
TTG CCC GCC TGA TTA TGG ACA GCA AGC 
GAA CCG  3' 
Insertion of kan into cat to 
construct pGEMfliA::cat::kan oligoAB242 kan into cat R 
5'  CGT CTT TCA TTG CCA TAC GTA ATT CCG 
GAT GAG CAT TCT CAG AAG AAC TCG TCA 
AGA AGG  3' 
     
oligoAB310 fliA-cat::kan opp F 
5'  CAA CAA TCC TAT TAA AGT CAA AGT ATC 
CAT ACT TAT TTT TGT GTA GGC TGG AGC 
TGC TTC  3' 
Deletion of fliA by cat::kan to 
construct pGEMfliA::cat::kan 
opposite orientation oligoAB311 fliA-cat::kan opp R 
5'  ATA ACT ACA ATC TGC TGT TAT TGT AAG 
GAG AGT ATC CAT ATG AAT ATC CTC CTT 
AGT TCC  3' 
     
oligoAB234 cat F 5'  TGT GAC GGA AGA TCA CTT CG  3'   
oligoAB235 catR fuse rdxA 
5'  CTG CCC CAT GCT CAA ATT GCC CTG CCA 
CTC ATC GCA GTA C  3'   
  
Construction by overlap-extension 




oligoAB236 rdxA F fuse cat 
5'  GTA CTG CGA TGA GTG GCA GGG CAA 
TTT GAG CAT GGG GCA G  3' 
oligoAB237 rdxA R fuse rpsL 
5'  CGA AAT TTG ACC AGT CAA ACC GCG 
TCA CAA CCA AGT AAT CGC ATC AAC  3' 
oligoAB238 rpsL F fuse rdxA 
5'  GTT GAT GCG ATT ACT TGG TTG TGA CGC 
GGT TTG ACT GGT CAA ATT TCG  3' 
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oligoAB113 rpsL R 5'  TTA AGC CTT AGG ACG CTT CAC G  3' 
oligoAB239 fliAup R fuse all 
5'  TAT TTA TTC TGC GAA GTG ATC TTC CGT 
CAC AGA TAC TCT CCT TAC AAT AAC AGC 
AGA TTG  3' 
oligoAB240 fliAdown R fuse all 
5'  GGC GTG AAG CGT CCT AAG GCT TAA 
AAA ATA AGT ATG GAT ACT TTG ACT TTA 
ATA GGA TTG  3' 
          
oligoAB296 fliA insert start F 
5'  AAT AAC TAC AAT CTG CTG TTA TTG TAA 
GGA GAG TAT CGT GTG TGA CGG AAG ATC 
ACT TCG  3' 
Insertion at start of FliA to 
construct pGEMfliA::cat-rdxA-
rpsL start oligoAB297 fliA insert start R 
5'  GGG TTT GTT GAT TTA CTT TGC TGT ATG 
CAG CCA AAG CAT CTT AAG CCT TAG GAC 
GCT TCA  3' 
    
oligoAB281 radA 500 bp 5‘ F 5' TCA CCA ACC AGT GTT TGT GG 3' 
Amplification of radA to construct 
pGEMradA oligoAB282 radA 500 bp 3‘ R 5' CTC CTG CAA ACT TCC TTC AGG 3' 
    
oligoAB386 radA P0 
5' AAA TGT ACT AAA TAA AAT GCT TGA ATC 
AAG GCA AAA ATT TGT GTA GGC TGG AGC 
TGC TTC 3' 
Deletion of radA by 
recombineering to construct 
oligoAB387 radA P2 
5' CGT AAA CTT GAA ATC ACT GCA GCC AAC 
AAA GCC AAA CAT ATG AAT ATC CTC CTT 
AGT TCC 3' pGEMradA::frt-gent-frt 
    
oligoAB261 
polA(pol) 500 bp 5‘ 
F 5' GCA TCT CTT TAG CAG TTG AGG AAG 3' 
Amplification of 
polA(polymerase) to construct 
oligoAB262 
polA(pol) 500 bp 3‘ 
R 5' GTT CGC ACA TTA TAC TTC TCT CGT AG 3' pGEMpolA(polymerase domain) 
    
oligoAB270 polA(pol) P0 
5' TTA TTA TTA AAT CCA ATA AAT TAA ACG 
CTT TTA TGC GCT TGT GTA GGC TGG AGC 
TGC TTC 3' 
Deletion of polA by 
recombineering to construct 
oligoAB269 polA(pol) P2 
5' CTG TTC TCG CAG ACA TGG AAA TGC ACG 
GCG TTC TCC ATA TGA ATA TCC TCC TTA 
GTT CCT 3' 
pGEMpolA(polymerase 
domain)::gent 
    
oligoAB395 priA 500 bp 5‘ F 5' CGA GTG AAA TGG GAG AGC TAT TC 3' 
Amplification of priA to construct 
pGEMpriA oligoAB396 priA 500 bp 3‘ R 5' CGC TCC AAC CCC TAT CGA CAT G 3' 
    
oligoAB401 priA P0 
5' CCC GGC CAA TCA GCG AGT CAT GAA TGG 
CTT AGA AGT TAA TGT GTA GGC TGG AGC 
TGC TTC 3' 
Deletion of priA by 
recombineering to construct 
pGEMpriA::frt-gent-frt oligoAB402 priA P2 
5' TTG CAT CCT ATG CTG GTT AGC TTT TCG 
TGG TAA AGG CAT ATG AAT ATC CTC CTT 





CHAPTER FOUR  
Discussion 
 
Genetic engineering of L. pneumophila and beyond 
A central theme of my thesis is the development of genetic engineering tools for 
L. pneumophila, especially strategies for the generation of unmarked mutations.  
Specifically, I demonstrate that synthetic oligonucleotides can delete or incorporate 
sequences when electroporated (Chapter 3); the Flp recombinase can be harnessed for 
construction of unmarked deletions in L. pneumophila (Chapter 2); and improved 
counter-selection tools can be coupled with more traditional methods of over-lap 
extension PCR (Appendix B).  Some of these tools would need little or no modification 
for application to other species.  Like all methods, including traditional methods of 
restriction enzyme-based cloning and allelic exchange, each of these methods has 
particular advantages and caveats. 
Prior to incorporating a resistance cassette into the L. pneumophila chromosome, 
a recombinant allele must be constructed either in vitro or in vivo using recombineering 
in E. coli.  The only way to circumvent this step is to use in vivo transposon mutagenesis, 
which results not in any sequence deletion, but only insertion of the resistance cassette.  
The goal of allele construction is to include sufficient flanking homology to direct a 
cassette to undergo RecA-mediated recombination at the desired sequence.  Particular 
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regions can be targeted either by in vitro transposon mutagenesis, restriction enzyme-
based cloning (whether constructing a simple insertion or an insertion-deletion allele), 
over-lap extension PCR, or recombineering in E. coli.  Since L. pneumophila undergoes 
natural transformation with linear DNA, allelic exchange vectors are only needed to 
construct unmarked deletions by traditional methods.  Transposon mutagenesis, though 
well established, has the disadvantage that no native sequences are deleted, and thus risks 
polar effects or incomplete gene inactivation.  Restriction enzyme-based cloning can be 
used to delete native sequence, is well established, and only requires basic molecular 
biology training; however, it requires existence of convenient restriction sites or 
incorporation of new ones.  Therefore, reliance on restriction sites complicates design of 
precise deletions at the exact nucleotides desired, including construction of in-frame 
deletions.  Using over-lap extension PCR, alleles can be constructed at the precise 
nucleotides desired by primer design.  The technique is also theoretically the fastest 
method, since recombinant alleles can be constructed by two sequential PCR steps in a 
single day.  A significant drawback, however, is that many experimentalists have 
difficulty assembling the recombinant allele reproducibly:   What may theoretically be 
faster, often results in a troubleshooting delay.  In Chapter 2, I propose the use of 
recombineering in E. coli to construct recombinant alleles.  Although this method can 
take extra time, due to the in vivo construction in a recombineering-proficient E. coli 
strain (e.g. DY330), followed by purification in a standard cloning strain (e.g. DH5α), 
recombineering has distinct advantages.  Chiefly, it allows the investigator to design the 
allele to the precise nucleotides desired, and it is extremely efficient.  That is, hundreds or 
thousands of recombinant clones are often obtained, and, once the method has been 
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established in a laboratory, the desired allele is achieved on the first try in nearly every 
attempt. 
After construction of a recombinant allele, all of the methods we employ and have 
recently used in the laboratory involve natural transformation to introduce the resistance 
cassette into the chromosome of L. pneumophila at some point in the procedure.  
Exploiting natural competence is usually chosen out of convenience, but electroporation 
of constructs should also produce the same results.  In fact, electroporation and RecA-
dependent recombination may not require circular DNA, since L. pneumophila lacks 
RecBCD, which contribute to the degradation of linear DNA.  Other methods of 
transformation, appropriate for other species, could also supplant the use of natural 
transformation as used for Legionella.  Previous work on natural transformation studied 
optimal conditions (Sexton and Vogel, 2004, Stone and Kwaik, 1999).  I have improved 
existing protocols by utilizing broth grown cells instead of patches on solid medium to 
increase the proportion of replicating cells—a requirement for natural transformation.  
Since stationary phase cells also undergo higher frequencies of spontaneous mutation 
(Figs 2.S1, 3.2, data not shown), use of replicating cultures also reduces the number of 
undesired mutational events.  I also suggest that PCR products are preferred for natural 
transformation, because even though their transformation frequency is lower than that 
obtained with circular molecules, nearly all recombinant clones have the desired 
mutation.  Indeed, one of my engineering principals is that, even if a new method does 
not decrease the total number of days needed to construct a recombinant allele, the 
technology should increase efficiency.  In particular, I aim to decrease the amount of 
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clone screening required while also increasing the percentage of the time the desired 
allele is obtained on the first attempt. 
After allele construction, natural transformation, and colony purification, a mutant 
strain that has been isolated can be used to test hypotheses.  However, a residual 
resistance cassette at the engineered locus has several drawbacks.  Foremost for 
laboratory studies is the increased risk of polar effects on downstream genes.  
Additionally, in L. pneumophila and many other species, few resistance cassettes are 
available for construction, which limits the ability of the investigator to construct 
multiple deletion mutants or introduce plasmids.  Leaving cassettes in a strain also limits 
downstream applications, since such strains are unethical for use in attenuated live 
vaccines or environmental applications, such as oil spill clean-up.  Therefore, to 
circumvent problems caused by residual drug resistance markers, several strategies for 
removing the cassettes from the host strain have been developed.   
Traditionally, one of the most common methods to remove resistance cassettes 
has been to employ allelic exchange vectors with counter-selectable markers.  Vectors are 
constructed with a desired recombinant allele, and once introduced into the chromosome, 
a merodiploid is obtained using a selectable marker.  The strain is then grown under 
conditions for negative selection of the vector, typically sucrose- or streptomycin-
resistance, which then enriches for clones that have undergone a second recombination 
event.  At some frequency, either the native or recombinant allele remains in the 
chromosome, and the other allele is excised.  The frequency of marker loss can vary 
dependent on vector and species, and thus can occur with reasonable frequency or be 
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fairly inefficient; another complication is the high spontaneous mutation frequency in 
most counter-selectable alleles.  To circumvent the problems associated with spontaneous 
point mutations in the counter-selectable marker, I have constructed a suicide vector 
containing a double counter-selectable cassette (pR6Kγcat-rdxA-rpsL, Chapter 3) flanked 
by recommended priming sites and restriction sites.   
Since L. pneumophila is naturally transformable, the use of the cat-rdxA-rpsL 
cassette is not limited to traditional allelic exchange, however.  In Appendix B, for 
example, I constructed an in-frame mutation in lpg0273 by first cloning the region 
flanking the gene and replacing the gene with the cat-rdxA-rpsL cassette by 
recombineering.  I have constructed E. coli strains for the maintenance of the plasmid 
(HB101λpir endA::FRT) and the rescue of subclones containing the cassette (HB101 
endA::FRT) that allow for phenotypic verification of the counter-selectable markers.  
Once a double counter-selectable allele is constructed and introduced into L. 
pneumophila by natural transformation, a second recombinant allele made by over-lap 
extension PCR that contains a precise deletion is introduced to L. pneumophila; finally, 
desired in-frame mutant cells are selected on streptomycin- and metronidazol-containing 
plates.  Compared to previous methods, this strategy eliminates the need to construct the 
more problematic three fragment product by over-lap extension, and it reduces the 
occurrence of spontaneous mutants which make screening clones more cumbersome. 
To eliminate the need for allelic exchange vectors and over-lap extension PCR, 
phage-based recombination can be exploited to remove resistance cassettes using a 
synthetic oligo.  This strategy is efficient and allows precise deletions by oligo design; on 
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the other hand it is limited to species that support the method, requires expression of the 
phage genes, and still relies on a counter-selectable cassette.  While L. pneumophila does 
not have a phage recombinase system, the double counter-selectable cassette I designed 
may have applications in other species, where it could reduce the frequency of 
spontaneous mutants. 
To harness oligos to remove chromosomal cassettes conveniently, but to eliminate 
the need for the mutant strain to express a phage recombinase, for the first time I describe 
a strategy of constructing unmarked deletions that appears to depend on conserved 
replication and repair machinery, but is RecA-independent (Chapter 3).  Although this 
approach is in its infancy and is currently not very efficient, it perhaps has the greatest 
potential for genetic engineering.  Removal of a cassette does not require expression of 
any exogenous genes; instead, one merely orders a synthetic oligo of desired sequence 
and transfers it to the bacterial strain by electroporation.  Because oligo mutagenesis 
relies on conserved machinery, it could also be applied to organisms with fewer genetic 
tools.  The method‘s drawbacks are its low efficiency and reliance on counter-selection.  
Future work focusing on increasing efficiency and decreasing occurrence of large 
spontaneous deletions (Fig. 3.9) could make this a future method of choice.  The ultimate 
goal would be to apply this technology for the initial introduction of cassettes, thereby 
eliminating the need for RecA-dependent incorporation of cassettes into the chromosome. 
Motivated by the desire to circumvent the difficulties associated with allelic 
exchange vectors and counter-selectable cassettes, the last decade has seen a significant 
rise in the use of site-specific recombinases to excise cassettes.  By flanking cassettes 
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with short FRT recognition sequences, the Flp recombinase can excise the intervening 
sequence.  This results in a small ‗scar‘ sequence left by the FRT site and priming 
sequences.  Therefore, the method may not be ideal for certain applications, although it 
eliminates the resistance cassette and associated risks of polarity.  Another disadvantage 
is that Flp must be expressed in the desired host strain, usually followed by removal of 
the expression vector, which demands extra steps.  Significant advantages, however, are 
that Flp is highly active in a large number of species and, once expressed, nearly all FRT-
flanked cassettes are excised—limiting the amount of clone screening needed.  I apply 
this strategy to L. pneumophila in Chapter 2 and, when coupled with recombineering in 
E. coli or over-lap extension PCR for initial allele construction, is my current method of 
choice for the construction of unmarked deletions in L. pneumophila.  
 
Oligo-induced mutagenesis 
In Chapter 3, I described the ability of short oligonucleotides to alter the 
chromosome of L. pneumophila, which I applied for engineering, as discussed above, 
while also striving to understand its underlying mechanism.  During the course of my 
thesis, oligo-induced mutagenesis was also observed in four other species, but was 
assumed to occur by a mechanism similar to λ Red recombination (Swingle, et al., 
2010b).  I expanded knowledge of oligo mutagenesis by showing that it occurs in L. 
pneumophila and is a distinct process from previously described mechanisms.  A model 
for oligo-induced mutagenesis in L. pneumophila was also proposed (Fig. 3.10).  
Modifying the annealing/integration model for λ Red recombination (Fig. 1.1), I propose 
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that oligo mutagenesis does not require direct polymerase extension; rather replication re-
start occurs, and the oligo may not be physically incorporated, depending on the end 
repair processes that resolve the intermediates (Fig 3.10).  Several aspects of this model 
remain to be elucidated, however. 
One lingering question is how the D-loop is excised and the remaining gap is 
filled in using the oligo as a template.  The cell has many endonucleases that could be 
involved in processing of the D-loop intermediate, but perhaps the most likely is 
nucleotide excision repair (NER).  NER is universally present throughout the Bacterial 
Domain, as well as having analogous systems in both Archaea and Eukaryotes, and thus 
would be consistent with the observed conservation of oligo mutagenesis (Bryan and 
Swanson, 2011, Snyder and Champness, 2007a, Swingle, et al., 2010b).  A UvrA-B 
complex binds to undamaged DNA, where it migrates and can detect helix distortions 
from damaged DNA or unpaired bases.  Once a lesion is detected, UvrC associates with 
the complex and cleaves 8 nucleotides 5‘ of the damage and 4 nucleotides 3‘ of the 
damage (Zou and Van Houten, 1999).  This endonuclease activity could excise the D-
loop while leaving sufficient overlapping sequence for pairing of the oligo to both the 5‘ 
and 3‘ ends of the chromosomal strand.  DNA Pol I could then fill in the gap left by the 
excised D-loop using the oligo as a template (Fig 3.7; Snyder and Champness, 2007a).  
The fact that UvrC cleaves a strand further from the damage at the 5‘ end is consistent 
with the observation that nuclease protection of oligos at the 3‘ end yields a more 
substantial increase in mutation frequency compared with protection of the 5‘ end (Fig 
3.5 vs. Fig 3.6).  That is, there is less disposable DNA at the 3‘ end of an oligo, since it 
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needs to be maintained for sufficient base-pairing following NER.  The role of NER in 
oligo mutagenesis could easily be tested by construction of an isogenic uvrA mutation, 
since UvrA is absolutely required for NER.  Alternate repair processes, such as base 
excision repair, or other uncharacterized endonucleases could also play a role in excising 
D-loops; however, many of these pathways repair more specific lesions or are less well 
conserved between species and therefore are less likely to play a role in oligo 
mutagenesis than NER. 
Yet another aspect of future investigation could be to further understand the 
role(s) of DNA polymerase(s) in the continuation of nascent strand synthesis following 
replisome collision with the annealed oligo and the post-replication repair process.  The 
model dictates that the advancing replicative polymerase encounters the annealed oligo, 
hops/slips over the oligo, and re-starts downstream, as suggested by PriA dependence 
(Fig 3.7) and increase in mutation frequency with non-extendable oligos (Fig 3.5).  The 
low, but observable, frequency of large deletions enriched for by strong selective 
pressure, even in the absence of oligo (Fig 3.9D), suggests that annealed homologous 
DNA may increase the propensity of a deletion event, but is not absolutely required.  
These observations can all be accounted for by strand slippage by DNA Pol III, as has 
been suggested by RecA-independent tandem repeat deletions in E. coli (Bierne, et al., 
1997).  To substantiate the evidence that DNA Pol III slippage leads to the observed 
deletions both with and without oligo, an E. coli dnaE486 mutant could be tested in the 
oligo assay (Fig 3.4A), as it has been observed to decrease polymerase fidelity and 
increase RecA-independent homologous recombination deletion events (Bierne, et al., 
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1997).  Alternatively, or in conjugation with Pol III slippage, it is possible that the 
translesion polymerases could be involved in circumventing the annealed oligo or in its 
subsequent repair.  As there may be redundancy in translesion synthesis, if phenotypes 
are not revealed with single mutations, double or triple mutants in Pol IV and Pol V could 
be analyzed (compared to E. coli, L. pneumophila appears to have two copies of Pol V, 
Table 1.1). 
In addition to their important polymerase activity, the DNA polymerases could 
also have a role in repair or excision of the oligo following D-loop processing.  The 
observation that nuclease protection of oligos at the 5‘ end lead to a decrease in mutation 
frequency suggests processing of the 5‘ end is important.  The data suggest that the RecJ 
and/or XseA nuclease(s) contribute to excision of the annealed oligo, since when oligos 
were protected by phosphorothioate bonds and examined in the nuclease mutant, only a 
low mutation frequency was observed (Fig 3.6).  However, RecJ and XseA are unlikely 
to be the only nucleases involved in excision/repair since the mutation frequency was not 
abolished in the double mutant and since unprotected oligos facilitated the same mutation 
frequency in both wild-type and nuclease mutant cells (Fig 3.6).  A likely culprit, then, 
could be the 5‘ to 3‘ exonuclease activity of DNA Pol I, which is normally involved in 
excision of RNA primers during lagging strand synthesis.  Following slippage of DNA 
Pol III over the annealed oligo, the 5‘ to 3‘ exonuclease activity of DNA Pol I could act 
in conjunction with RecJ and/or XseA to digest the oligo, while the 3‘ to 5‘ polymerase 
activity fills in the gap.  Since the 5‘ to 3‘ exonuclease domain of Pol I is essential, it 
would have to be tested in E. coli using the appropriate temperature sensitive alleles.  In 
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the less likely scenario that oligos are excised from the 3‘ end despite potent nuclease-
resistant modifications, the 3‘ to 5‘ exonuclease activity of Pol I or DnaQ (the 3‘ to 5‘ 
proofreading activity of the Pol III holoenzyme) could facilitate oligo excision.  By 
examining both the polymerase and exonuclease activity of the DNA polymerases, in 
addition to testing a possible contribution of nucleotide excision repair, a more complete 
model of oligo-induced mutagenesis could be developed. 
 
Alternative models of oligo mutagenesis 
As I have outlined in Chapter 3 and above, I believe the annealing model of oligo 
mutagenesis is the most likely scenario that explains my results.  It is important, however, 
to consider alternatives.  I therefore explore a different model of oligo mutagenesis, 
modified from another precedent in the λ literature (Poteete, 2008) that suggests that the 
annealing/integration λ model may not hold as well for recombination that involves the 
deletion/insertion of large DNA sequences.  In particular, it is difficult to imagine how 
the hydrogen bonding of ~35 nt of homology flanking a ~1 kb cassette sufficiently 
stabilize a D-loop against the structural forces in the helix needed for recombination to 
occur.  Specifically, Poteete proposed that the Beta protein facilitates annealing of the 
donor DNA to the lagging strand during replication, but leaves the 3‘ end of the donor 
not fully annealed.  The advancing replisome from the leading strand could then switch 
templates, jumping from the chromosomal template to the free 3‘ end of the donor DNA, 
thus incorporating the oligo sequence into the nascent strand.  Although many of 
112 
 
mechanistic details are not resolved, this model need not invoke the steric limitations that 
the annealing/integration model entails. 
A modification of the template switch model for λ is consistent with the results 
presented in this thesis (Fig. 4.1).  DNA replication exposes the leading and lagging 
strands while the oligo is transformed.  The 5‘ end of the oligo anneals to the appropriate 
sequence on the lagging strand, while the 3‘ terminus remains free, avoiding the need to 
invoke complete formation of a sterically limited D-loop.  During replication from the 
leading strand, DNA polymerase then switches templates, re-starting on the 3‘ end of the 
oligo.  After replicating the sequence of the oligo, the replisome undergoes a second 
template switch to resume replication from chromosomal DNA.  Nucleases then digest 
the intervening sequences not replicated, and single-strand gaps are filled.  Data 
supporting physical annealing and strand bias are also consistent with this model (Figs 
3.1, 3.2, 3.4, 3.5; Swingle, et al., 2010b), due to availability of ssDNA on each strand and 
advancement of polymerases.  RecA-independent template switching may, but need not, 
require PriA for re-start, depending on the experimental system (Dutra and Lovett, 2006, 
Ozgenc, et al., 2005).  Consistent with our data, inactivation of single-stranded 
exonucleases increases the frequency of mutations from template switching (Dutra and 
Lovett, 2006).  Also consistent with our results is that single-stranded gap filling by DNA 
Pol I could contribute to this proposed mechanism.  An observation that possibly refutes 
the model is the lack of incorporation of non-homologous DNA (Fig. 3.8); a template 
switch process may be more promiscuous to replicating and incorporating non-
homologous DNA from the donor.   Our assay, however, demands rescue of 
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chloramphenicol resistance, and in-frame insertions of 1-10 amino acids encoded by our 
non-homologous oligos (Fig. 3.8) may inhibit the enzyme activity of chloramphenicol 
acetyltransferase (Cat).  Due to the contributions of PriA and results showing no 
incorporation of non-homologous DNA, our data fit the strand annealing model slightly 
better than the template switch model, but not conclusively so.  As such, future work may 
help distinguish the two. 
Distinguishing the single-stranded annealing (Fig. 3.10) and template switch (Fig 
4.1) models of oligo mutagenesis would be difficult, given that many of the same 
components are invoked for not only both mechanisms, but also other aspects of 
replication and repair.  Genetic tests of the contribution of different genes would also be 
limited in L. pneumophila, since many of the proposed processes are essential—although 
some could be tested in E. coli using temperature sensitive alleles, assuming the 
contribution is the same in the two organisms.  Template switching with DNA repeats has 
been shown to partially depend on the DnaK chaperone, possibly by remodeling the 
replisome (Goldfless, et al., 2006).  Mutations in dnaK would likely be pleotrophic, but 
may help differentiate the two models.  Another difference between the two models is the 
prediction of differing frequencies of incorporating non-homologous sequences.  The 
counter-selection system in Figure 3.9 could be used to test non-homologous 
incorporation, but data from such experiments would be very indirect and likely 
complicated by the background level of spontaneous resistance.  Future work, therefore, 
may require new experimental models in organisms with a greater number of tools 
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available or laborious in vitro assays using purified components. 
 
Concluding remarks 
Having examined applications of RecA-independent recombination to L. 
pneumophila and possible mechanisms of underlying oligo-induced mutagenesis, it is 
useful to re-consider the broader biological and evolutionary implications of my 
observations.  In the process of exploring oligo mutagenesis in L. pneumophila, I have 
observed some interesting differences in its replication, recombination, and repair 
machinery compared to model organisms.  Notably, genome sequence analysis predicts 
that L. pneumophila has a non-canonical SOS response system; lacks the replication re-
start proteins PriBC and DnaT; lacks the site-specific recombinases XerCD; and is 
missing the RecBCD helicase-nuclease.  I also provide in silico and experimental 
evidence that L. pneumophila has fewer single-stranded exonucleases and a less 
responsive methyl-directed mismatch repair system.  These observations provide 
important clues to the biology of the organism and illustrate the limitations of 
extrapolating data collected in model organisms to other species.   
My work is also the first to observe oligo mutagenesis in a naturally 
transformable organism.  L. pneumophila lives in both multi-species biofilms and within 
a broad array of Eukayrotic hosts—environments that might bring the organism in close 
contact with foreign DNA.  Significantly, the same Type IV pili organelle has been 
shown to be involved in both adhesion to its phagocytic hosts and natural transformation 
(Stone and Kwaik, 1999).  It is thought that the organism‘s lifecycle and ability to take up 
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DNA has led to the surprising number of Eukaryotic-like proteins present in the 
genome—approximately 3.5% of its predicted proteins (Gomez-Valero, et al., 2009).  
While Eukaryotic-like proteins are present in other intracellular bacteria, L. pneumophila 
appears to contain the widest variety of any known prokaryote (Gomez-Valero, et al., 
2009).  This diversity of proteins could be a result of the organism‘s ubiquity and the 
broad number of phagocytic hosts it can effectively parasitize (Fields, 1996).  Due to the 
divergent nature of Eukaryotic DNA compared to its own genome, however, RecA-
mediated recombination may be inefficient at incorporating these foreign sequences into 
its chromosome.  Furthermore, L. pneumophila does not appear to contain the machinery 
for non-homologous end joining. As such, there does not appear to be any major 
canonical recombination pathway that can adequately account for the observed diversity 
in the species.  It remains possible that a process akin to oligo mutagenesis, with its 
ability to undergo homologous recombination with short sequences, has therefore 
contributed to the diversity of L. pneumophila by facilitating horizontal gene transfer.  A 
significant avenue of future work would be to more thoroughly test whether exogenous 
foreign DNA, either in the laboratory or environmental setting, can be a substrate for 
natural transformation and subsequent incorporation into the genome by a mechanism 
similar to the annealing model for oligo mutagenesis I describe.   
Together with the microorganism‘s lower nucleolytic potential and less sensitive 
repair system, oligo-induced mutagenesis may equip L. pneumophila to incorporate 
divergent sequences into the genome, thereby increasing fitness of this intracellular 
pathogen to thrive in the environment and to infect a range of phagocytic hosts.  
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Although a possible role in the evolutionary history of Legionella is intriguing, since 
oligo mutagenesis appears to be conserved, it may play an even larger role in remodeling 
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Figure 4.1.  Template switch model of oligo-induced mutagenesis in L. pneumophila,  
an alternate model to that described in the text and in Figure 3.10.  Red line with black 
center represents an oligo with homology to a chromosomal sequence (red) and a foreign 
sequence (black).  Green Pac-Man characters indicate exonucleases or other unknown 






Inhibition of Host Vacuolar H
+
-ATPase Activity by a  
Legionella pneumophila Effector 
 
SUMMARY 
Legionella pneumophila is an intracellular pathogen responsible for Legionnaires' 
disease. This bacterium uses the Dot/Icm type IV secretion system to inject a large 
number of bacterial proteins into host cells to facilitate the biogenesis of a phagosome 
permissive for its intracellular growth. Like many highly adapted intravacuolar 
pathogens, L. pneumophila is able to maintain a neutral pH in the lumen of its 
phagosome, particularly in the early phase of infection. However, in all cases, the 
molecular mechanisms underlying this observation remain unknown. In this report, we 
describe the identification and characterization of a Legionella protein termed SidK that 
specifically targets host v-ATPase, the multi-subunit machinery primarily responsible for 
organelle acidification in eukaryotic cells. Our results indicate that after being injected 
into infected cells by the Dot/Icm secretion system, SidK interacts with VatA, a key 
component of the proton pump. Such binding leads to the inhibition of ATP hydrolysis 
and proton translocation. When delivered into macrophages, SidK inhibits vacuole 
acidification and impairs the ability of the cells to digest non-pathogenic E. coli. We also 
show that a domain located in the N-terminal portion of SidK is responsible for its 
119 
 
interactions with VatA. Furthermore, expression of sidK is highly induced when bacteria 
begin to enter a new growth cycle, correlating well with the potential temporal 
requirement of its activity during infection. Our results indicate that direct targeting of v-
ATPase by secreted proteins constitutes a virulence strategy for L. pneumophila, a 
vacuolar pathogen of macrophages and amoebae.   
This work has been published (Xu, et al., 2010), with my contributions including 
the measurement of vacuolar pH by live cell microscopy and intracellular degradation 




The delivery of newly formed phagosomes to the lysosomal system by the 
endocytic pathway is essential for the digestion of phagocytosed materials. To evade such 
destruction, successful intracellular bacterial pathogens have evolved various 
mechanisms, including inhibition of phagolysosomal fusion, resistance to lysosomal 
digestion or the escape to the host cell cytosol. For intravacuolar pathogens, active 
modification of lipid and protein composition of phagosomal membrane is critical for 
their survival and replication. Moreover, since lysosomal enzymes often are active only 
in an acidic environment, regulation of pH in the phagosomal lumen is one common 
strategy employed by pathogens to avoid lysosomal killing (Huynh and Grinstein, 2007, 
Ohkuma and Poole, 1978). 
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Legionella pneumophila is a facultative intracellular pathogen responsible for 
Legionnaires' disease. Upon being phagocytosed, this bacterium orchestrates various 
cellular processes to initiate a unique trafficking pathway that eventually leads to the 
formation of a phagosome permissive for its multiplication (Shin and Roy, 2008). The 
biogenesis and maintenance of the bacterial replicative vacuole is mediated by protein 
substrates of the Dot/Icm type IV secretion system (Isberg, et al., 2009, Liu, et al., 2008). 
For example, RalF activates and recruits the small GTPase Arf1 to the bacterial vacuole 
(Nagai, et al., 2002). Similarly, another small GTPase Rab1 is recruited to the bacterial 
vacuole by SidM/DrrA, which with LepB (Chen, et al., 2004), completely hijacks the 
activity of this important regulatory molecule in membrane trafficking (Machner and 
Isberg, 2006, Murata, et al., 2006). Whereas SidM/DrrA functions to release Rab1 from 
its GDI and activates the protein by loading it with GTP, LepB promotes the GTPase 
activity (Ingmundson, et al., 2007). These proteins, along with other effectors such as 
SidJ that is involved in the recruitment of endoplasmic reticulum (ER) proteins to the 
bacterial vacuole (Liu and Luo, 2007), are thought to be responsible for the 
transformation of the nascent phagosome into a vacuole derived from the ER that 
resembles an immature autophagosome (Amer and Swanson, 2005, Swanson and Isberg, 
1995, Tilney, et al., 2001). L. pneumophila also actively modulates cell death pathways 
of infected macrophages, presumably to ensure the well being of the host cell for a 
complete infection cycle. Inhibition of cell death is mediated through the activation of an 
NF-κB-dependent induction of antiapoptotic genes and by effectors such as SidF that 
directly antagonize proapoptotic BNIP3 and Bcl-rambo (Abu-Zant, et al., 2007, Banga, et 
al., 2007, Losick and Isberg, 2006), and SdhA, an effector of unknown mechanism of 
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action (Laguna, et al., 2006). Effectors that modulate other cellular processes, including 
protein synthesis, ubiquitination and lipid metabolism have also been identified, but how 
the bacterium benefits from the functions of these virulence factors is less clear (Belyi, et 
al., 2006, Kubori, et al., 2008, Shen, et al., 2009, Weber, et al., 2006). Finally, a recent 
study indicated that the effector AnkB contributes significantly to bacterial intracellular 
growth but does not affect any of the above host cellular processes, suggesting the 
targeting of yet unidentified host pathways by L. pneumophila (Al-Khodor, et al., 2008). 
The yeast Saccharomyces cerevisiae has been widely used to study bacterial 
effectors, largely due to its genetic manipulability and the conservation of many 
eukaryotic cellular processes (Siggers and Lesser, 2008). A large number of L. 
pneumophila effectors have been identified by their ability to kill yeast cells 
(Campodonico, et al., 2005, Shen, et al., 2009) or to interfere with its vesicle trafficking 
processes (Heidtman, et al., 2009, Shohdy, et al., 2005). In eukaryotic cells, the pH of 
intracellular compartments is an intricately regulated parameter that is crucial for many 
biological processes, including membrane trafficking, protein degradation and coupled 
transport of small molecules (Forgac, 2007). Organellar acidification primarily is 
mediated by ATP-dependent proton transporters known as the vacuolar H
+
-ATPases or v-
ATPases, which is a large multisubunit complex with an approximate molecular mass of 
10
3
 kDa (Forgac, 2007). The structure of v-ATPases can be divided into two major 
functional domains: a 570-kDa peripheral subcomplex, known as V1, that binds and 
hydrolyzes ATP, and an integral membrane subcomplex, termed V0, that serves as the 
pore through which protons traverse the membrane bilayer (Forgac, 2007). L. 
122 
 
pneumophila is able to maintain a neutral luminal pH during infection, particularly within 
the first 6 hrs after uptake (Horwitz, 1983, Sturgill-Koszycki and Swanson, 2000), a 
hallmark shared by many intravacuolar pathogens. One such example is Mycobacterium 
avium whose vacuoles fail to acidify below pH 6.3, probably by selectively inhibiting 
fusion with v-ATPase-containing vesicles or by rapidly removing the complex from its 
phagosomes (Sturgill-Koszycki, et al., 1994). Interestingly, a recent organelle proteomic 
study reveals that, in the soil amoebae host Dictyostelium discoideum, v-ATPase is 
associated with the Legionella containing vacuole (LCV) even in early phase of infection 
(Urwyler, et al., 2009). This finding is contradictory to the well-established notion that in 
macrophages the bacterial phagosome maintains a neutral luminal pH for several hours, 
suggesting that the pathogen may initially antagonize the activity of the proton 
transporter. 
Proton transporters from different orders of eukaryotes are highly conserved in 
structure and function, and some genes of mammalian or plant v-ATPase components can 
complement the corresponding yeast mutants (Kim, et al., 1999, Lu, et al., 1998). 
However, whereas in mammals mutations eliminating subunits of v-ATPase generate 
various phenotypes, ranging from the absence of any severe phenotype to lethality to 
embryonic development (Finberg, et al., 2005, Inoue, et al., 1999), yeast v-ATPase 
mutants are viable but only in acidic medium (Nelson and Nelson, 1990). In this study, 
we have taken the advantage of this conditional phenotype of yeast vma mutants to 
identify L. pneumophila proteins that may target the host v-ATPases. Here we report one 






Bacterial strains and growth conditions.   
Bacterial strains used in this study are listed in Table A.S2. Strains of E. coli were 
grown in LB and the medium was supplemented with the appropriate antibiotics when 
necessary. The L. pneumophila strain Philadelphia-1 strain Lp02 (Berger and Isberg, 
1993) was the parent of all derivatives used in this study. L. pneumophila was grown and 
maintained on CYE medium as previously described (Conover, et al., 2003). When 
necessary antibiotics were included as described (Conover, et al., 2003). To construct the 
sidK in-frame deletion mutant ZL114, we constructed plasmid pZL886 by cloning two 
DNA fragments generated by primers PL192/PL193 and PL194/PL195 (Table A.S4) into 
SacI/SalI digested pSR47s (Berger and Isberg, 1993). The primers were designed so that 
after deletion, only the first and last 15 amino acids are left in the mutant. pZL886 was 
introduced into Lp02 and the deletion mutant was obtained by following the standard 
allelic exchange method (Merriam, et al., 1997). To complement the mutation, we 
inserted the coding region of sidK into pJB908 (Bardill, et al., 2005). In complementation 
experiments, the vector used for expressing the gene of interest was introduced into the 
wild type strain or mutants and the bacterial cultures grown to the post-exponential phase 
as determined by optical density of the cultures (OD600 = 3.3-3.8) as well as an increase 
of bacterial motility. 
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Plasmid construction.   
The plasmids used in this study are listed in Table A.S3 and the sequences of all 
primers are in Table A.S4. Plasmids harboring individual full-length L. pneumophila 
hypothetical genes were in Table A.S1. The open reading frame of sidK and its 
derivatives were cloned into pEGFPC1 (Clontech) for expression in mammalian cells. A 
number of vectors, including pGBKT7 (Clontech), p415ADH, p415TEF, p425TEF and 
p425GPD (Mumberg, et al., 1995) were used to express sidK in yeast either as an 
untagged form or as GFP fusions (see text for details). To express His6-SidK in L. 
pneumophila, we first amplified the multiple cloning site region of pQE30 (Qiagen) with 
primers QE5′EcoRV/QE3′XbaI and inserted it into Ecl136II/XbaI digested pJB908 
(Bardill, et al., 2005). to generate pZL507. The sidK gene was then inserted into pZL507 
as a BamHI/XhoI fragment to give pZL1333. cDNA clones coding for relevant subunits 
of the v-ATPase were amplified from a human kidney cDNA library (Clontech) or from 
clones purchased from the ATCC. For expression in mammalian cells, sidK or each of 
these genes was inserted into pEGFPC1 (Clontech) or pFlag-CMV (Sigma). The vatH 
gene (pEF-HA-NBP1) was a gift from Dr. M. Peterlin of University of California, San 
Francisco. The integrity of all genes was verified by sequencing analysis. 
 
Yeast manipulation and screening of L. pneumophila proteins that inhibits yeast 
growth in neutral pH medium.   
Yeast strains used were PJ69-4A (James, et al., 1996), BY4741 (Winzeler, et al., 
1999) and their derivatives (Table A.S2). Yeast was grown in YPD medium or in 
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appropriate amino acid dropout minimal media at 30°C. Using a standard protocol (Gietz, 
et al., 1995), we transformed plasmids carrying full-length hypothetical L. pneumophila 
genes (Shen, et al., 2009) into yeast strain PJ69-4A (James, et al., 1996) and grew the 
resulting strains over night in minimal medium of pH 5.5. After diluting at 1:40 into 
medium of pH 7.5 buffered with 50 mM MES and 50 mM MOP, the cultures were 
incubated with vigorous shaking for 24 hrs. Cultures that did not grow to high density 
were retained for further analysis. For quantitative study of growth, yeast subcultures of 
2×10
6
 cells/ml were made in appropriate Dropout medium and cell growth was monitored 
by measuring the OD600 at indicated time points. 
To prepare cell lysates for protein analysis, cells from 5 ml overnight cultures 
were first lysed with a cracking buffer (40 mM Tris-Cl [pH 6.8], 5% SDS, 0.1 mM 
EDTA, 8 M urea, bromothymol Blue 0.4 mg/ml) with glass beads. Samples were 
resolved by SDS-PAGE after adding Laemmli buffer. 
 
Cell culture and transfection.   
Mouse macrophages were prepared from bone marrow of female A/J mice of 6–
10 weeks of age following published protocols (Swanson and Isberg, 1995). U937 cells 
were cultured in RPMI medium supplemented with 10% fetal bovine/calf serum (FBS) 
and 5 mM glutamate, and if needed, the cells were differentiated into macrophages with 
50 ng/ml phorbol myristic acid (PMA) as described (Swanson and Isberg, 1995). 293T 
cells were cultured in Dulbecco's modified minimum Eagle's medium (DMEM) 
supplemented with 10% FBS. For transfection, we grew cells to about 80% confluence 
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and transfected them with Lipofectamine 2000 (Invitrogen) following manufacturer's 
instructions. For growth curve experiments, macrophages were plated into 24-well plates 
at 2×10
5
 cell per well. For immunoprecipitation and fractionation, about 2×10
7
 cells 
plated on standard petri dishes were used. Infection was performed at the indicated MOIs 
as required by the particular experiments. 
 
Protein expression and purification.   
To purify GST-SidK, we inserted the predicted sidK orf into pGEX-4T-1 
(Qiagen) to generate pZL797. E. coli strain XL1Blue containing pZL797 was grown in 1 
liter LB to OD600 of 0.7. After inducing with 0.2 mM IPTG for 6 hrs at 25°C, harvested 
cells were lysed by passing through a French press twice at 1,500 psi. Cleared 
supernatant was incubated with glutathione beads (Qiagen) for 2 hrs at 4°C and the beads 
were washed with 40X bed volume of PBS buffer containing 0.5% Triton X-100. GST-
SidK was eluted with PBS containing 10 mM reduced glutathione. When needed, GST 
tag was removed by Thrombin, a protease that was subsequently removed by 
benzamidine-Sepharose beads (GE). GST-VatA was purified with a similar procedure. 
To purify His6-SidK from L. pneumophila, we introduced pZL1333 into the non-
virulent strain Lp03 (Berger and Isberg, 1993). A 50 ml of saturated culture was diluted 
into 1 liter AYE broth, when the culture reached exponential growth phase (OD600 = 0.5), 
expression of the gene was induced with 0.2 mM IPTG for 16 hrs. Cleared cell lysates 
were incubated with Ni
2+
-Agrose beads for 2 hrs at 4°C and the beads were washed with 
40 times of the bed volume of TBS buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4) 
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containing 10 mM imidazole. The protein was eluted with 200 mM imidazole. After 
dialyzing against TBS to remove imidazole, the protein was further purified by gel 
filtration with an FPLC system using a Superdex 200 10/300 GL column (GE 
Healthcare). TBST buffer (50 mM Tris-Cl, 150 mM NaCl, 0.1% Triton-X100, pH 7.4) 
was used as eluent and the flow rate was set at 0.4 ml/min. The single peak corresponding 
to the protein was collected, dialyzed in the appropriate buffer for subsequent use. His6-
Hsp70 was similarly purified from E. coli. Protein concentrations were determined by the 
Bradford assay; the purity of all proteins was more than 95% as assessed by SDS-PAGE 
followed by Coomassie bright blue staining (Figs. A.S3 and A.S7). 
 
Affinity chromatograph from cell lysates and in vitro protein binding.   
The procedure for affinity pulldown was described elsewhere (Shen, et al., 2009). 
Briefly, U937 cells collected from 500 ml culture suspended in 3.0 ml PBS containing 5 
mM DTT and protease inhibitors (Roche) were lysed with a glass homogenizer 
(Wheaton). The lysates were subjected to centrifugation at 10,000×g for 10 min at 4°C to 
remove unbroken cells and nuclei, the post-nuclear supernatant was added to Affigel 
beads coated with SidK and incubated for 14 hrs at 4°C. We then washed the beads five 
times with PBS and dissolved bound proteins with SDS sample buffer. After SDS-PAGE, 
proteins were visualized by silver staining (Bio-Rad). Individual protein bands retained 
by beads coated by SidK but not by GST were excised, digested with trypsin, and 
analyzed by matrix-assisted laser desorption/ionization/mass spectrometry (MALDI/MS) 
(Taplin Biological Mass Spectrometry Facility, Harvard Medical School). 
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For GST pull down experiments, 10 µg purified GST or GST-VatA was mixed 
with 2 µg His6-SidK in PBS for 4 hrs at 4°C. After adding 40 µl of 50% pre-washed 
glutathione beads slurry, binding was allowed to proceed for 1 hr. The beads were then 
washed 5 times with PBS containing 500 mM NaCl. Retained proteins were detected by 
immunoblot after SDS-PAGE. 
 
Coimmunoprecipitation.   
Twenty-four hrs after transfection, cells were collected and lysed in a lysis buffer 
(0.2% of NP-40, 50 mM Tris-HCl pH = 7.5, 150 mM NaCl, 1 mM EDTA, 15% glycerol, 
and protease inhibitors (1 mM Na3VO4, 1 mM PMSF, 10 µg/ml Aprotinin, 2 µg/ml 
Leupeptin, 0.7 µg/ml Pepstatin)). After removing debris by centrifugation at 10,000 g for 
10 min at 4°C, 2 mg protein (approximately 1 ml) was used for immunoprecipitation by 
adding the appropriate antibody and 30 µl of 40% protein G-sepharose beads (GE 
Healthcare). After incubating at 4°C on a rotary shaker for 4 hrs, the beads were washed 
5 times with the lysis buffer before being dissolved in Laemmli buffer. 
For immunoprecipitation with yeast lysates, cells harvested from 50 ml mid-log 
phase cultures were digested with Zymolyase, and the resulting spheroplasts were lysed 
with the lysis buffer used for mammalian cells. The lysates containing approximately 2 
mg proteins were incubated with appropriate antibody and protein G sepharose for 16 hrs 
at 4°C. The beads were removed by washing 5 times with the lysis buffer. In both cases, 
protein associated with beads were dissolved in Laemmli buffer and resolved by SDS-
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PAGE. Proteins transferred to nitrocellulose membranes were detected by immunoblot. 
 
Antibodies and Western blot.   
Antisera against Legionella, ICDH (isocitrate dehydrogenase) were described in 
an early study (Liu, et al., 2008). SidK cleaved from GST-SidK were used as an antigen 
to produce a specific antibody following a standard protocol (Pocono Rabbit Farm and 
Laboratory, Canadensis, PA). GFP antibody was prepared similarly with purified His6-
GFP. When necessary, antibodies were affinity-purified against the antigens covalently 
coupled to an Affigel matrix (Bio-Rad) using standard protocols (Dumenil and Isberg, 
2001). Monoclonal or polyclonal antibodies against Flag, Vma1, Vma2, PGK (3-
phosphoglycerate kinase), VatA and Hsp70 were purchased from Sigma, Invitrogen, 
Abcam and Santa Cruz Biotechnology (sc-65521), respectively. 
For Western blots, samples resolved by SDS-PAGE were transferred onto 
nitrocellulose membranes. After blocking with 4% milk in PBS buffer containing 0.2% 
Tween 20, membranes were incubated with the appropriate primary antibody: anti-SidK, 
1:2,500; anti-VatA, 1:10,000; anti-Vma1, 1:1,000; anti-Vma2, 1:1,000; anti-GFP, 
1:50,000; anti-PGK, 1: 2000; anti-ICDH, 1:5,000; anti-Hsp70, 1:2000. Horseradish 
peroxidase conjugated secondary antibodies and enhanced bioluminescence reagents 
were used to detect the signals (Pierce, Rockford, IL). Alternatively, membranes were 
incubated with an appropriate IRDye infrared secondary antibody (Li-Cor's Biosciences, 
Lincoln, Nebraska, USA) and the signals were detected, and if necessary, the intensity of 
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the bands are quantitiated by using the Odyssey infrared imaging system. 
 
Preparation of yeast vacuolar membrane vesicles.   
Yeast vacuolar membrane vesicles were prepared according to the standard 
method (Uchida, et al., 1985) with some modification. Briefly, exponentially growing 
yeast cells (O.D. = 0.6) were harvested, washed twice with distilled water and digested 
with zymolyase at 30°C for 90 min in 1 M sorbitol. The spheroplasts were resuspended in 
7 volumes of Buffer A (10 mM MES/Tris (pH 6.9), 12% Ficoll 400, and 0.1 mM MgCl2), 
homogenized in a loosely fitting Dounce homogenizer (Wheaton) with 20 strokes, and 
centrifuged in a swinging bucket rotor at 4,500 g for 10 min. The supernatants were 
transferred to new centrifuge tubes, and buffer A was layered on the top. After 
centrifugation at 51,900×g for 40 min, the white layer on the top was collected and 
resuspended in Buffer A with a homogenizer, and Buffer B (10 mM MES/Tris (pH 6.9), 
8% Ficoll 400, and 0.5 mM MgCl2) was layered on the top. After similar centrifugation, 
vacuoles free from lipid granules or other membranous organelles were collected from 
the top of the tube. Vacuolar membrane vesicles were prepared by diluting the purified 
vacuoles in a vesicle buffer (10 mM MES/Tris (pH 6.9), 5 mM MgCl2, and 25 mM KC1). 
 
V-ATPase-mediated ATP hydrolysis assay.   
Equal amount of vacuolar membranes in ATPase buffer (10 mM HEPES, 5 mM 
MgCl2, 125 mM KCl, pH = 7.0) were preincubated for 40 min at room temperature with 
or without the testing chemicals or proteins. To test the effect of antibody, purified 
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antibody was added to the reactions for 20 min before the addition of ATP. BSA 
dissolved in the same buffer as that of SidK was used as a negative control. The reaction 
was initiated by adding 1 mM of ATP, and samples were withdrawn at indicated time 
points to measure the production of inorganic phosphate using the malachite green 
method (Yim, et al., 2003). Briefly, the malachite green reagent was made of 2 volumes 
of 0.0812% malachite green, 1 volume of 5.72% ammonium molybdate dissolved in 6 M 
HCl, 1 volume of 2.32% polyvinyl alcohol and 2 volumes of distilled water. 90 µl of the 
malachite green reagent was added to 10 µl samples withdrawn at indicated time points. 
The reactions were allowed to proceed for 2 min and were terminated with 1/10 volume 
of 34% sodium citrate. After incubation for another 20 min, absorbance at OD620 nm was 
measured. A standard curve simultaneously obtained with a series of phosphate solutions 
of known concentrations was used to determine the amount of phosphate released by the 
membranes. 
 
Proton translocation activity.   
The ATP-driven proton transport activity was assayed by measuring the uptake of 
proton in the yeast membrane vesicles using acridine orange (AO) quenching assay 
(Shiraishi, et al., 2000). Purified vacuolar membrane vesicles were diluted in AO buffer 
(5 mM HEPES, pH = 7.0, 5 mM MgCl2, 150 mM KCl, 6 µM AO), and preincubated for 
40 min at room temperature with or without the testing chemicals or proteins. The 
reaction was initiated by adding 2 mM of ATP and quickly mixed. The quenching of 
acridine orange was monitored by the Spex FluoroMax 3 spectrofluorometer (Jobin 
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Yvon) with excitation at 493 nm and emission at 525 nm. 
 
Measurement of vacuolar pH.   
The pH of L. pneumophila-containing phagosomes was determined by 
fluorescence ratio imaging using 5(6)-carboxyfluorescein-N-hydroxysuccinamide ester 
(FLUOS, Fluka) stained L. pneumophila as previously described (Sturgill-Koszycki and 
Swanson, 2000) with the modifications detailed below. For labeling, L. pneumophila 
were cultured to the post-exponential phase, defined by motility and OD600 = 3.6 - 4.6, 
washed once with 100 mM potassium phosphate buffer, pH 8.0, and then incubated for 
20 min at room temperature with 0.8 mg/ml FLUOS in 4% DMSO in 100 mM potassium 
phosphate, pH 8.0. This treatment did not affect viability of bacteria as determined by 
quantifying colony formation. 
We infected macrophages plated on 24 mm coverslips with an MOI of ~10. 
Infections were synchronized by washing infected cells 4 times with RPMI/FBS 60 
minutes after uptake. Following an additional 70–180 minutes of incubation, we washed 
the monolayers 3 times with 37°C Ringers Buffer (RB; 55 mM NaCl, 5 mM KCl, 2 mM 
CaCl2, 1 mM MgCl2, 2 mM NaH2PO4, 10 mM HEPES, and 10 mM glucose, pH 7.2), and 
placed the samples at a 37°C chamber with 1 ml RB and visualized on an Olympus IX70 
inverted microscope. Images were acquired from the attached CoolSNAP HQ2 14-bit 
CCD camera (Photometrics) and subsequently analyzed using Metamorph Premier v6.3 
software (Molecular Devices). 
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Fluorescence images were obtained at excitation wavelengths of 492 nm and 436 
nm and corrected for bias, shading, and background. Individual bacteria were masked by 
manual thresholding using an addition image of both wavelengths. The mask was then 
applied to each original corrected image, and the average fluorescence intensity over the 
masked area of each particle was determined at each wavelength. The pH of each L. 
pneumophila-containing phagosome was calculated from the ratio of the fluorescence 
intensity at an excitation wavelength of 492 nm to the intensity at excitation 436 nm. The 
fluorescence intensity ratios from two independent experiments were converted to pH 
using a single standard curve of quartic function. The standard curve was established 
using FLUOS-labeled bacteria immobilized on a coverslip coated with poly-(L)-lysine. 
Samples were processed as above, with greater than 130 bacteria analyzed per pH at 10 
incremental values ranging from pH 3.5 to 8.5 in clamping buffer (130 mM KCl, 1 mM 
MgCl2, 15 mM HEPES, 15 mM MES). 
Only intact rod-shaped bacteria were evaluated, with greater than 50 bacteria 
analyzed per coverslip in each of two independent experiments. To verify that sidK did 
not affect lysosomal degradation, the fraction of wild-type and sidK mutant bacteria that 
were degraded was quantified 1 h post-infection by fixed immunofluorescence 
microscopy as previously described (Dalebroux, et al., 2009) (Fig. A.S2). Heat killed 
(80°C 20 minutes) wild-type bacteria served as a control for particles that trafficked to an 




Protein loading, lysosomal digestion of bacteria and phagosomal pH evaluation.   
We delivered recombinant proteins into macrophages by the syringe loading 
method (McNeil, 2001) with some modifications: Briefly, cells were washed and 
collected in ice cold Dulbecco's PBS (DPBS) (Cellgro) by centrifugation (200 g 5 min). 
We then washed the cells twice with 37°C DPBS containing 1.2 mM CaCl2 before adding 
200 µl warm loading solutions (DPBS containing 1.2 mM CaCl2 and the protein to be 
loaded at 0.4 mg/ml) to cell pellet containing 5×10
6
 cells. A P-200 micropipettor (Rainin) 
set at 100 µl was used to pipett the cell suspension for 100 times at 37°C. After pipetting, 
the mixture was incubated at 37°C for 2 min. After washing twice with warm DPBS 
containing 1.2 mM CaCl2, cells were seeded onto glass coverslips in 24-well plates with a 
density of 4×10
5
 per well and were incubated at 37°C for 12–16 hrs. 
The bactericidal activity of macrophages loaded with different proteins was 
measured according to a published method (Sun-Wada, et al., 2009) with minor 
modifications. Cells of E. coli strain XL1-Blue expressing the mCherry RFP or GFP were 
added to macrophages at an MOI of 10 for 1 hr at 37°C. The culture supernatant was 
replaced with fresh tissue culture medium containing 100 µg/ml gentamicin to kill 
extracellular bacteria. After 1 hr of incubation, the medium was replaced with fresh 
medium containing 10 µg/ml gentamicin. At indicated time points, cells were washed 
extensively (5x) with warm PBS and lysed with 0.02% saponin. The lysates were plated 
on LB plates and colonies were counted after overnight incubation at 37°C. 
For the staining with fluorescein dextran, 10 kD fluorescent dextran (Invitrogen) 
was added to the cells to 0.2 mg/ml; the pH insensitive 10 kD Cascade Blue dextran 
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(Invitrogen) was added at 0.2 mg/ml as a loading control. After incubating at 37°C for1 
hr, the cells were washed 5 times and incubated at 37°C for an additional 4 hrs before 
being imaged. For the staining with LysoRed (LysoTracker Red DND-99, Invitrogen), 
cells of an E. coli strain expressing GFP were added to macrophage monolayer at an MOI 
of 20 for 1 hr at 37°C. After incubating with a medium containing 100 µg/ml gentamicin 
for 1 hr and then a medium containing 10 µg/ml gentamicin for an additional 8 hrs, a 
medium containing 50 nM LysoRed was added to the samples for 15 min. Cells were 
washed 3 times with fresh medium and subjected to imaging analysis immediately under 
an Olympus X-81 fluorescence microscope. All images were acquired with identical 
digital imaging parameters (objectives, exposure duration, contrast ratios, etc.) and were 
similarly processed using the IPlab software package (BD Biosciences). 
 
RESULTS 
Identification of SidK, a Legionella protein that affects growth of yeast cells in 
neutral pH medium.   
One of the prominent phenotypes associated with yeast v-ATPase mutants is their 
inability to grow in neutral pH medium (Nelson and Nelson, 1990). We reasoned that if 
L. pneumophila codes for proteins that inhibit v-ATPase activity, expression of such 
proteins in a yeast strain would impair its ability to grow in neutral pH medium. To this 
end, we cloned individual L. pneumophila hypothetical genes into pGBKT7 (Clontech) 
(Shen, et al., 2009). Yeast strains harboring each of the plasmids were tested for their 
ability to grow in medium with a pH of 7.5. Of the first 97 genes screened (Table A.S1), 
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one gene that consistently interferes with yeast growth under this condition was obtained 
(Fig. A.1A and B). This gene (lpg0968), designated SidK is predicted to code for a 
protein of approximately 65 kDa. It is present in the genomes of all sequenced strains of 
L. pneumophila but has no detectable homology to proteins in the database, nor does it 
contain predictable domains or motifs suggestive of known biochemical activities. 
Interestingly, this gene is divergently transcribed from lpg0969, a gene that appears to 
inhibit yeast growth by interfering with unknown host functions (Heidtman, et al., 2009). 
Since the original construct was made by fusing the testing gene to the DNA 
binding domain of the Gal4 protein on pGBKT7 (Clontech), we attempted to eliminate 
the potential effect of protein fusion by expressing untagged sidK in yeast strain BY4741 
(Winzeler, et al., 1999). To this end, we used a series of vectors that differ in copy 
number and promoter strength (Table A.S3; Mumberg, et al., 1995). The expression of 
sidK on these vectors is proportional to the strength of the promoter, with the GPD 
(glyceraldehyde-3-phosphate dehydrogenase) promoter giving the highest protein level 
(Fig. A.1C). Consistent with the protein levels, in 18 hrs after the establishment of 
subcultures of identical cell density, strains in which SidK was expressed from the GPD 
promoter almost completely lost the ability to grow in neutral pH medium (Fig. A.1D). 
On the other hand, only a marginal growth defect was observed when the gene was 
expressed from the moderate ADH promoter (Fig. A.1C and D, strain 1), indicating that 
the effect of SidK on yeast growth under this condition is dose-dependent. Taken 
together, these data indicate that we have identified a L. pneumophila gene that affects 
yeast growth in neutral pH medium, probably by interfering with its v-ATPase activity 
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directly or with activities relevant to the proton transporter. 
 
SidK is a substrate of the Dot/Icm system that is delivered into host cytosol during 
infection.   
To exert an effect on its cellular targets, a bacterial virulence factor must first 
reach the host cytosol via specialized secretion systems. We thus examined whether SidK 
is a substrate of the Dot/Icm secretion system. We first employed the Cya assay (Bardill, 
et al., 2005) by fusing SidK to the carboxyl end of the catalytic domain of the Bordetella 
pertusis cyclic AMP synthetase. Infection of macrophages with a L. pneumophila strain 
expressing Cya fused to the known effector SidJ led to production of high-level cAMP in 
a Dot/Icm-dependent manner (Fig. A.2A). Importantly, although the Cya-SidK fusion 
expressed similarly in the wild type and the dotA mutant, high levels of cAMP were only 
detected in infections using the wild type strain (Fig. A.2A), indicating that SidK contains 
signals recognizable by the Dot/Icm system. Similar results were obtained with the SidC 
staining assay (VanRheenen, et al., 2006), in which fusion to SidK restores the 
translocation of the transfer deficient SidCΔC100 mutant to wild type levels (Fig. A.2B–
D). These results indicate that SidK is a substrate of the Dot/Icm system. 
To determine whether SidK is injected into host cells by L. pneumophila during 
infection, we attempted to detect SidK in lysates of infected cells generated by saponin 
fractionation (VanRheenen, et al., 2006). Despite considerable effort, we were unable to 
detect this protein in the soluble fraction of lysates of cells infected by L. pneumophila 
for up to 3 hrs (data not shown). Considering the possibility that the amount of 
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translocated SidK is beyond detection by this method; we used a SidK specific antibody 
to enrich the protein. After immunoprecipitation, SidK protein was detected in lysates of 
cells infected with wild-type strain but not with the Dot/Icm deficient mutant or a sidK 
deletion mutant (Fig. A.2E, lanes 2–3). Expression of SidK from a plasmid in the sidK 
deletion mutant restored the delivery of this protein into infected cells (Fig. A.2E, lane 4). 
Collectively, these results indicate that SidK is a substrate of the Dot/Icm system and is 
injected into infected cells by L. pneumophila during infection. Furthermore, we cannot 
readily detect SidK in concentrated lysates of infected cells (data not shown), suggesting 
that the amount of translocated protein is low. 
Next, we examined the potential role of sidK in L. pneumophila infection by 
constructing an in-frame deletion mutant and tested its intracellular growth. The mutant 
did not exhibit detectable growth defect in either mouse bone marrow-derived 
macrophages or D. discoideum (Fig. A.S1). These observations extend the list of L. 
pneumophila effectors not essential for its intracellular growth in standard infection 
models, thus adding another layer to the remarkable potential functional redundancy 
among substrates of the Dot/Icm system (Isberg, et al., 2009). 
Since wild type L. pneumophila maintains a neutral pH in its vacuole and SidK 
appears to interfere with the functions of v-ATPase, we analyzed whether deletion of 
sidK affects luminal pH of LCVs in mouse macrophages. Relevant L. pneumophila 
strains labeled with 5(6)-carboxyfluorescein-N-hydroxysuccinamide ester (FLUOS, 
Fluka) were used to infect macrophages and images obtained from individual 
phagosomes were used to calculate intravacuolar pH against a standard curve as 
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described (Sturgill-Koszycki and Swanson, 2000). As expected, vacuoles containing 
heat-killed bacteria quickly acidified to pH values of about 4, whereas phagosomes 
harboring wild type L. pneumophila maintain a neutral pH at the time points examined 
(Fig. A.S2-A). Furthermore, although the dotA mutant was not lysed by the macrophages 
in the experimental duration (Fig. A.S2-B), its vacuoles were also acidified, indicating 
that the Dot/Icm system is required for the biogenesis of a bacterial phagosome of neutral 
pH. Interestingly, vacuoles containing the sidK deletion mutant still are able to block 
their acidification, thus maintaining a neutral luminal pH in the experimental duration 
(Fig. A.S2-A). Given the proficient intracellular growth displayed by the mutant (Fig. 
A.S1), this result was not unexpected. L. pneumophila mutants lacking a single effector 
gene rarely exhibit detectable intracellular growth defect, possibly due to functional 
redundancy among bacterial and/or host factors (Isberg, et al., 2009, Ninio and Roy, 
2007). 
 
Expression of sidK is repressed at stationary phase and is induced within one hour 
after transition into fresh medium.   
Consistent with the observation that L. pneumophila grown at post-exponential 
phase are more infectious, many substrates of the Dot/Icm system are highly induced 
when bacterial cultures enter this growth phase (Isberg, et al., 2009). That the luminal pH 
of LCVs is neutral in the early phase of infection points to the requirement of bacterial 
factors that target v-ATPase in this period of infection. We thus examined the protein 
level of SidK at different time points throughout the L. pneumophila growth cycle in 
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broth. In contrast to many substrates of the Dot/Icm transporter whose expression is 
induced at post-exponential phase, very little SidK was present in L. pneumophila grown 
at this stage (Fig. A.3). Rather, accumulation of SidK was apparent within 1 hr after 
diluting saturated cultures into fresh medium, and reached the peak 2 hrs after dilution 
(Fig. A.3B). When the bacterium begins to replicate (approximately 4–5 hrs after 
dilution), protein level of SidK begins to decrease and became difficult to detect 
throughout the rest of the growth cycle (Fig. A.3A–B), a pattern consistent with the slow 
progression of LCVs to lysosomal organelles (Sturgill-Koszycki and Swanson, 2000). 
We also determined the kinetics of SidK translocation during infection by saponin 
fractionation. Translocated SidK was not detectable until 3 hrs after infection and the 
protein is present in the soluble fraction of infected cells in the first 12 hrs of infection 
(Fig. A.3C). 
 
SidK interacts with the host vacuolar ATPase.   
Since mutations affecting various yeast genes not directly involved in v-ATPase 
function can result in mutants sensitive to neutral pH medium (Sambade, et al., 2005), we 
furthered our study on the mechanism of action of SidK by identifying its cellular targets 
with the unbiased affinity chromatograph method. We incubated Affigel beads (Bio-Rad) 
coated with purified SidK (Fig. A.S3) with PBS soluble fraction of U937 cell lysates. 
After removing unbound proteins by washing with PBS, proteins retained on the beads 
were separated by SDS-PAGE and were visualized by silver staining. At least three 
proteins with molecular weights ranging between 20 kDa and 75 kDa were retained by 
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beads coated with SidK, but not by uncoated beads (Fig. A.4A, lane 3). By mass 
spectrometry analysis, we identified these proteins as three components of the 
mammalian vacuolar H
+
-ATPase: VatA, the ubiquitous VatB2 subunit and VatE (Fig. 
A.4A, lane 3). These results indicate v-ATPase is the potential target of SidK. 
To further investigate the interactions between v-ATPase and SidK, we 
transfected mammalian cells with combinations of plasmids that direct the expression of 
GFP-SidK or Flag-VatA, one essential component of the proton transporter (Forgac, 
2007). Lysates of transfected cells were subjected to co-immunoprecipitation (co-IP) with 
an anti-Flag antibody to detect possible SidK/VatA complexes. GFP-SidK was detected 
in immunoprecipitates only from cells coexpressing Flag-VatA (Fig. A.4B). No signals 
were detected in untransfected samples or in samples transfected with plasmids 
expressing only Flag-VatA or GFP-SidK, indicating that the interactions were specific. 
Similar results were obtained in reciprocal experiments using the anti-GFP antibody (Fig. 
A.4C). Furthermore, VatA was detected in precipitates from cells that was transfected 
only with the plasmid expressing SidK, indicating that this protein interacts with 
endogenous VatA (Fig. A.4C, lane 3). 
The structure and function of v-ATPase from mammals and yeast are highly 
similar (Forgac, 2007). We thus examined whether SidK interacts with yeast v-ATPase. 
When lysates of yeast cells expressing GFP or GFP-SidK were immunoprecipitated with 
a GFP-specific antibody, Vma1 (equivalent of VatA) was detected in precipitates, again 
only in samples expressing SidK (Fig. A.4D, lane 1 in left panel). Similar results were 
obtained in reciprocal immumoprecipitation using a Vma1 specific antibody (data not 
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shown). Taken together, these data establish that v-ATPase is the cellular target of SidK. 
 
SidK directly interacts with the VatA (Vma1) subunit of the v-ATPase.  
 Under normal physiological condition, components of the V1 domain of v-
ATPases form a stable complex (Forgac, 2007). In agreement with this notion, in 
immunoprecipitation experiments aiming at detecting interactions between SidK and 
components of the V1 complex, positive interactions were observed in many if not all 
components (data not shown). Thus, we further investigated which subunit of the V1 
domain is directly targeted by SidK. Because some V1 components are recalcitrant to 
purification in their soluble form, we used yeast mutants that lack individual V1 
component genes (Winzeler, et al., 1999) to identify the subunit that directly interacts 
with SidK. We first examined the formation of protein complexes between SidK and two 
V1 subunits, Vma1 and Vma2 in these mutants. Vma1 and Vma2 can be 
coimmunoprecipitated by the SidK antibody in mutants lacking vma4, 5, 7, 8, 10 or 13, 
indicating that none of these subunits is required for the formation of protein complexes 
between SidK and Vma1 or Vma2 (Fig. A.5A). However, in the absence of Vma1, no 
interactions between SidK and Vma2 or any other V1 components were detected (Fig. 
A.5A, lane 7 and data not shown). Importantly, although at a low level, Vma1 was 
detected in precipitates obtained by the SidK antibody in the vma2 mutant (Fig. A.5A, 
lane 3). Furthermore, when beads coated with SidK were incubated with lysates of 
different vma mutants, Vma1 from the lysates of the vam2 mutant was retained (Fig. 
A.5B, lane 3). Under the same condition, SidK coated beads did not retain Vma2 or other 
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V1 components expressed in the vma1 mutant (Fig. A.5B, lane 2 and data not shown). 
Collectively, these results point to Vma1 as the direct target of SidK. To confirm this 
conclusion, we purified recombinant mammalian VatA as a GST tagged protein (GST-
VatA) and tested its interaction with SidK. As expected, formation of SidK/GST-VatA 
complexes can be captured by GST beads (Fig. A.5C). From these results, we conclude 
that SidK targets the v-ATPase by directly interacting with the VatA (Vma1) subunit. 
 
A N-terminal domain of SidK is important for binding to Vma1.  
We extended our analysis of the interactions between SidK and VatA by 
determining the region on SidK important for target binding. To this end, we constructed 
a series of SidK deletion mutants (Fig. A.6A). To eliminate the potential discrepancy that 
may arise from the loss of epitopes in these mutants when the polyclonal anti-SidK 
antibody is used in subsequent experiments, we expressed GFP fusions of these mutants 
in mammalian cells. Deletion of 30 amino acids from the N-terminus of SidK did not 
detectably affect its binding with VatA (Fig. A.6B, lane 2). However, although it was 
expressed at a high level, a mutant missing the first 94 amino acids no longer detectably 
bound VatA (Fig. A.6B, lane 3). On the other hand, the VatA binding activity of SidK is 
far more tolerant to deletions in its carboxyl end. A mutant lacking as many as 382 amino 
acids from this end of SidK still co-precipitated with VatA at a level similar to that of the 
full-length protein (Fig. A.6B, lane 8). Similar results were obtained in yeast, with the 
exception of sidKΔC382, which did not bind Vma1, probably due to the different binding 
affinity of SidK to v-ATPases from these two organisms (Fig. A.S4). Collectively, these 
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results indicate that a domain that lies within residue 30 to 191 of SidK is important for 
interacting with VatA. 
To determine whether any of the SidK deletion mutants are still active in 
inhibiting v-ATPase functions, we tested their ability to inhibit yeast growth in neutral 
pH medium. Our results indicate that under this condition, SidKΔN30 consistently 
inhibits yeast growth, whereas the binding inactive mutant SidKΔN94 exhibits very little 
effect (Fig. A.6C). Similarly, the binding of SidKΔC98 and SidKΔ286 to VatA is 
comparable to that of full-length protein and both mutants exhibit detectable inhibition in 
yeast growth (Fig. A.6C). Although these mutants can be stably expressed in yeast from 
the GPD promoter, their expression levels are considerably lower than that of full-length 
SidK (Fig. A.S5). Since high protein level is required for SidK to exert full inhibitory 
effect on yeast growth (Fig. A.1), the low activity exhibited by these mutants may result 
from the their low protein levels in yeast. 
 
SidK inhibits v-ATPase-mediated ATP hydrolysis and proton translocation. 
The V1 domain of v-ATPase provides the energy required for proton translocation 
across membranes by binding and hydrolyzing ATP via subunit Vma2 and Vma1, 
respectively (Stevens and Forgac, 1997). Our observation that SidK directly binds Vma1 
prompted us to examine the effect of such binding on ATP hydrolysis. Thus, we followed 
a standard procedure (Uchida, et al., 1985) to prepare yeast membrane and examined the 
effect of SidK on its ATPase activity. In this assay, exogenous ATP was added to 
purified yeast membranes and the release of free phosphate was measured by malachite 
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green (Yim, et al., 2003). In samples receiving 2 µM BSA, the level of free phosphate 
steadily increased throughout the experimental duration (Fig. A.7A, open triangles). On 
the other hand, the addition of 1 µM bafilomycin A1 (Baf A1), a commonly used 
inhibitor of v-ATPase (Huss and Wieczorek, 2009) led to strong inhibition of ATP 
hydrolysis, thus low level of free phosphate (Fig. A.7A, diamonds). Importantly, we 
found that recombinant SidK inhibited v-ATPase activity in a dose-dependent manner. 
Significant inhibition was observed by 0.1 µM SidK, and a higher amount of protein 
caused more severe inhibition (Fig. A.7A, closed triangles); 1 µM of SidK exerted 
inhibition at a level similar to that of Baf A1 (Fig. A.7A, squares). Next, we probed the 
mechanism of action of SidK by adding its antibody to the reactions. The antibody did 
not detectably affect SidK activity even when it was two-fold in excess (Fig. A.S6). 
To confirm that the observed inhibition of ATP hydrolysis was indeed a result of 
blocking v-ATPase activity, we did similar experiments with membranes prepared from 
the vma1 mutant. For the same amount of membranes, the overall ATP hydrolysis 
activity of the mutant markedly decreased (compare 3
rd
 bar of mutant and 1
st
 bar of WT 
in Fig. A.7B). Moreover, the ATP hydrolysis activity of membranes from the mutant is 
resistant to Baf A1 or SidK, but not to EDTA and vanadate, two general inhibitors for 




 bar). On the other hand, ATPase 
activity in membranes prepared from wild type yeast consistently exhibited sensitivity to 




 bar). We also tested 
the effect of SidK on the ATP hydrolysis activity of mammalian Hsp70, an ATPase 
structurally distant from the v-ATPase (Sousa and Lafer, 2006). EDTA but not SidK 
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abolished ATP hydrolysis by this heat shock protein; vanadate also exhibited inhibitory 
effect, but to a lesser extent (Fig. A.S7). Taken together, these results indicate that 
binding of SidK to Vma1 leads to specific inhibition of the ATP hydrolysis activity of the 
proton transporter. 
Because v-ATPase-mediated ATP hydrolysis is coupled with proton 
translocation, and thus the acidification of vesicles (Nishi and Forgac, 2002), inhibition 
of v-ATPase activity by SidK would block vesicle acidification. To test this hypothesis, 
we determined the effect of SidK on the sequestration of the lipophilic amine acridine 
orange (AO) by yeast vesicles. Nonprotonated AO permeates membranes, and, if the pH 
of the vesicles drops as a result of v-ATPase-mediated proton translocation, it becomes 
protonated and sequestered, leading to quenching of its fluorescence (Palmgren, 1991). In 
samples receiving the solvent DMSO that does not affect v-ATPase activity, more AO 
was trapped in the vesicles as proton translocation was initiated by adding ATP, leading 
to quenching of fluorescence at 525 nm (Fig. A.7C, diamonds). On the other hand, 
inclusion of 1 µM SidK to the reaction blocked such quenching during the entire 
experimental duration (Fig. A.7C, squares). The effect of SidK at this concentration is 
comparable to that of Baf A1, which almost completely blocked AO fluorescence 
quenching (Fig. A.7C, triangles). From these observations, we conclude that inhibition of 




SidK interferes with phagosome acidification and phagolysosomal digestion of 
bacteria.   
To determine whether SidK affects the functions of v-ATPase in vivo, we 
delivered His6-SidK into mouse bone marrow-derived macrophages by syringe loading 
(McNeil, 2001) and examined the acidification of phagosomes by using the dextran-
coupled pH sensitive fluorescein, whose fluorescence drops very sharply at pH values 
below 5.5 (Han and Burgess, 2009). The pH insensitive Cascade Blue dextran was 
included in the feeding mixture as a loading control. Macrophages in all samples emitted 
blue fluorescence signals at similar intensity, indicating that the dyes were equally loaded 
into the cells (Fig. A.8A, lower panel). Importantly, compared to macrophages receiving 
BSA, cells loaded with SidK gave significantly stronger green fluorescence signals (Fig. 
A.8A, upper panel, the first two images). Similarly, compared to cells loaded with BSA, 
cells treated with the v-ATPase inhibitor Baf A1 also emitted stronger fluorescence 
signals (Fig. A.8A, upper panel, the right image). These results indicate that SidK 
interferes with efficient acidification of phagosomes, thus inhibiting the decrease of their 
luminal pH values. To substantiate this observation, we used LysoRed, which 
accumulates in acidified organelles to stain protein-loaded macrophages that have been 
fed with E. coli cells expressing GFP for 10 hrs. Strong red fluorescence signals were 
readily detected in cells loaded with BSA, but not in cells receiving SidK (Fig. A.8B, left 
panel), further supporting the notion that SidK inhibits phagosomal acidification. No 
effect was detected in additional controls with two other Legionella effector proteins 
(data not shown). Moreover, at this time point, we observed that the number of E. coli 
cells in macrophages loaded with SidK was significantly higher than that of cells 
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containing BSA (Fig. A.8B, middle panel), suggesting that inhibition of phagosomal 
acidification by SidK impaired the lysosomal digestion of internalized bacteria. 
Since macrophages from mice lacking a functional a3 subunit exhibit delayed 
digestion of bacteria , we set to more thoroughly examine the effect of SidK on 
macrophage-mediated lysis of E. coli cells. We first determined the survival of E. coli in 
macrophages loaded with different proteins. Macrophages loaded with His6-SidK or BSA 
are capable of killing phagocytosed bacteria, but cells containing SidK were less efficient 
in the clearance of the bacteria, and such differences became significant 6 hrs after 
adding the bacteria (Fig. A.8C). Similar results were obtained when macrophages 
harboring one or more intact E. coli cells were scored. In cells receiving His6-SidK, more 
than 90% of the cells harbor intact bacterial cells throughout the 24 hrs experiment 
duration (Fig. A.8D). However, 8 hrs after adding the bacteria, less than 40% of the 
macrophages loaded with BSA contained intact bacterial cells and the ratio of such cell 
population dropped to less than 10% at the12-hr time point (Fig. A.8D and E). Taken 
together, these results indicate that SidK can inhibit v-ATPase activity in vivo and such 
inhibition leads to defects in phagosomal acidification and impairment in lysosomal 
digestion of bacteria by macrophages. 
 
DISCUSSION 
Many intracellular bacterial pathogens reside and replicate in phagosomes of 
unique physiological and biochemical properties. One such property is an actively 
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regulated pH homeostasis important for successful infection of these pathogens. Since the 
vacuolar ATPase is the primary cellular machinery involved in controlling vacuolar pH 
(Nishi and Forgac, 2002), it is believed that pathogens capable of maintaining a neutral 
phagosomal pH encode specific traits to inhibit the accumulation of the proton 
transporters on their vacuolar membranes. However, although the importance of 
maintaining proper phagosomal pH, presumably by actively regulating the activity of v-
ATPase, is generally recognized, almost nothing is known concerning the molecular 
mechanisms responsible for such regulation. Using a screening strategy based on the 
sensitivity of yeast v-ATPase mutants to neutral pH medium, we have identified SidK, a 
L. pneumophila protein that targets the proton transporter. 
A pathogen can employ at least two mechanisms to maintain a neutral luminal pH 
in its phagosomes: By preventing the accumulation of v-ATPases on the phagosomal 
membranes or by inhibiting the activity of acquired v-ATPases. Although we have not 
been able to consistently detect SidK on LCVs, probably because of low protein level 
and/or poor antibody quality (Fig. A.2 and data not shown), the presence of v-ATPases 
on LCVs (Urwyler, et al., 2009) strongly suggests that SidK targets the proton pumps on 
the bacterial phagosomes. This feature differs from vacuoles of Mycobacterium ovium 
that do not contain detectable v-ATPases (Sturgill-Koszycki, et al., 1994). However, 
these two mechanisms are not mutually exclusive, because in addition to blocking its 
acquisition, the pathogen may need to antagonize v-ATPases that accidentally associate 
with its phagosomes. It is worth noting that detecting the association of v-ATPase with 
specific organelles can be complicated by low abundance of this protein complex on the 
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membranes. For example, only a few v-ATPases were detected on a phagosome 
containing a latex bead (Kinchen and Ravichandran, 2008). Similarly, v-ATPases 
associated with LCVs can be detected by the sensitive mass spectrometry but not by 
standard immunostaining (data not shown; Urwyler, et al., 2009). Thus, direct targeting 
of v-ATPase by specific virulence factors could be a mechanism shared by many 
intravacuolar pathogens. 
Our data showed that SidK interacts with v-ATPases by directly binding to the 
VatA subunit (Fig. A.5). Moreover, this protein appears to have a higher affinity for 
VatA in the presence of VatB (Fig. A.5A). Such differences may result from the 
conformation assumed by VatA when it is associated with VatB (Forgac, 2007). 
Preferably binding to the VatA/VatB and/or the fully assembled v-ATPase complex 
clearly will result in higher inhibitory efficiency for SidK, as its effect can be diluted by 
free VatA if these two proteins interact similarly regardless of their statuses. Reversible 
assembly of the V1 and V0 domain is important in regulating v-ATPase activity under 
different physiological conditions (Forgac, 2007). Whether binding of SidK to v-ATPase 
causes disassembly of the transporter, block of its rotary movement or other functional 
mechanisms of the proton transporter remains to be determined. Our biochemical studies 
indicate that SidK blocks organelle acidification during infection. Two lines of evidence 
indicate that SidK inhibits v-ATPase in vivo. First, macrophages harboring physically 
delivered recombinant SidK failed to block emission of fluorescence signals by the pH 
sensitive fluorescein (Fig. A.8A). Second, cells loaded with SidK sequester significantly 
lower levels of LysoRed, a fluorescence dye that prefers to accumulate in acidic 
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environments (Fig. A.8B). Moreover, similar to macrophages from mice lacking a 
subunit of the v-ATPase (Sun-Wada, et al., 2009), cells loaded with SidK displayed a 
significant delay in the digestion of phagocytosed bacteria (Fig. A.8C–E). Thus, it is clear 
that by binding to VatA, SidK is able to block phagosomal acidification, thus 
contributing to the protection of internalized L. pneumophila during infection. 
Bacterial effectors often enzymatically modify their targets to divert the cellular 
processes in ways beneficial to the survival of the pathogens (Ninio and Roy, 2007). 
However, despite considerable effort, we were unable to detect novel post-translational 
modifications on VatA co-purified with SidK from yeast (data not shown). Moreover, our 
attempt to determine the mechanism of action of SidK by its antibody is not conclusive 
because the antibody is able to immunoprecipitate Vma1 or VatA, indicating that it can 
form a stable complex with these two proteins (Fig. A.5A and data not shown). Although 
SidK-mediated modifications of VatA or other v-ATPase subunits could substantiate its 
effect, two lines of evidence indicate the importance of physical binding in the activity of 
SidK. First, in contrast to other highly effective L. pneumophila effectors, such as those 
involved in inhibiting host protein synthesis or membrane trafficking (Isberg, et al., 
2009), a much higher level of SidK is required to significantly inhibit yeast growth in 
neutral pH medium, a condition that is completely unable to support growth of yeast vma 
mutants (Fig. A.1). For instance, if the effect of SidK was mediated by a highly catalytic 
mechanism, one would expect more severe inhibition when expressed from the ADH 
(alcohol dehydrogenase) promoter (Fig. A.1C). Similarly, a considerable amount of SidK 
is needed to inhibit v-ATPase activity in yeast membranes (Fig. A.7). Second, some 
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deletion mutants capable of binding VatA still are able to exert inhibitory effect on yeast 
growth in neutral pH medium (Fig. A.6C). Given the requirement of high-level SidK for 
full growth inhibition, the loss of inhibitory effect by deletion mutants still competent for 
binding VatA very likely is a result of lower protein levels (Fig. A.S5). Alternatively, 
SidK may need other L. pneumophila proteins to exert its full activity or our experimental 
conditions are not optimal for its activity. 
In A/J mouse macrophages, vacuoles containing L. pneumophila become acidified 
during the replication phase of infection. Delayed maturation of the LCV promotes 
intracellular growth, since Baf A1 treatment blocks acidification and acquisition of 
lysosomal markers and also reduces the bacterial yield (Sturgill-Koszycki and Swanson, 
2000). Consistent with the observation that expression of sidK peaks early in the lag 
phase before declining to almost undetectable levels as the bacteria enter the post-
exponential phase, translocated SidK did not become detectable until 3 hrs after bacterial 
uptake. That translocated SidK is still detectable 12 hrs after infection suggests a delayed 
inhibition of SidK expression during infection or that SidK expresses differently in 
intracellular bacteria. In D. discoideum, the association of v-ATPases with the LCV is 
detectable from 15 min to 14 hrs after bacterial uptake (Urwyler, et al., 2009). The 
presence of this transporter in the early phase of infection suggests that the undetected 
SidK and/or other effectors antagonize its activity. Given the important roles of v-
ATPase in vesicular trafficking, particularly in the endocytic pathway (Marshansky and 
Futai, 2008) that was recently shown to be involved in remodeling the membranes of the 
LCVs in D. discoideum (Urwyler, et al., 2009), prolonged biochemical modifications of 
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the v-ATPase may interfere with the ability of the bacteria within phagosomes to 
efficiently acquire nutrients and materials from certain membrane trafficking pathways. 
Thus, L. pneumophila appears to use a combination of strategies to modulate the 
activities of v-ATPase at different phases of infection for its benefit. 
L. pneumophila appears to acquire many of its genes important for its interactions 
with host by horizontal gene transfer, which may account for at least in part the high 
plasticity of its genomes (Cazalet, et al., 2004, de Felipe, et al., 2005). Although the 
distinct biochemical activities of these genes can interfere with host cellular processes, a 
single gene often plays only a small incremental role in its evolution to parasitize its 
hosts, which may explain the remarkable functional redundancy among effectors of the 
Dot/Icm system (Isberg, et al., 2009, Ninio and Roy, 2007). For example, at least four 
proteins are involved in inhibiting host protein synthesis by targeting the elongation 
factor eEF1A (Belyi, et al., 2008, Shen, et al., 2009). Consistent with this notion, with a 
few exceptions, deletion of one or more Dot/Icm substrate genes did not cause detectable 
defect in intracellular growth (Isberg, et al., 2009, Luo and Isberg, 2004, Ninio and Roy, 
2007). Thus, our observation that deletion of sidK did not impair intracellular growth of 
L. pneumophila or its phagosomal pH is not completely unexpected. It is very likely that 
multiple Dot/Icm substrates are involved in the modulation of v-ATPase activity. 
Identification and elucidation of activities of such proteins should pave the way toward 
further understanding of the mechanisms underlying organelle acidification and of the 








Figure A.1. Identification of L. pneumophila protein that inhibits yeast growth in 
neutral pH medium. Yeast strains grown to saturation were diluted in medium buffered 
to the indicated pH at a density of 2×10
6
 cells/ml and the subcultures were incubated at 
30°C with vigorous shaking. Cell growth was monitored by measuring OD600 18–24 hrs 
after establishing the subcultures. A. Growth of a yeast strain expressing SidK fused to 
the DNA binding domain on pGBKT7. B. Expression of the fusion protein. Yeast strains 
grown to mid-log phase were lysed with a cracking buffer; SDS-PAGE resolved samples 
were probed with a SidK specific antibody (upper panel). The 3-phosphoglycerate kinase 
(PGK) was probed as a loading control (lower panel). Relevant protein size markers (in 
kDa) are indicated. C. Expression of SidK from different promoters, samples were 
prepared and probed as described in B (upper panel), the PGK protein was probed as a 
loading control (lower panel). D. Dose-dependent inhibition of yeast growth in neutral 
pH medium by SidK. The growth of yeast strains expressing SidK from vectors differing 
in promoter strength (Materials and Methods) was examined as described in A. Lanes: 1, 
pADH-SidK(CEN/ARS); 2, pTEF(translation elongation factor 1α)-SidK(CEN/ARS); 3, 
pTEF-SidK(2 μ); 4, pGPD-SidK(2 μ); 5, pGPD. Data shown are one representative 




Figure A.2. SidK is translocated into infected cells by the Dot/Icm transporter.  A. 
SidK promoted the translocation of the pertusis toxin Cya into host cells. Differentiated 
U937 cells were infected with indicated L. pneumophila strains at an MOI of 5 for 1 hr. 
Cyclic AMP present in lysates of infected cells was measured by ELISA. Lower panel, 
expression of Cya fusions in L. pneumophila detected with a Cya specific antibody. B–D. 
Fusion to SidK restores the translocation of the transfer deficient SidΔC100. U937 
macrophages were infected with bacteria expressing SidC, SidCΔC100 or 
SidCΔC100::SidK for one hr; L. pneumophila and SidC was differently labeled by 
immunostaining. At least 150 vacuoles in triple samples were scored in each experiment. 
Representative images of vacuoles harboring sidCΔC100 (C) or sidCΔC100::sidK(D); 
bacteria were labeled in red and SidC was stained in green. E. Dot/Icm-dependent 
translocation of SidK into infected cells. U937 cells were infected with indicated L. 
pneumophila strains at an MOI of 5 for 3 hrs. Cleared supernatant obtained with 0.2% 
saponin was subjected to immunoprecipitation with a SidK specific antibody. Proteins 
associated with the precipitates were detected by the SidK antibody (upper panel). The 
Hsp70 in the cell lysates was probed as a loading control and the cytosolic protein ICDH 
was probed to assess the integrity of the bacterial cells. Note that SidK is present in 
pellets of all infections except for the deletion mutant (3
rd





); 3, Lp02ΔsidK; 4, Lp02ΔsidK/pSidK. *, bacterial 













Figure A.3. Expression of sidK is induced within hours at the initial phase of 
bacterial growth.  A. The growth cycle of L. pneumophila in AYE broth. Cultures 
grown at stationary phase was diluted 1:20 into fresh medium and the growth of bacteria 
was monitored by measuring OD600 at indicated time points. B. The expression of SidK at 
different bacterial growth phase. Lysates were prepared from equal amount of cells 
withdrawn at the indicated time points and were resolved by SDS-PAGE, the level of 
SidK was detected by immunoblot with a specific antibody. Lysates of the sidK deletion 
mutant grown for 2 hrs after dilution was used as a control. The metabolic protein 
isocitrate dehydrogenase (ICDH) was probed as a loading control. C. Kinetics of SidK 
translocation during infection. Lysates of U937 cells infected by the dotA mutant or wild 
type L. pneumophila for indicated time were immunoprecipitated with α-SidK and 
probed by immunoblott. Note the non-specific band about 100 kDa can serve as a loading 




Figure A.4. The vacuolar H
+
-ATPase is the cellular target of SidK.  A. Subunits of 
the v-ATPase V1 domain were retained by agarose beads coated with SidK. Affigel beads 
blocked with Tris-HCl buffer (lane 1) or coated with SidK (lane 3) were incubated with 
mammalian cell lysates. SidK coated beads incubated with lysis buffer (lane 2) served as 
a second control. After washing with lysis buffer, proteins separated by SDS-PAGE were 
visualized by silver staining; bands only retained by the SidK coated beads were 
identified by MALDI/mass spectrometry analysis. B. SidK and VatA form protein 
complexes in mammalian cells. Lysates of 293T cells transfected to express GFP-SidK 
or/and Flag-VatA were subjected to immunoprecipitation with an anti-Flag antibody, the 
presence of SidK in precipitated proteins was detected with GFP specific antibody. C. 
SidK forms protein complexes with endogenous VatA. Lysates of cells transfected with 
combinations of plasmids were precipitated with a SidK specific antibody, and proteins 
bound to beads were detected for VatA. Note that VatA also was precipitated in cells 
only transfected to express GFP-SidK (lane 3). D. SidK formed complexes with Vma1 of 
yeast v-ATPase. Lysates of yeast strains expressing GFP or GFP-SidK were 
coimmunoprecipitated with an anti-GFP antibody, and the presence of Vma1 in the 
precipitates was detected. In all cases, 5% (50 µg) of total protein was probed as input 
















Figure A.5. SidK directly interacts with VatA, the ATP hydrolyzing subunit of v-
ATPase.  A. SidK interacts with Vma1 in the absence of other V1 subunits. Lysates of 
individual vma mutant expressing SidK were coimmunoprecipitated with the anti-SidK 
antibody and the presence of Vma1 and Vma2 in the precipitates were detected with 
specific antibodies. Lanes: 1, Δvma4; 2, wild type; 3, Δvma2; 4, Δvma5; 5, Δvma7; 6, 
Δvma8; 7, Δvma1; 8, Δvma10; 9, Δvma13. The presence of SidK, Vma1 and Vma2 in the 
samples were probed with 5% proteins used for immunoprecipitation. B. SidK coated 
beads retained Vma1. Affigel beads coated with SidK were incubated with cell lysates of 
wild type Δvma1 or Δvma2 mutant. Proteins associated with the beads after extensive 
wash were probed for Vma1 and Vma2. 5% of lysates was used to probe for the presence 
of these proteins. Relevant protein size markers (in kDa) were indicated. C. SidK directly 
interacts with VatA. His6-SidK was incubated with GST-VatA or GST in PBS and 








Figure A.6. SidK binds to VatA via a N-terminal domain.  A. Diagrams of sidK 
truncation mutants. The numbers at the ends of the bars are the numbers of remaining 
amino acids for the mutants. +: binds VatA; -, no longer binds VatA. B. Interactions 
between VatA and the SidK deletion mutants. Lysates of 293T cells expressing each of 
the mutants fused to GFP were subjected to coimmunoprecipitation with an anti-GFP 
antibody and the presence of VatA in the precipitates were probed. The middle panel 
shows protein levels of the mutants probed with a GFP specific antibody after 
immunoprecipitation. Note that the several mutants that no longer interact with Vma1 
still code for stable proteins. Endogenous VatA also was probed as input controls (lower 
panel). C. Inhibition of yeast growth in neutral pH medium by SidK mutants. Indicated 
mutants (without any tag) were cloned into p425GPD and yeast growth was assayed as 







Figure A.7. SidK inhibits v-ATPase-mediated ATP hydrolysis and proton 
translocation.  A. SidK inhibits ATP hydrolysis in yeast vesicle membranes. BSA, Baf 
A1 or three different concentrations of His6-SidK was incubated with yeast vesicle 
membranes, ATP was added to initiate the reaction. The concentration of free phosphate 
in samples withdrawn at indicated time points was determined by the malachite green 
method (Materials and Methods). B. SidK specifically inhibits ATPase activity of v-
ATPase. Yeast vesicle membranes prepared from wild type or the vma1 mutant were 
used for similar assays. Note that SidK and the v-ATPase specific inhibitor Baf A1 block 
ATPase activity in membranes from the wild type but not the vma1 mutant. Lanes 
(mutant): 1, 1 µM SidK; 2, 1 µM Baf A1; 3, 1 µM BSA; 4, 10 mM EDTA; 5, 1 mM 
vanadate. Lanes (wild type): 1, 1 µM BSA; 2, 0.1 µM SidK; 3, 0.4 µM SidK; 4, 1 µM 
SidK; 5, 1 µM Baf A1. C. SidK prevents v-ATPase-mediated proton translocation. ATP 
was added to reactions containing vacuolar membrane vesicles, acridine orange and the 
indicated reagents that had been preincubated for 40 min at room temperature. The 




Figure A.8. Macrophages loaded with SidK are defective in phagosomal 
acidification and lysosomal digestion of bacteria.  A–B. Phagosomal acidification in 
macrophages assessed by pH sensitive fluorescein dextran and LysoRed staining. Mouse 
bone marrow-derived macrophages were loaded with His6-SidK or BSA by syringe 
loading. Treated cells were incubated with a mixture of fluorescein dextran and cascade 
blue dextran (0.2 mg/ml) for 1 h, washed 5 times and incubated at 37°C for 4 hrs before 
being imaged. As a control, Baf A1 (250 nM) was added 40 min before taking the images 
(A). E. coli cells expressing GFP were incubated with loaded macrophages at an MOI of 
20 for 1 hr at 37°C. After incubating with gentamicin for 8 hrs, cells were stained with 
LysoRed (50 nM) for 15 min. Images were acquired using a fluorescence microscope 
with identical parameters (B). Bar, 5 µm. C. SidK affects bacterial killing by 
macrophages. Loaded macrophages were fed with E. coli cells expressing mCherry RFP 
at an MOI of 10 for 1 hr at 37°C. Samples were treated with gentamicin for 1 h and were 
extensively washed. Viable E. coli cells were evaluated by plating macrophage lysates on 
bacteriological media at indicated time points. D. Digestion of bacteria by macrophages. 
Samples prepared similarly as C were used to evaluate the ratios of macrophages that 
contain intact E. coli cells. Cells harboring one or more bacterial cells were quantitated at 
indicated time points. Experiments were performed in triplicates and at least 200 cells 
were examined each sample. The P values of the relevant data points are indicated. 
Similar results were obtained in more than three independent experiments. E. 
Representative images of macrophages fed with fluorescent E. coli cells. Samples at 
indicated time points were processed and analyzed under a fluorescence microscope and 











Table A.S1.  L. pneumophila proteins tested for conferring yeast sensitivity to 
neutral pH.    
Number Lpg number Number Lpg number Number Lpg number 
1 lpg0008 34 lpg1496 67 lpg2424 
2 lpg0012 35 lpg1602 68 lpg2464 
3 lpg0086 36 lpg1666 69 lpg2523 
4 lpg0096 37 lpg1683 70 lpg2526 
5 lpg0149 38 lpg1684 71 lpg2527 
6 lpg0150 39 lpg1687 72 lpg2529 
7 lpg0196 40 lpg1705 73 lpg2568 
8 lpg0269 41 lpg1717 74 lpg2582 
9 lpg0284 42 lpg1751 75 lpg2603 
10 lpg0360 43 lpg1809 76 lpg2622 
11 lpg0634 44 lpg1949 77 lpg2627 
12 lpg0642 45 lpg1958 78 lpg2637 
13 lpg0696 46 lpg1963 79 lpg2719 
14 lpg0771 47 lpg1969 80 lpg2744 
15 lpg0774 48 lpg1979 81 lpg2745 
16 lpg0788 49 lpg1986 82 lpg2758 
17 lpg0944 50 Lpg2050 83 lpg2759 
18 lpg0968 51 lpg2148 84 lpg2804 
19 lpg0969 52 lpg2155 85 lpg2826 
20 lpg0974 53 lpg2160 86 lpg2844 
21 lpg1073 54 lpg2161 87 lpg2853 
22 lpg1109 55 lpg2166 88 lpg2856 
23 lpg1129 56 lpg2220 89 lpg2864 
24 lpg1145 57 lpg2223 90 lpg2877 
25 lpg1148 58 lpg2239 91 lpg2879 
26 lpg1183 59 lpg2242 92 lpg2912 
27 lpg1227 60 lpg2248 93 lpg2913 
28 lpg1228 61 lpg2313 94 lpg2939 
29 lpg1234 62 lpg2399 95 lpg2959 
30 lpg1265 63 lpg2400 96 lpg2976 
31 lpg1329 64 lpg2410 97 lpg3000 
32 lpg1354 65 lpg2422     




Table A.S2.  Bacterial and yeast strains used in this study. 
Strains Genotype, relevant markers Reference 
E. coli   
Stratagene XL1-Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F' proAB lacIqZM15 Tn10(Tetr)] 
DH5α(λpir) 
supE44 dlacU169(φ80lacZΔM15) hsdR17 recA1 
endA1 gyrA96 thi-1 relA1 pir tet::Mu recA Our collection 
   
L. pneumophila   
Lp02 Philadelphia-1 rpsL hsdR thyA (Berger and Isberg, 1993) 
ZL25 LP02∆sidC (Luo and Isberg, 2004) 
ZL25(pZL199) LP02∆sidC(pZLSidC) (VanRheenen, et al., 2006) 
ZL25(pZL204) LP02∆sidC(pSidC∆C100) (VanRheenen, et al., 2006) 
ZL370 LP02∆sidC(pZL204::K) This study 
ZL371 LP03(pZL204::K) (VanRheenen, et al., 2006) 
Lp03 Lp02(dotA-) (Berger and Isberg, 1993) 
Lp02(pJB908) Lp02(pJB908) (Liu and Luo, 2007) 
ZL14 Lp03(pJB908)    (Liu and Luo, 2007) 
ZL114 Lp02∆sidK This study 
ZL115 Lp02∆sidK (pJB908) This study 
ZL207 Lp02∆sidK (pJB908::K) This study 
ZL156 Lp02(pJB2581::K) This study 
ZL157 Lp03(pJB2581::K) This study 
ZL269 Lp03∆K , pZL507::K This study 
   
Yeast    
PJ69-4A 
MATa GALI-HIS3 GAL2-ADE8 GAL7-lacZ leu2 
ura3 his3 gal4 gal80 (James, et al., 1996) 
BY4741 MATa his3 1 leu2 0 met15 0 ura3 0 (Winzeler, et al., 1999) 
BY4741 vma1∆::KanMX (Winzeler, et al., 1999) 
BY4741 Vma2∆::KanMX (Winzeler, et al., 1999) 
BY4741 Vma4∆::KanMX (Winzeler, et al., 1999) 
BY4741 Vma5∆::KanMX (Winzeler, et al., 1999) 
BY4741 Vma7∆::KanMX (Winzeler, et al., 1999) 
BY4741 Vma8∆::KanMX (Winzeler, et al., 1999) 
BY4741 Vma10∆::KanMX (Winzeler, et al., 1999) 




Table A.S3.  Plasmids used in this study. 
Plasmid Relevant phenotypes Sources 
pQE30 Amp Qiagen 
pJB908 Amp, thy+ (Bardill, et al., 2005) 
pJB2581 Cm, Amp (Bardill, et al., 2005) 
pGEX-4T-1 Amp Qiagen 
pZL204 Amp, thy+  SidC∆C100 on pJB908 (Luo and Isberg, 2004) 
pZL507 For expression His6-tagged protein L. pneumophila This study 
pEGFPC-1 For expressing C-terminal GFP fusion proteins Clontech 
p415-ADH Amp, leu+, ADH promoter (Mumberg, et al., 1995) 
p415-TEF Amp, leu+, TEF promoter (Mumberg, et al., 1995) 
p425-GPD Amp, leu+, GPD promoter (Mumberg, et al., 1995) 
p425-TEF Amp, leu+, TEF promoter (Mumberg, et al., 1995) 
pGBKT7 Km, trp+ Clontech 
pZL796 pZL204::K, BamHI, XbaI This study 
pZL797 pGEX-4T-1::K, BamHI, XbaI This study 
pZL812 pGBKT7::K, EcoRI, BamHI This study 
pZL863 pEGFPc1::K, BglII, EcoRI This study 
pZL864 pCMVFlagM-VatA, BglII, SalI This study 
pZL866 pSR47s::SidK-knockout This study 
pZL1048 pQE-30::Hsp70, BamHI/SalI This study 
pZL1109 pCMVFlagM::VatC, BglII, SalI This study 
pZL1264 pEGFPc1::K-C1, BglII/BamHI, PstI This study 
pZL1265 pEGFPc1::K-C2, BglII/BamHI, PstI This study 
pZL1266 pEGFPc1::K-C3, BglII/BamHI, PstI This study 
pZL1272 pEGFPc1::K-N2, BglII/BamHI, EcoRI This study 
pZL1273 pEGFPc1::K-N1, BglII/BamHI, EcoRI This study 
pZL1281 pEGFPc1::K-C4, BglII/BamHI, EcoRI This study 
pZL1282 pEGFPc1::K-C5, BglII/BamHI, EcoRI This study 
pZL1283 pEGFPc1::K-N30, BglII/BamHI, EcoRI This study 
pZL1333 pZL507::K, BamHI, SalI/XhoI This study 
pZL1463 p415-ADH::K, BamHI, SalI/XhoI This study 
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PZL1508 p416-ADH::Flag-Vma5,  BamHI, SalI/XhoI This study 
pZL1517 p415-ADH::GFP-K, BamHI/BglII, SalI/XhoI This study 
pZL1518 p415-ADH::GFP-KN30, BamHI/BglII, SalI/XhoI This study 
pZL1519 p415-ADH::GFP-KC2, BamHI/BglII, PstI This study 
pZL1520 p415-ADH::GFP-KC3, BamHI/BglII, PstI This study 
pZL1521 p415-ADH::GFP-KC4, BamHI/BglII,PstI This study 
pZL1543 p415-ADH::GFP-KN1, BamHI/BglII, SalI/XhoI This study 
pZL1544 p415-ADH::GFP-KN2, BamHI/BglII, SalI/XhoI This study 
pZL1546 p415-ADH::GFP-KC5, BamHI/BglII, PstI This study 
pZL1572 p415-ADH::GFP, BamHI/BglII, SalI This study 
pZL1585 p415-TEF::K, BamHI, SalI/XhoI This study 
pZL1586 p425-GPD::K, BamHI, SalI/XhoI This study 
pZL1587 p425-TEF::K, BamHI, SalI/XhoI This study 
pZL1593 p425-GPD::KN1, BamHI, SalI/XhoI This study 
pZL1594 p425-GPD::KC1, BamHI, SalI/XhoI This study 
pZL1596 p425-GPD::KC3, BamHI, SalI/XhoI This study 
pZL1628 p425-GPD::KN30, BamHI, PstI This study 
pZL1645 p416-ADH::Flag-Vma4, BamHI, SalI/XhoI This study 




Table A.S4. Primers used in this study.  
  
Primer Sequence (Restriction enzyme sites are underlined) Note 
 
QE3 CTCTTCTAGAGTTCTTTACGATGCCATTGGG QE3'XbaI 
QE5 CTAGGATATCCGGAAATGTTGAATACTCATAC QE5'EcoRV 
PL130 CTGGGATCCTTGTCTTTTATCAAGGTAGG sidK5’BamHI 
PL131 CTGTCTAGATTAAAGGCTTAGGCTTTCTT sidK3’XbaI 
PL142 CTGGAATTCTTGTCTTTTATCAAGGTAG sidK5’EcoRI 
PL143 CGCGGATCCTTAAAGGCTTAGGCTTTC sidK3’BamHI 
PL177 CTAGAGATCTATGGATTTTTCCAAGCTACC VatA 5'BglII 
PL178 CCTGGTCGACCTTCTAATCTTCAAGGCTAC VatA 3'SalI 
PL192 CCTGGTCGACGCAAAGAACCGGGAAGAG sidK up SalI knock-out 
PL193 CTAGGATCCCCAGAACCTGTGTGGATC sidK up BamHI knock-out 
PL194 CTAGGATCCAGCCACCCATTTTTATACC sidK down BamHI knockout 
PL195 CTAGAGCTCGCTTTATCTCTGTTTCAGG sidK down SacI knock-out 
PL208 CTAGAGATCTAACTGAGTTCTGGCTTATAATCTG VatC1FBglII 
PL209 CCTGGTCGACTCACTTGAATTCCAGCAAGTTG VatC1RSalI 
PL312 CTGGGATCCGCCAAAGCCGCGGCGATCGG Hsp70 5’ BamHI 
PL313 CTGGTCGACCTAATCTACCTCCTCAATGG Hsp70 3’ SalI 
PL391 ACCGGATCCATGTCTTTTATCAAGGTAGG sidK 5’BamHI  
PL494 GCCCTGCAGTTAAAGGCTTAGGCTTTCTTCC sidK 3’ PstI 
PL495 AGGCTCGAGTTAAAGGCTTAGGCTTTCTTCCTG sidK 3’ XhoI 
PL526 GCCGGATCCATGAGATGCATGCAAACTATAGATC sidK-N30 5’ BamHI 
PL528 CCAGGATCCATGGTTTCATCAATTAGTCCC sidK-N100 5’ BamHI 
PL416 GCCGGATCCATGATAGATGAACAATATCACCTG sidK-N200 5' BamHI 
PL529 ACCGGATCCATGATCAGGGAAATTGAAGTG sidK-N300 5’ BamHI 
PL530 CGGCTGCAGTTACCCAAGAAGCTAATACAATTC sidK-C100 3’ PstI 
PL531 CAACTGCAGTTACTATGGAGTAATATCTTC sidK-C200 3’ PstI 
PL532 AGGCTGCAGTTAATCCAGGCCAAATTTACC sidK-C300 3’ PstI 
PL533 GTGCTGCAGTTATGAAACAAGCCGCAGCAATTC sidK-C400 3’ PstI 
PL534 GTCCTGCAGTTATGAAACAAGCCGCAGCAATTC sidK-C500 3’ PstI 
PL556 GGCGGATCCATGGACTACAAAGACGATGACGA  M2-Vma5 5'BamHI 
 CAAGGCTACTGCGTTATATACTGC  
PL564 GCACTCGAGTTATTCGTTAGCCATTGCGAGC sidK-C4 3'XhoI 
PL565 CGGCTCGAGTTAATCCAGGCCAAATTTACC sidK-C3 3'XhoI 
PL571 TCAAGATCTATGGTGAGCAAGGGCGAGGAG GFP 5’BglII 
PL572 GACGGATCCATGGACTACAAAGACGATGACGAC M2-Vma4 5'BamHI 
 AAGTCCTCCGCTATTACTGCTTTGAC  








Figure A.S1. Deletion of sidK did not affect intracellular growth of L. pneumophila. 
Indicated bacterial strains grown to post-exponential phase were used to infect mouse 
macrophages (A) or Dictyostelium discoideum (B). Infections were synchronized 1 h 
after uptake and the total bacterial counts at indicated time points were determined by 
lysing infected cells with 0.02% saponin and plating appropriately diluted lysates on 
CYE plates. Data shown are one representative experiment done in triplicates. Similar 







Figure A.S2. Vacuoles containing the sidK deletion mutant maintain a neutral luminal 
pH. Mouse macophages were infected with indicated L. pneumophila strains for 2 hours 
and vacuolar pH of the phagosomes was measured as described in Materials and Methods 
(A). The integrity of the internalized bacteria also was examined (B). More than 50 









Figure A.S3. Purification of SidK from L. pneumophila. A derivative of the avirulent 
strain Lp03 containing pZL1333 that direct the expression of His6-SidK was grown in 
AYE broth and the expression of the protein was induced with IPTG for 16 hours. His6-
SidK was first purified by a Ni
2+
 column followed by FPLC with an AKTA system. 
Fractions containing the protein were pooled and dialysed in TBS buffer. Image shown 
are different amount of His6-SidK resolved SDS-PAGE and stained by Coomassie bright 








Figure A.S4. Interactions between v-ATPase and SidK deletion mutants in yeast. The 
indicated SidK deletion mutants (A) were expressed in yeast as GFP fusions. Total cell 
lysates were subjected to co-immunoprecipitation with a GFP specific antibody and the 
presence of Vma1 and Vma2 in the precipitates were detected by immunoblot (B). The 
presence of Vma1 and Vma2 in the cell lyates was detected (C, upper panel) and the 








Figure A.S5. Expression of sidK mutants in yeast. Indicated mutants were cloned into 
p425GPD, a start codon (ATG) was added to N-terminal deletion mutant. Samples were 







Figure A.S6. The SidK specific antibody did not affect SidK activity. v-ATPase assays 
were performed as described in Fig. 7A. 0.4 µM of SidK was used in each reaction. 
Indicated amount of antibody specific for SidJ or SidK was added 20 min after the 
addition of SidK. Reactions were allowed to proceed for 60 min and the release of free 







Figure A.S7. SidK does not affect ATPase activity of Hsp70. Mammalian Hsp70 was 
purified from E. coli as a His6-tagged protein (A). 0.5 ug of purified protein was 
incubated with 2 mM ATP and the indicated compounds or proteins for various periods 
of time (X-axis). Hydrolysis of ATP was monitored by measuring released free 
phosphate with malachite green (B). Similar results were obtained in two experiments 
done in triplicates. Concentrations of testing materials: BSA, 1 µM; SidK, 1 µM; 






L. pneumophila major facilitator superfamily protein Lpg0273  
provides protection from toxic concentrations of nicotinic acid 
 
SUMMARY 
High concentrations of nicotinic acid inhibit growth and stimulate differentiation 
of Legionella pneumophila from the replicative to transmissive phase. In response to 
nicotinic acid, the bacteria induce expression of the gene lpg0273, which is predicted to 
encode a major facilitator superfamily protein. Indeed, Lpg0273 likely functions as an 
efflux pump to combat toxic accumulation of nicotinic acid or related metabolites, as 
judged by the response of the corresponding mutant bacteria to nicotinic acid.  
 
INTRODUCTION 
The ability of L. pneumophila to differentiate between replicative and 
transmissive forms is critical for its ability to efficiently infect its phagocytic hosts 
(Molofsky and Swanson, 2004).  Central to this transition is the LetA/S two-component 
system, which is predicted to sense environmental triggers and relay the message to 
subsequent regulatory components (Edwards, et al., 2010, Hammer, et al., 2002, Lynch, 
et al., 2003).  Nicotinic acid can trigger the analogous two-component systems that 
regulate virulence in Bordetella (Cotter and DiRita, 2000, Cummings, et al., 2006, 
McPheat, et al., 1983, Miller, et al., 1989, Schneider and Parker, 1982) and multi-drug 
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resistance in E. coli (Eguchi, et al., 2003, Masuda and Church, 2002, Masuda and 
Church, 2003, Nishino, et al., 2003, Nishino and Yamaguchi, 2001, Utsumi, et al., 1994).  
Since the concentrations of nicotinic acid needed to trigger these responses are generally 
considered to be non-physiologic, nicotinic acid may be a surrogate for some other 
environmental signal. 
Edwards (2008) recently demonstrated that nicotinic acid can also stimulate the 
differentiation of L. pneumophila from the replicative to transmissive phase in a LetA/S-
dependent manner.  For example, nicotinic acid induces the virulence-associated traits of 
macrophage cytotoxicity and lysosome evasion.  Microarray analysis of the L. 
pneumophila response to 5 mM nicotinic acid revealed a transcriptional profile unique 
from cells that had naturally transitioned to the post-exponential phase.  The two most 
highly induced genes, lpg0272 and lpg0273, are annotated as a cysteine transferase and a 
major facilitator superfamily (MFS) transporter, respectively (Fig. B.1).  Protein 
alignment of Lpg0273 (Altschul, et al., 1997) shows the most significant similarity to a 
putative MFS from the phylogenetically related Coxiella burnetii (ZP_02219825.1).  
Structural prediction (Kelley and Sternberg, 2009) yields significant homology to the 
solved structure of the MFS multi-drug transporter EmrD from E. coli (Yin, et al., 2006).  
To test more directly whether Lpg0273 or Lpg0272 might equip L. pneumophila to 
respond to nicotinic acid, isogenic mutants were constructed and their growth 





Bacterial strains and plasmids.   
L. pneumophila strain Lp02 and derivatives were cultured as previously described 
(Byrne and Swanson, 1998); E. coli DH5α, HB101 and derivatives were cultured using 
standard laboratory conditions.  Chloramphenicol (5 and 25 μg/ml), gentamycin (10 
μg/ml), ampicillin (100 μg/ml), streptomycin (0.5 and 1 mg/ml), and metronidazole (10 
µg/ml) were used for selection of L. pneumophila and E. coli, respectively.  A shuttle 
vector for IPTG-inducible expression of lpg0273 was constructed by standard methods 
using pMMBGent (pMB741).  An isogenic mutant of lpg0272 in strain Lp02 was 
generated by constructing recombinant alleles in E. coli after cloning into pGEM T easy 
(Promega, Madison, WI) and replacing the desired sequence with a resistance cassette by 
recombineering (Bryan, et al., 2011).  An in-frame unmarked deletion in lpg0273 was 
made by first replacing the first 1200 bp of the coding sequence with a cat-rdxA-rpsL 
cassette by recombineering and verifying the phenotype in HB101 λpir endA::frt 
(MB740)  (Bryan, et al., 2011, Bryan and Swanson, 2011). The recombinant 
selectable/double counter-selectable allele was then transferred to Lp02 by natural 
transformation (Sexton and Vogel, 2004), yielding lpg0273::cat-rdxA-rpsL (MB866).  To 
remove the cassette, an allele containing a precise 1200 bp deletion was constructed by 
overlap-extension PCR, transferred to MB866 by natural transformation, and the mutant 
strain selected  on metronidazole- and streptomycin-containing plates.  The resulting in-




Growth curves.   
Bacterial strains were cultured to mid-exponential phase in AYET. Cultures were 
back-diluted and their cell density normalized in triplicate using a dilution factor of 
0.00696.  A Bioscreen Growth Curve Analyzer, set at continuous shaking at medium 
amplitude, measured optical density at 600 nm every hour over a 48 hour time period. 
 
RESULTS 
To substantiate the transcriptional response of L. pneumophila to nicotinic acid 
and to more directly test whether the putative lpg0272-3 operon contributes to nicotinic 
acid metabolism, isogenic mutations in each gene were constructed and their growth 
phenotype in response to a range of concentrations of nicotinic acid analyzed.  The 
growth behavior of cells containing mutations in lpg0272 did not appreciably differ from 
wild-type cells (data not shown).  However, a mutant with an in-frame deletion of 
lpg0273 was consistently more sensitive to nicotinic acid than wild-type cells, as assessed 
by OD600 (Fig. B.2).  The growth defect showed a consistent dose-response relationship 
and was complemented by providing lpg0273 in trans (Fig. B.2).  Furthermore, both 
mutant and wild-type L. pneumophila induced to express lpg0273 displayed a slight 






Gene annotation and protein prediction suggest Lpg0273 belongs to the major 
facilitator superfamily of proteins (Altschul, et al., 1997, Chien, et al., 2004, Kelley and 
Sternberg, 2009, Wass, et al., 2010).  Moreover, it is structurally similar to the multi-drug 
efflux pump EmrD (Kelley and Sternberg, 2009, Yin, et al., 2006).  Previous data from 
our lab revealed that lpg0273 is up-regulated when replicating L. pneumophila  are 
exposed to nicotinic acid (Edwards, 2008).  Here, I show that plasmid-born lpg0273 
confers a growth advantage to cells when exposed to nicotinic acid (Fig. B.2).  The 
heightened, but not complete, sensitivity of the lpg0273 mutant to nicotinic acid is 
consistent with its function as a contributing, but not sole, transporter of nicotinic acid or 
related metabolites.  The mild growth advantage to cells over-expressing lpg0273 in the 
absence of nicotinic acid suggest that this putative transporter may contribute to other 






Table B.1. Bacterial strains and plasmids. 
Strain Genotype or plasmid Source 
E. coli and plasmids  
DH5α 
supE44 ∆lacU169 (80 lacZ∆M15) hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 Laboratory collection 
DY330 W3110 ∆lacU169 gal490 λcI857 ∆(cro-bioA) (Yu, et al., 2000) 
 pGEM-T easy Promega 
 pKD3 (FRT-cat-FRT allele) (Datsenko and Wanner, 2000) 
MB739 HB101 endA::frt (Bryan and Swanson, 2011) 
MB741 DH5α  pMMBGent (Bryan and Swanson, 2011) 
MB776 HB101 λpir endA::frt  pR6KcatrdxArpsL (Bryan and Swanson, 2011) 
MB870 DH5α  pGEMlpg0272-3 This work 
MB871 DH5α  pGEMlpg0272::FRT-cat-FRT This work 
MB872 HB101 endA::frt  pGEMlpg0273::cat-rdxA-rpsL This work 
MB873 DH5α  pMMBGent-lpg0273 This work 
  
L. pneumophila   
MB110 Lp02 wild type, thyA, hsdR, rpsL (StrR) (Berger and Isberg, 1993) 
MB864  Lp02 ∆lpg0272::FRT-cat-FRT This work 
MB865  Lp02 ∆lpg0272::FRT This work 
MB866  Lp02 lpg0273::cat-rdxA-rpsL This work 
MB867  Lp02 ∆lpg0273 This work 
MB860  Lp02 pMMBGent This work 
MB861  Lp02 pMMBGent-lpg0273 This work 
MB862  Lp02 ∆lpg0273  pMMBGent This work 
MB863  Lp02 ∆lpg0273 pMMBGent-lpg0273 This work 
 






























Figure B.1.  A) Chromosomal locus of lpg0272-3 and transcriptional response upon 
supplementing wild-type cells with 5 mM nicotinic acid.  Adapted from (Edwards, 2008).  
B).  Predicted structure of Lpg0273 and ligand binding site (blue) using 3DLigandSite 
prediction software (Wass, et al., 2010) showing predicted transmembrane helices typical 
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Figure B.2.  Broth growth curves reveal increased sensitivity to nicotinic acid for an 
lpg0273 mutant. Indicated strains were cultured  overnight in AYET, cell density 
normalized, and OD600 followed for 48 h in a Bioscreen Growth Curve Analyzer. All 
strains were grown in the presence of 200 μM IPTG. NA indicates 5mM (A) or 2.5mM 
(B) nicotinic acid. Data is representative of at least three independent experiments, and 
represents the mean ± SD of triplicate wells of a single experiment.  Kaoru Harada 
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